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Computed Tomography: A Comparative Study 
1006-176.4488 
Diagnostic Value of Two and Three-Dimensional 
Image Reconstruction Techniques for the 
Detection of Coronary Artery Stenoses by 
Contrast-Enhanced Electron-Beam CT 1033-28 
.416A 
Electron Beam CT-Determined Coronary Artery 
Calcium Is Correlated With Parameters of the 
Insulin Resistance Syndrome 1145-37 l 4638 
Frequency and Magnitude of Coronary Calcification 
in Patients With Early Plaque Formation After 
Heart Transplantation: Comparison Between 
Intracoronary Ultrasound and Electron Beam 
Computed Tomography 830-2*433A 
Impact of Age and Ethnicity on Coronary 
Calcification in the Women’s Health Initiative 
Observational Study 1145.34*462A 
National Guidelines May Not Accurately Reflect 
Atherosclerosis Risk in Women as Defined by 
Electron Beam Tomography 1145-35 l 462A 
Noninvasive Angiography With Multi-Detector 
Helical Computed Tomography for Evaluation 
of Coronary Artery Disease 1145-38 l 463A 
Noninvasive Coronary Angiography Using 
Contrast-Enhanced Magnetic Resonance 
Imaging and Electron Beam Computed 
Tomography: Comparison of the 
Contrast-to-Noise Ratio 1033-26.4158 
Noninvasive Quantification of Myocardial Perfusion 
Reserve With Electron Beam Computed 
Tomography in Comparison to Intracoronsry 
Blood Flow Reserve by Doppler Ultrasound 
904.I.4848 
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Prediction of Abnomal Coronary Flow Reserve 
With Electron Beam Computed Tomography for 
Coronary Calcification 904-4 *484A 
Prognostic Value of Coronary Calcification in a 
Chest Pain Population 1145-33 l 462A 
Progression of Coronary and Aortic Calcification in 
Middle-Aged Women as Measured by Electron 
Beam Tomography X30-4.433A 
Quantitative Evaluation of Intramyocardial 
Microvascular Function in 
Hypercholesterolemic Pigs Using Electron 
Beam Computed Tomography 1145-39 * 4638 
Eiectropharmacology 
Acute Effects of Dronedarone on Potassium Currents 
in isolated Rabbit Ventricular Myocytes: 
Comparison With Amiodarone 1030-99 l 98A 
Amiodarone Inhibits Cardiac ATP-Sensitive K+ 
Channels 1030-93 l 97A 
Electrophysiological Effects of Toborinone on 
Rabbit Heart Pacemaker and Purinie Cells 
1210.95 *157A 
H 345/52-A Novel Repolarization-Delaying 
Antiarrhythmic Agent With Greatly Reduced 
Proarrhythmic Potential 1030-94*97A 
The Antipsychotic Agents Thioridarine. 
Chlorpromazine, and Clozapine Block the 
Human-Ether-a-go-go Related Gene (HERG) 
Potassium Channel: Cellular Mechanism for 
Proarrhythmia 1030.97 l 98A 
Electrophysiology 
8-Br-cGMP Reverses Isoproterenol Induced 
Changes of Cardiac Single L-Type Calcium 
Channel Gating 121 O-97 l 158A 
A Constant Interval From the Stimulus Artifact to 
the Local Atrial Electrogram During Coronary 
Sinus Pacing: An Electrophysiologic Tool for 
Albation of Atrial Flutter 1074-67 l 109A 
A Randomized, Controlled Trial of Groin Shielding 
During Catheter Ablation and Cardiac 
Catheterization 1129-79 *54A 
A Single Anatomic Linear Lesion Prevents Induction 
of Uniform Ventricular Tachycardia in a Porcine 
Model of Healed Infarction 1187-98 = 150A 
Action Potential Remodeling in the Human Right 
Atrium With Chronic Lone Atria1 Fibrillation 
1164-68.139A 
Angiotensin II Antagonist Reduces 
Tachycardia-Induced Electrical Remodeling of 
the Atiiia 1030.100*98A 
Antiarrhythmic Drug Therapy in the Multicenter 
Unsustained Tachycardia Trial (MUSTT): 
Penetrating the Matrix 910.4.160A 
Antiarrhythmic Effects of a Novel Cardioprotective 
Drug, 3TV519, on Atria1 Fibrillation and Flutter 
in the Canine Sterile Pericarditis Model 
1030.98 *98A 
Assessing Myocardial Viability Using NOGA Left 
Ventricular Mapping System in a Chronic 
Ischemic Porcine Model: A Con-elation With 
Histology and Thallium Scintigraphy 1079-38 * 
430A 
Changes in P-Wave Dispersion and P-Wave Duration 
Following Open Heart Surgery Correlate With 
the Peak Incidence of Atria1 Fibrillation 
1164.73 * 140A 
Characterization of Pulmonary Vein Anatomy and 
Physiology in Patients With and Without Atria1 
Fibrillation 866-l *131A 
Clinical Significance of Focal Atrial Arrhythmias 
Following Cardioversion of Persistent Atria1 
Fibrillation 1209.72 *156A 
Development of Impressive Neovascularization in 
Chronic Radiofrequency Energy Lesions 
1186.73 l 149A 
Differential Effects of Anesthesia on 
Atrioventricuiar Nodal Fast and Slow Pathways 
1140.71. X34A 
Effects of Adrenergic Stimulation on Atria1 
Electrical Activity During Atria1 Fibrillation 
1164-70 * 140A 
Electroanatomical Left Ventricular Mapping 
(NOGA) for Prediction of Functional Recovery 
1095.142*185A 
Electrophysiological Mapping and Histological 
Examinations of the Swine Atrium With 
Sustained Atria1 Fibrillation: A Suitable Animal 
Model for Studying Human Atria1 Fibrillation 
866-6 l 132A 
Evolution of Ventricular Fibrillation in a Canine 
Model 11X7-95 l 150A 
Exercise Noise Seen by Pacemaker From Leads 
1075.96*112A 
Feasibility of Ablation of Focal Atria1 Fibrillation 
Guided by Noncontact Left Atrial Mapping 
802-5 l 123A 
Feasibility of Combined Noncontact and 
Electmanatomical Mapping for Guiding 
Ablation of Complex Arrhythmias 1 I 1X-72 l 
126A 
Inducibility of Ventricular Tachycardia After Dor 
Procedures 1128.133.383A 
Is It Necessary to Prove Bidirectional Block After 
Unidirectional Block at a Long Pacing Cycle 
Length? 1210-93 l 157A 
Localization of the Orifice of the Pulmonary Veins 
by Unipolar and Bipolar Impedance 
Measurements 1074-71 l 1lOA 
Manifestation of Antidromic Reciprocating 
Tachycardia in Subjects With Paraseptal 
Accessory Pathways 1209-68 l 155A 
New Electrophysiological Finding Favoring the 
Existence of a Distal Common Pathway in 
Atioventricular Nodal Reentrant Tachycardias 
1140-67 l 133A 
Organized and Reproducible Atria1 Activation Is 
Present Globally and Regionally During Phases 
of Human Atrial Fibrillation 1164-69 - 139A 
Origin of Junctional Tachycardia During 
Radiofrequency Ablation of Atrioventtical 
Nodal Reentrant Tachycardia in Humans 
1140-69 l 133A 
Overlapping Cycle Index: A Marker for the 
Prediction of the Outcome of Near Defibrillation 
Threshold Shocks 414.2*552A 
Potential for Intraahial Reentrant Tachycardia Prior 
to the Fontan Operation 1170-160*515A 
Pure Iridium Metal Microelectrode for 
Trammembrane Potential Recording in Isolated 
Swine Right Ventricle 1186-68 l 147A 
Reduced B-Adrenergic Responsiveness of Calcium 
Inward Cutrents in Human Atria1 Myocytes of 
Patients With Heart Failure 883-60 147A 
Right Atrial Postero-Septal Double Potentials as an 
Indicator of Left Atrial Origin of Ectopic 
Tachycardia 1118-68 l 125A 
Short-Term Electrophysiological Changes of the 
Atria After Internal Cardioversion: Cause of 
Immediate Reinitiation of Atrial Fibrillation? 
1164-67 l 139A 
Single Puncture, Repeated, and Multicenter 
Transseptal Electrophysiological Access to the 
LeftAtrium 111%73.1268 
Source of Trigger Ca2+ fpr CICR Is Swtched From 
Ca2+ Channels to Na+-Ca2+ Exchangers 
During Heart Failure Transition in Hypertrophic 
Rat Ventricular Myocytes 1186-69 l 148A 
Spectral Analysis of Atrioventricular Conduction 
Time Variability: A New Method for 
Quantitative Evaluation of the Effect of 
Autonomic Nervous Activity on the 
Atrioventricular Node 848-2 l 123A 
Spontaneous Atrial Fibrillation Is Initiated by 
Premature Beats From Different Atrial Regions 
and Involves Atria1 Regions Adjacent to the 
Trigger(s) at Initiation 1209-71 l 156A 
T-Wave Altemans During Ventricular Pacing 880-6 
l 145A 
The Antipsychotic Agents Thioridazine, 
Chlorpromazine, and Clozapine Block the 
Human-Ether-a-go-go Related Gene (HERG) 
Potassium Channel: Cellular Mechanism for 
Proarrhythmia 1030-97 l 9SA 
The Presence of a Left Atria1 “Isthmus”: 
Implications for Radiofrequency Ablation of 
Lateral Accessory Pathways 1210.94*157A 
The Value of Bundle Branch or Fascicle Block in 
Locating the Site of Septal Accessory Pathway 
1209.69 l 155A 
SUBJECT INDEX 645A 
Time Course of Atrial Electrical Remodeling After 
Conversion of Chronic Atrial Fibrillation: Is It 
Related With Recurrence? 866-5 l 132A 
Transcription Factors in the Pwkinje Fibers 
1186-67 l 147A 
Transmural Dispersion of Repolarizatlon Recorded 
During Acute Myocardial Ischemia in In Situ 
Canine Hearts 1187.940 149A 
Use of an Implantable Loop Recorder in Patients 
With Recurrent Syncope of Unknown Origin Is 
a Cost-Effective Diagnostic Strategy 1120-61* 
129A 
Emergency care 
A Critical Pathway for Chest Pain Patients Allow 
Acute Triaging Within 90 Minutes of 
Presentation to the Emergency Room 1127-136 
l 379A 
An Emergency Department Chest Pain Center 
Impacts the Disposition of All Patients With 
Acute Chest Pain: A Two-Year Registry 
1216.13.559A 
Comparison of a Biphasic Tnmcated Exponential 
Waveform to Two Standard Monophasic 
Waveforms for External Defibrillation 889-20 
400A 
Emergency Access to the Thoracic Central Venous 
Circulation Using Femoral Venipuncture During 
Cardiopulmonary Resuscitation 1174-128. 
399A 
Emergency Hospital Admission of Adults With 
Congenital Heti Disease: A Multicenter Study 
1103-164.5038 
Impact of an Emergency Department Cardiac 
Clinical Decision Unit on a Population of 
Patients With Episodic Chest Discomfort 
1127.138*380A 
Is Quantitative Bedside Determination of Troponin T 
Equal to Laboratory Testing? Results of a 
German Multicenter Study of Emergency 
Rooms 1082-107*362A 
Judicious Use of Radionuclide Myocardial Perfusion 
Imaging in an Emergency Department Chest 
Pain Center Optimizes the Triage of Patients 
With Chest Pain 884.4*474A 
Low-Risk Patients Undergoing Evaluation of Acute 
Chest Pain Do Not Benefit From Heart Rhythm 
Monitoring 1174-130 l 3998 
Secure and Accessible Electronic Medical Records: 
Setting Up Your Own Reliable, Low-Cost 
Web-Based System 1503-l l 554A 
Usefulness of a Rapid, Bedside Test for Brain 
Natriuretic Peptide in the Evaluation of Patients 
Presenting to the Emergency Room With 
Possible Congestive Heart Failure 1049-152. 
171A 
Endocarditis 
Clinical Course of Infective Endocarditis in the 
Years 1996-1998: Preliminary Results of the 
ALKK Endocarditis Registry 1205-65 l 537A 
Determinants of Acute and Long-Term Survival in 
245 Patients With Infective Endocarditis 
1205-63 l 536A 
Factors Associated With Increased Morbidity and 
Mortality in the Initial Assessment of Patients 
Presenting With Acute Infective Endocarditis 
1205-66.537A 
Is Echocardiography Cost-Effective in the Diagnosis 
and Treatment of Endocarditis? 1122.31*452A 
Long-Term Outcome of Surgical Versus Medical 
Treatment in Endocarditis Complicated by 
Perivalvular Abscess 83 l -4.529A 
Predictive Factors of Systematic Embolism in 
Left-Sided Infective Endocarditis 1205-640 
536A 
Prospective Evaluation of Clinical Criteria for the 
Diagnosis of Pacemaker Lead Infection 
1075-97 l 112A 
Endothelin 
Acute Hemodynamic and Neurohumoral Effects of 
Selective ETA Receptor Blockade in Patients 
With Congestive Heart Failure 909-5 l 241A 
Chronic Endothelin A Receptor Antagonism 
Improves Vasorelaxations to Natriuretic 
Peptides in Atherosclerosis 1178-53.3168 
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Endothelin-1 Increases Diastolic Distensibility of 
Human and Nonhuman Myocardium in 
Conditions of Cardiac Overload 865-3 l 204A 
Endothelin-1 Suppresses Nitric Oxide Induced 
Caspase-3 Activation and Antagonizes 
Apoptosis in Cardiomyocytes 104%1470 170A 
Endothelin-1, Nitric Oxide Metabolites, Left 
Ventricular Mass, and Hemodynamic Responses 
to Vasoconstrictive Stress in Normotensive 
Youth 1181.22*321A 
Functional Significance of G-33A Promoter 
Mutation of Thrombodulin Gene and Its 
Influence on Plasma Soluble Thrombomodulin 
Level in Patients With Coronary Artery Disease 
1066.44*259A 
Improved Hemodynatnics With the ETA Selective 
Receptor Antagonist BMS-193884 in Patients 
With Heart Failure 909.6.2418 
Increased Endothelin-1 Concentrations in Response 
to Pulmonary Hypertension in the Newborn 
Lamb 1113-50*285A 
Induction of Endothelin-1 Expression by Oxidative 
Stress in Vascular Smooth Muscle Cells 
1133-46 l 2948 
Is There a Release of Endothelin-I During Exercise 
Testing in Patients With Syndrome X? 
1061.129.3538 
Mechanical Unloading Versus Neurohumoral 
Stimulation on Myocardial Structure and 
Endocrine Function In Viva 803-3 l 2OOA 
Neurohumoral Response During Exercise in Healthy 
Controls and Patients With Chronic Heart 
Failure 1071.144.1758 
Noninvasive Assessment of Exercise-Induced 
Alterations of the Conduit Artery Tone in 
Healthy Controls and Patients With Chronic 
Heart Failure: Relationship to Endothelin-1 and 
Norepinephrine 1071.150*177A 
Obesity, a Cardiovascular Risk Factor, Is Associated 
With Tissue-Specific Activation of Renal 
Angiotensin Converting Enzyme Activity In 
Vivo: Evidence for a Regulatory Role of 
Engothelin 1133-45 l 294A 
Plasma Atrial Nattiuretic Peptide, Cyclic Guanosine 
Monophosphate, and Endothelin Response to 
Omapatrilat in Heart Failure 1137-1440206A 
Role of ET-l in Foam Cell Formation by Human 
Macrophages In Vitro 1178-58*317A 
Superiority of Mixed ET .4/B Over Specific ETA 
Antagonist in Treatment of Pulmonary 
Hypertension and Right Ventricular 
Hypertrophy in the Monocrotaline Rat Model 
894-4 l 3238 
Systemic and Pulmonary Hemodynamic Effects of 
Endotracheal Aitway Receptor Antagonism 
1025-19*249A 
The Contribution of Endothelin to Pulmonary 
Vascular Tone Under Normoxic and Hypoxic 
Conditions 868-3 l 290A 
Use of the Apical Sound Window Involves 
Tangential Cuts of the Left Ventricle: Proof of 
the Hypothesis Using Real-Time 
Three-Dimensional Imaging and Volumetry 
116%6*468A 
Endothelium 
Absehce of L-Arginine Effect on the Coronary 
Hypersensitivity to Serotonin in Cardiac 
Transplant Recipients 120X-120 l 238A 
Activated T-Cells Stimulate Endothelial Cells to 
Release Pro-Inflammatoty Cytokines in a 
Contact-Dependent Manner: A Clue About the 
Pathogenesis of Atherosclerosis? 1178.54 l 
316A 
Activation of Mitogen Activated Protein Kinases by 
Monocyte Chemoattractant Protein-l in Human 
Endothelial Cells 1s Suppressed by a 
Cerivastatin 1044-SO*2508 
Activation of Protein Kinase A Inhibits Endothelial 
Cell Apoptosis Induced by Stimulation of the B 
Subtype of the Thromboxane Receptor 1157.55 
l 307A 
Adhesion Molecules in Patients With Coronary 
Artery Disease Are Markers of the Extent of 
Disease 1089-42*271A 
Alterations of Release Pattern of Endotbelial 
Dependent Hemostatic Factors and Cell 
Adhesion Molecules in Nonvalvular Atrial 
Fibrillation 1051-720103A 
Angiotensin Converting Enzyme Inhibition 
Improves Endolhelial Dysfunction and 
Myocardial Ischemia 1023.44*246A 
Angiotensin II Induces the NADPH Oxidase Subunit 
p22phox in Endothelial Cells: Effect on Platelet 
Derived Growth Factor Dependent Production 
of Reactive Oxygen Species 1133.43 l 294A 
Antisense Directed at Endothelium Oxidized LDL 
Receptor LOX-l Inhibits Apoptosis in Human 
Coronary Artery Endothelial Cells 1134.50. 
2958 
Arterial Flow-Mediated Dilatation Is Linearly 
Proportional to Vascular Wall Shear Stress: 
Endotbelial Function Assessed by Phase 
Contrast Magnetic Resonance Angiography 
414-3 l 553A 
Assessment of Leg Arterial Vasodilatory Capacity in 
Elderly Heart Failure Patients and Normals 
Using Phase Contrast Magnetic Resonance 
imaging 847-3 l 192A 
Barorecepter Dysfunction Induced by Nitric Oxide 
Synthase Inhibition in Humans 868-l l 290A 
Blunted Reactive Hyperaemia Is Associated With 
Reduced Tissue Plasminogen Activator Release 
in Atheroscerotic Men 1201-44*327A 
Bone Marrow-Dedved Endothelial Progenitor Cells 
Do Not Significantly Contribute to Angiogenesis 
in a Tumor Model 1092.24 l 2788 
Bradykinin-Induced Tissue Plasminogen Activator 
Release Is Enhanced by Angiotensin Converting 
Enzyme Inhibition but Not Angiotensin II 
Receptor Antagonism in Healthy Humans 
1023.45*246A 
Comparative Effects of Captopril and Losartan on 
Endothelial Function and Vascular Endothelial 
Growth Factor 860-3 l 288A 
Comparative Effects of Paroxetine and Nefazodone 
on Human Platelet Aggregation and Vascular 
Reactivity 832-402668 
Comparison of the Evaluation of Endothelial 
Function by Flow Mediated Dilation Using 
Brachial Artery or Popliteal Artery 1201-460 
327A 
Coronaty Artery Endotlxlial Protection Following 
Local Delivery of 17-B& Estradiol During 
Balloon Angioplasty: A Potential New 
Pharmacological Approach to Improve 
Long-Term Outcome of Angioplasty 1131.118 
-58A 
Coronaty Flow and Diameter Increase and 
Immediate Epicardial Endothelial Dysfunction 
Improvement by Quinaprilat Intracoronarily in 
Heart Transplant Recipients 1208.121 l 238A 
Creating Lipid-Rich Lesions in Porcine Coronary 
Arteries: A Novel Model of Vulnerable Plaque 
1133-48.2958 
Cycle-Oxygenase Inhibitor Diclofenac Improves 
Chlamydia Pneumoniae-Induced End&h&al 
Dysfunction 1022-56*244A 
Differential Cytotoxicity of Radiocontrast Agents on 
Human Umbilical Vein Endothelial Cell 
Monolayers In Vitro 1018.XO*ZA 
Divergent Effect of Eating Fat and Carbohydrate on 
Endothelial Function 1156.43 l 304A 
Early Neutrophil Recruitment and Intimal 
Hyperplasia: Studies in a Murine Model of 
Femoral Artery Transluminal Injury 1092-220 
2188 
Effect of Angiotensin AT1 Receptor Inhibition on 
Circulating Markers of Endothelial Dysfunction 
860-4 l 288A 
Effect of Chronic Exercise and Long-Term 
Angiotensin-Converting Enzyme Inhibitors on 
Endothelial Function of Rat Thoracic Aorta 
1089.49 l 273A 
Effects of Losartan on Endothelium-Dependent 
Vasodilation in Patients With Chronic Heart 
Failures 1045.42 l 254A 
Effects of Single-Drug Antihypertensive Therapy on 
Endothelium-Dependent Vasodilation in 
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Hypertensive Postmenopausal Women 860-l l 
287A 
Elevated Levels of Soluble Fas in Postmenopausal 
Women 1156-48.3058 
Endothelial Dysfunction Following Oral Methionine 
Is Not Mediated by an Increase in Free Radicals 
1089.48 l 273A 
Endothelial Dysfunction in Patients With Systemic 
Lupus Erythematosus 1156.49 l 305A 
Endothelial Nitric Oxide Synthase Is a Site of 
Superoxide Synthesis in Endothelial Cells 
Treated With Glyceryl Trinitrate 1044-57 l 
252A 
Endothelium-Dependent and Independent Vascular 
Responses and Blood Flow in the Brachial 
Artery of Healthy Controls and Patients With 
Chronic Heart Failure: Relationship to Peak 
Oxygen Consumption and Left Ventricular 
EjectionFraction 1071.149*177A 
Epineprine Induces Free Radical Release and 
Upregulates Endogenous Superoxide Dismutase 
Gene and Protein Expression in Human 
Coronary Artery Endothelial Cells 1050-121 l 
173A 
Estradiol Inhibits Nuclear Factor-kB Binding 
Activity In Vitro and In Viva 1044-51 l 250A 
Evidence of Prolonged Inflammation in Patients 
With Unstable Angina and Non Q-Wave 
Myocardial Infarction 1090.53 l 274A 
Exercise Perfusion Scintigraphy Positivity Is 
Associated With Peripheral Vascular End&h&al 
Dysfunction in Patients With Normal Coronary 
Arteries 1191.29*482A 
Free Radicals Mediate Coronary Vascular 
Dysfunction Associated With Direct Current 
Shocks 1089-46.2728 
Galectin-3 Accumulation in Foam Cells of 
Atherosclerotic Lesions and Lipid Loaded 
Mouse Peritoneal Macrophages 1133.41.2938 
Glutathione-Mediated Biotransformation of Glyceryl 
Trinitrate to Nitric Oxide: A Potential Role for 
Peroxynittite in Nitrate Tolerance in Patients 
With Unstable Angina 1156.44*304A 
Greater Endothelial Protection by the Vasopeptidase 
Inhibitor Omapatrilat Compared to the 
ACE-Inhibitor Captopril in Salt Induced 
Hypertension 102518.2488 
Homocysteine in Patients Is Associated With 
Surrogate Markers of Endothelial Dysfunction 
1089-47 l 272A 
Hypercholesterolemia and Hypertension Have a 
Synergistic Deleterious Effect on Coronary 
EndotbelialFunction 1089-45.2728 
Immediate and Long Term Endothelial Activation in 
Diabetics Patients With Acute Coronary 
Syndromes 1084-132-3668 
Inactivation of Nitric Oxide by Superoxide Is a 
Mechanism Leading to Age-Related Endothelial 
Dysfunction 1092.190277A 
Increased Adhesion Molecules Levels in Patients 
With Chest Pain and Normal Coronary 
Arteriograms 87 l-5 l 384A 
Inhibition of Angiogenesis by Peptides Derived 
From Kininogen Domain 5 and by a 
Monoclonal Antibody to Kininogen Domain 5 
1134-5 1 l 2958 
Is Endotoxin a Trigger in Congestive Heart Failure 
Patients With Acute Cardiogenic Pulmonary 
Edna? 1183.1500224A 
Local and Systemic Hemostatic and Fibrinolytic 
Effects of Intra-Arterial Desmopressin In Vivo 
in Humans: Role of Monocyte Activation 
1201.41 l 326A 
Long-Term Consequences of Coronary Aneurysms 
After Kawasaki Disease: Vascular Wall 
Morphology and Endothehum Function 
1146.161*513A 
Long-Term Exercise Training Leads to Sustained 
Improvement of Coronaty Endotbelial Function 
and Flow Reserve in Patients With Coronary 
Artery Disease 1073.122*18OA 
Long-Term Therapy With Enalapril Augments 
Endothelium Dependent Vasodilation in a Dose 
Dependent Manner in Patients With Congestive 
Heart Failure 1156-45.304A 
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Losartan and Captopril Reduce Myocardial Infarct 
Size, Arrhythmias, and Mortality in a Rat Model 
of lschemia-Reperfusion 1105-141 l 370A 
Low-tan Improves Endothelium-Dependent 
Vasodilation in Patients With Noninsulin 
Dependent Diabetes Mellitis 102346*246A 
Neither Previous Chlamydia Pneumoniae Infection 
nor Elevated C-Reactive Protein Are Associated 
With Endothelial Dysfunction in Healthy Young 
Adults 1201.43’327A 
Nitric Oxide Synthase lnbibition Improves Coronary 
Microcirculatory Function in Patients With 
Coronary Artery Disease 1191.30*482A 
Oral Folic Acid Treatment Improves Endothelial 
Function in Patients With 
Hyperhomocysteinemia 868-5 l 29lA 
Protective Effects of the Combiiation of 
Nonhypotensive Doses of Valsartan and 
Enalapril in Spontaneously Hypertensive Rats 
With End&&l Dysfunction 1025.17 l 248A 
Quantitative Relationship Between Cardiovascular 
Fitness and Endothelial Function 1089-44* 
212A 
Rapid Improvement of Endothelial Function After 
Lipid-Lowering Therapy With Cerivastatin 
Within Two Weeks 1046-9 *256A 
Relationships Between Genetic Predispositions to 
Hypertension and Coronary 
Endothelium-Dependent Vasodilation in 
Essential Hypertension 1204-17 l 331A 
Selective Impairment of End&helium-Dependent 
Vasadilatian of Resistance Vessels in Patients 
With Obstructive Sleep Apnea 868-2 *290A 
Serum Xanthine Oxidase and Nitric Oxide Synthase 
Activities and Malondialdehyde as Markers of 
Coronary Ischemia During Stress Test 1090-52 
l 2748 
Shoti-Term Endurance Exercise Training Enhances 
Endothelium-Dependent Vasodilation in Healthy 
Premenopausal Women 1073-121*179A 
Simultaneous Administration of Glycoprotein 
IIb/IIIa Inhibitors With Low-Molecular-Weight 
Heparins Does Not Augment the Release of 
Tissue Factor Pathway Inhibitor: Implications in 
the Management of Cardiovascular Patients 
1092-20 l 277A 
Soluble Forms of P-, and E-Selectin in Children 
With Immune Globulin-Resistant Kawasaki 
Disease 1146-162-5148 
SQ885, A Novel Nonpeptide Integrin Antagonist for 
Vascular Cell Integrins avb?, avb5, and aSb1 
Potently Inhibit An~ogenesis-Medicated 
Disorders 1157-53 l 306A 
Tamoxifen Is Not Detrimental to Endothelial 
Function in Women With Breast Cancer 
1045.45 l 254A 
The Direct Effects of Can&, Olive, and Fish Oils on 
Endothelial Function 860.6.2888 
The Effects of Oral Methionine and Homocysteine 
on Endothelial Function 860-5 l 2888 
The Influence of Short-Term Therapy With 
Simvastatin on Inflammatory Profile in 
Hypercholesterolemic Patients 1046-1’2*256A 
The Positive Inotropic Effects of Hydrostatic 
Pressure Are Buffered by the Endocardial 
Endothelim via Prostaglandins 1071-148 0 176A 
The Relation Between End&&al Dysfunction of 
Coronary Artery and Major Adverse Coronary 
Events 1061.1340354A 
The Selective Serotonin Reuptake Inhibitor 
Paroxetine Inhibits Endothelial-Dependent 
Vasodilation 1089-43 *271A 
Transient Hypertension Directly Impairs 
Endothelium-Dependent Vasodilation in Human 
Resistance Arteries 913-6 l 33.5A 
Troglitazone Improves Endothelial and Exercise 
Performance in Patients With Coronary Artery 
Disease 1196.107-4098 
Use of Elecrrical Stimulation to Prevent 
Atherosclerosis in the Abdominal Aorta 
(Experimental Study) 1022-S7*244A 
Vitawin E Prevents Resistance Vessel Endothelial 
Dysfunction Induced by Experimental 
Hyperhomocysteinemia in Human Subjects 
860-2 * 2878 
Endotbelium-derived relaxing factor 
Absence of L-Arginine Effect on the Coronary 
Hypersensitivity to Serotonin in Cardiac 
Transplant Recipients 120%120*238A 
Barorecepter Dysfunction Induced by Nitric Oxide 
Synthase Inhibition in Humans 868-l l 290A 
Comparative Effects of Paroxetine and Nefacodone 
on Human Platelet Aggregation and Vascular 
Reactivity 83%4*266A 
Effect of Chronic Exercise and Long-Term 
Angiotensin-Converting Enzyme Inhibitors on 
End&&al Function of Rat Thoracic Aorta 
1089.49 l 2738 
Effect of Intramuscular Gene Transfer With 
VEGFlZl on Endothelial Function in Patients 
With Peripheral Atherosclerotic Occlusive 
Disease 852-5 -279A 
Hypertriglyceridemia Is a Risk Factor for Arterial 
Endothelial Dysfunction in Asymptomatic 
Westernized Chinese 10%41.2458 
Sustained Improvement in Homocyst(e)ine Levels 
and Arterial Endothelial Function After 
One-Year Folic Acid Supplementation 868-60 
291A 
Synthetic Progestin Improves 
Endothelium-Dependent Vasodilator 
Responsiveness Comparable to Natural 
Progestin in Healthy Postmenopausal Women 
1023.48 02468 
Tetrahydrobiopterin Restores Endothelial Function 
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Coronary Occlusions 1152-83 l 66A 
KEY: Abstract title. Session-abstract number l page number 
662A SUBJEYCT INDEX 
Coronary Plaque Regression Over Twelve Months Is 
Correlated With Increase in High-Density 
Lipoprotein Cholesterol Levels During Therapy 
1046-23 l 257A 
Depth Distortion in Intravascular Ultrasound Tissue 
Characterization: A Major Pitfall in Gray Scale 
Interpretation 1088-110*38A 
Diabetes and Ostial Lesion Location Have an 
Additive Effect on Target Lesion 
Revasculariration on Stent Implantation 
1043.116*17A 
Does “Stent-On-Stent” for In-Stent Restenosis 
Exaggerate Intimal Hyperplasia? A Volumetric 
Intravascular Ultrasound Analysis X97-5 l 84A 
Does Late Arterial Response After Cutting Balloon 
Angioplasty Differ From That of Conventional 
Balloon Angioplasty? A Volumetric 
Intravascular Ultrasound Analysis 1152-77 l 
64A 
Does the Pattern of Arterial Remodeling Impact 
Vessel Behavior Following Balloon 
Angioplasty? A Serial Intravascular Ultrasound 
Study 1175.83*77A 
Edge Effect in a Nonselect Stent Population: Results 
From Six-Month Intravascular Ultrasound 
Examination in the HIPS Trial 1108.91 l 46A 
Effects of Obesity on Coronary Atherosclerosis, 
Vascular Remodeling, and Endothelial Function 
1090-51 l 273A 
Efficacy of Intravascular Ultrasound Radiofrequency 
Signal Analysis in Evaluation of Coronary 
Atherosclerotic Plaques Compared With 
Conventional Video Images 862-2*51A 
Elimination of Restenosis by Stentiug After Plaque 
Reduction With Platelet Inhibitor Trial 
(ESPRIT): A Prospective Randomized Trial 
79-5*8A 
Endoluminal Ultrasound Enhances Local Drug 
Delivery Efficiency 1177- 113 l 8OA 
Extent of Neointima Predicts Subsequent Neointimal 
Proliferation in In-Stent Restenosis: A 
Volumetric Intravascular Ultrasound Study 
907.6*95A 
Feasibility and Safety of a Novel Intravascular 
Brachytherapy Device 1134-55 l 2968 
Feasibility of Four-Dimensional Myocardial Doppler 
Tissue Velocity Imaging for Full-Thickness 
Myocardial Mapping 1056-33 l 423A 
Four-Dimensional Myocxdial Modeling From 
Orthogonal Rotational Intracardiac Ultrasound 
1098.95 l 119A 
Heart Transplant Recipients With Normal Coronary 
Angiograms: Is Intravascular Ultrasound Really 
Necessary? 1208.125.2398 
High Frequency Intravascular Ultrasound Identifies 
Atherosclerotic Lipid Lakes With High 
Accuracy 10X8-114*398 
High-Pressure Stent Implantation Is Requested Even 
With less Rigid Second-Generation Stents to 
Obtain Large Follow-Up Lumen Dimensions: 
Au Intravascular Ultrasound Study 110X-87 l 
45A 
Impact of Coronary Debulking Prior to Stenting 
Versus Conventional Stenting on Early 
Outcome: Initial IVUS Findings 907-l l 94A 
Impact of Different Definitions of the Interpretation 
of Coronary Remodeling by Intravascular 
Ultrasound 113%112*59A 
Impact of Remodeling on Coronruy Lumen Loss in 
Transplant Vasculopathy: A Serial Intravascular 
Ultrasound Study 1208-124.2398 
Impact of the Vessel Size and Procedural Result on 
the Long-Term Outcome Following Coronary 
Stenting 1043-117*17A 
Improved Condor Detection for Three-Dimensional 
Intravascular Ultrasound: An In Vivo Validation 
Study 1109-116*47A 
Incomplete Stent Apposition as Determined by 
Post-Procedure Intravascular Ultrasound Does 
Not Effect Clinical Outcome After Elective 
Coronary Stent Placement: A Report From 
AVID andCRUISE 110X-88*45A 
Increased In-Stent R&en&s in Diabetes Is the 
Combination of Small Vessel Size and 
Exaggerated Intimal Hyperplasia 907-5 l 95A 
Increased Presence of Matrix-Metalloproteinase 3 in 
Human Coronary Lesions With Positive Arterial 
Remodeling 1132-109*58A 
Influence of a Change in Gender on Coronary 
Arterial Size: A Longitudinal Intravascular 
Ultrasound Study in Transplant Recipients 
1132-111*59A 
Influence of Calcium on Coronary Dissection 
Following Cutting Balloon Angioplasty: An 
Intravascular Ultrasound Study 1043-l 19 l 18A 
Intracoron~ Ultrasound Volumetric Assessment of 
Stent Expansion and Plaque Redistribution After 
Direct Stenting 1108-90 l 46A 
Intravascular Sonotherapy Impacts Neointimal 
Hyperplasia Following Stent Implantation in 
Swine Femoral Arteries 826-5 l 28A 
Intravascular Ultrasound Analysis of the Effect of 
Post-Dilation With Noncompliant Balloons 
Following Initial High Pressure Stent 
Implantation Using Newer Generation Stem 
Delivery Systems 1108-86,458 
Intravascular Ultrasound Assessment of a New 
Biodegradable Self-Expanding Corona Stent 
in Humans 1086.85*34A 
Intravascular Ultrasound Lesion Calcium Predicts 
Adverse Clinical Events After Carotid Artery 
Stenting 1021-117*7A 
Intravascular Ultrasound Measurement of Plaque 
Volume: Validation of a Method for Serial 
Regression-Progression Studies 1109-l 18 l 47A 
Intravascular Ultrasound Study of Residual 
Dissection Following Percutaneous Coronary 
Intervention 907-4*94A 
Intravascular Ultrasound-Guided Stent Placement 
Improves Clinical Outcome for Patients With 
High-Grade Lesion Severity: Observations From 
AVID 1108.89 l 45A 
Is Angiographic Guidance Sufficient for Optimal 
Stent Deployment in Ostial Steno%%? Insight 
FromIVUS 1198.118*89A 
Is High Pressure Optimization Necessary in Second 
Generation Stents? Results From the IVUS 
DUETStudy 1108-85.448 
Left Anterior Descending Coronary Blood Flow Is 
Unaffected by Complete Occlusion of the 
Anterior Interventricular Vein 1020-l 13 l 6A 
Lipoprotein (a), a Predictor of Coronary Artery 
Remodeling: An Intravascular Ultrasound Study 
1132-113*59A 
Long-Term Consequences of Coronary Aneurysms 
After Kawasaki Disease: Vascular Wall 
Morphology and End&helium Function 
1146-161 l 513A 
Long-Term Morphological Effect of Post 
Angioplasty b-Radiation: An IVUS Study 
1018.76.1A 
Mechanisms of Systolic Flow Reversal in Internal 
Mammary Artery Grafts 1200.113*93A 
Medical Costs Over 18 Months After Stent 
Implantation With Versus Without Intravascular 
Ultrasound Guidance: Results of the . 
Randomized “Restenosis After Intravascular 
Ultrasound Stenting” (RESIST) Study 1019-86 
l 3A 
Negative Remodeling Is an Important Determinant 
of Lumen Compromise in the Aortoostial 
Location: Intravascular Ultrasound Analysis of 
Coronary and Renal Artery Atherosclerosis 
1132.110*59A 
Noninvasive Quantification of Myocardial Perfusion 
Reserve With Electron Beam Computed 
Tomography in Comparison to lntracoronary 
Blood Flow Reserve by Doppler Ultrasound 
904-l l 4848 
Normal Intimal Thickness Is An Age Dependent 
Phenomenon: An Intravascular Ultrasound 
Study in Asymptomatic Iudividuals 907-2 l 94A 
Predictors of Intimal Hyperplasia After Stenting: 
Serial IVUS Study 1043.114*16A 
Prognostic Significance of Left Main Disease 
Assessed by Three-Dimensional IVUS 
1043.115*17A 
Recruitable and Nourecmitable Collateral 
Circulation After Successful Recanalization of 
JACC February 2000 
Chronic Total Coronary Occlusions 1152.760 
64A 
Renal Artery Stenosis Interventions Guided by 
Intravascular Ultrasound and Pressure Gradient 
Measurements 1154.90*69A 
Reversible Left Ventricular Regional Dysfunction 
Following Radiofrequency Ablation in Chronic 
Myocardial Infarction 1098-93 l 119A 
Serial Assessment of Coronary Flow Reserve in 
Pediatric Cardiac Transplant Recipients 
1208.123*239A 
Statin Therapy Reduces Restenosis After 
Percutaneous Transluminal Angioplasty by 
Inducing Vascular Enlargement: Au 
Intravascular Ultrasound Study 1009-1680 
314A 
St& and Stent-Edge Remodeling After 
Conventional and Radioactive Stent 
Implantation 1063-l 14*22A 
Stent Underexpansion With Intermediate Inflation 
Pressures 110X-84*44A 
The Effect of b-Radiation Therapy on Stented in 
Coronq Segments and Adjacent Stent Edges: 
A Three-Dimensional Intravascular Ultrasound 
Interpretation 896-5 l 83A 
The Effect of Catheter-Based b-Radiotherapy on 
Coronary Artery Remodeling and Plaque 
Formation After Percutaneous Interventions 
854-2*50A 
The Impact of Remodeling on the Acute Results of 
Saphenous Vein Graft Stent Implantation 
1132-114*60A 
The Influence of De Nova Atherosclerotic 
Remodeling on Luminal Narrowing Follows a 
Normal Distribution: An Intravascular 
Ultrasound Study 1109.117*47A 
The Use of IVUS-Guided PTCA and Spot Stenting 
for the Treatment of Long Lesions: A 
Comparison to Traditional Stenting 1008-1690 
62A 
Three-Dimensional Intracardiac Ultrasound Toroidal 
Reconstructions in the Beating Heart 1100.70 
4378 
Time Dependent Morphologic Characteristics in 
Angiograpbic Chronic Total Coronary 
Occlusions: An Intrav&cular Ultrasound Study 
1043.118*17A 
Tramcranial Doppler Detection of Microemboli 
During Endocardial Biventricular Pacing in 
End-Stage Heart Failure 1165.94 l 141A 
Transcranial Doppler Detection of Microemboli 
During Left Heart Catheterization 1197.770 
87A 
Ultrasound Accelerated Tbrombolysis in a Canine 
Carotid Model of Thrombo-Embolic Stroke 
1177.114*8OA 
Unstable Coronary Atherosclerotic Plaques: 
Intracoronary Ultrasound Characteristics With 
In Viva Measurement of Culprit Lesion 
Temperature 862-3 l 52A 
Validation of IVUS Volumetric Assessment of 
Instent Neointimal Hyperplasia: A Comparison 
Between Manual and Automated Processing 
1109.115*47A 
Vessel Wall Distance Variation Between Centered 
and Non-Centered Radiation: Cross-Sectional 
and Longitudinal Analysis by Intravascular 
Ultrasound 1021.115*7A 
Investigational devices 
360 Degrees Thermal Color Mapping of the 
Atherosclerotic Plaque by Means of a Special 
Thermography Catheter and Computer Software 
1088.111*38A 
A New Nonobstructive Intravascular Magnetic 
Resonance Imaging Probe for High Resolution 
In Viva Imaging of Atherosclerotic Plaques 
1190-3*479A 
A New Protection Filter Device to Prevent Distal 
Embolization in Peripheral Interventions: Fist 
Results in Renal and Carotid Arteries 1154-87 l 
68A 
A Novel Guidance System for Facilitating the 
Crossing of Plaque and Chronic Total 
Occlusions 844-l l 4OA 
KEY: Abstract title, Session-abstract number l page number 
JACC February 2000 
Acute and Long-Term Follow-Up Results With the 
HELEX Septal Occulder in an Animal Model 
1057-361.4984 
AngioJet Rheolytic Tbrombectomy: An Important 
Tool for Percutaneous Coronary Interventions in 
High Risk Patients; VeGAS 11 Trial I1 75-78 0 
7jA 
Catheter-Based Ultrasound With Urokinase 
Enhances Thrombolysis and Improves TIM1 
Flow: In Viva Studies 1177.112*79A 
Clinical Safety and Efficacy of the PercuSurge 
Guardwire in the Saphenous Vein Graft 
Angioplasty Free of Ernboli (SAFE) Study 
844-6 l 41A 
Comparison of Early Outcomes in Age and Gender 
Matched Patients Undergoing Conventional 
Open Surgical Repair of Abdominal Aneurysms 
Versus Patients Treated Percutaneously With the 
AneuRx Stem Graft 106486*22A 
Correspondence of BIOSENSE-Guided Endocardial 
Catheter Maps With Magnetic Resonance 
Imaging: Influence of Number of Locations 
Sampled 888-2 *81A 
Design of an Infrared Fiber Catheter for Thermal 
Imaging of Atherosclerotic Plaques 1088.1090 
37A 
Electromechanical Characterization of Treatment 
Response to Laser Myocardial 
Revascularization Guided by Left Ventricular 
Mapping 1177-l 15*80A 
Endocardial Electromechanical Mapping to Assess 
Myocardiai Viability: A Comparative Receiver 
Operating Characteristic Analysis With 
Radionuclide Perfusion Imaging 888-40 81A 
Experiences With a New Fractally Coated Single 
Pass. Single Lead Electrode for Dual Chamber 
Implantable Cardicverter Defibrillator Systems 
in 30 Patients 1119-97 l 127A 
Fontan Fen&ration Closure Using the Amplatzer 
Septal Occluder 1057.160.4388 
Helixcision Atherectomy for In-St& Stenosis: 
Initial in Viva Experience 844-5*41A 
Hibernating Myocardium Diagnosed With 
Nonfluoroscopic Electromechanical (NOGA) 
Mapping: A Comparison With Dobutamine 
Stress Echocardiography 888-l *SlA 
Induction of Extracellular iMatrix Expression in the 
Arterial Wall After the Application of 
Cryotherapy in a Porcine PTCA Model 
1131-116.578 
Intracoronary Radiation Therapy With Liquid 
Rhenium-186: The RadioCatb Trial 1018.770 
1A 
Intravascular Sonotherapy Impacts Neointimal 
Hyperplasia Following Stent Implantation in 
Swine Femoral Arteries 826-5 l 2SA 
Platypnea Orthodeoxia: Management by 
Tramcatheter Buttoned Device Implantation 
1117-159*199A 
Prevention of Distal Embolization During 
Interventions in CABG and Native Coronary 
Lesions Using a New Protection Filter Device 
X3-5 * 1OA 
Pure Iridium Metal Microelectrode for 
Transmembrane Potential Recording in Isolated 
Swine Right Ventricle. I 186-68 l 147A 
Single-Center Experience With Transvenoos 
Biventricular Pacing to Treat Advanced Heart 
Failure: Long-Term Clinical Results 839-l l 
116A 
Small Vessel Stenting-Camp&on of Modular 
Versus Slotted Tube Design: Six-Month Results 
From the EXTRA Trial 1130.X9-56A 
Sustained Symptomatic and Exercise Improvements 
at Six Months Following Percutaneous Direct 
Myocardial Revascularization Guided by 
Biosense Left Ventricular Mapping in Patients 
With Refractory Ischemic Syndromes 83-60 
546A 
The Kit Carson Approach to Chronic Total 
Occiusions of the SFA Biamino G 1064-92 * 
MA 
Thermosensor Catheter: A Nitinol Shape Memory 
Basket Catheter to Measure Temperature of 
Vessel Wall With Continuous Blood Flow 
862-l l 5lA 
Transcatheter Therapy of Critical Stenoses in Infants 
and Neonates Using a New Low Profile High 
Pressure Balloon Catheter 1080.163 l 501A 
Ultrasound Accelerated Thrombolysis in a Canine 
Carotid Model of Thrombo-Embolic Stroke 
1177.114*80A 
Investigational drugs 
Cholestagel, A Novel, Highly Potent, Polymeric Bile 
Acid Sequestrant Significantly Lowers LDL 
Cholesterol 1046-24*25SA 
Effects of Azimilde, an IKr and IKs Potassium 
Channel Blocker in Patients With Implantable 
Cardioverter Defibrillator 891-l l 152A 
Effects of Sodium/Hydrogen Exchange Inhibition 
With Cariporide on Wall Motion Abnormalities 
and Stunning in the GUARDIAN Trial 837-2 l 
357A 
H 345/52-A Novel Repolarization-Delaying 
Antiarrhythmic Agent With Greatly Reduced 
Proarrhythmic Potential 1030.94*97A 
Improved Power Doppler Imaging of Normal 
Myocardial Contrast Using a New Dual-Frame 
Trigger Harmonic Angio Algorithm 1032-S * 
414A 
Randomized Comparison of Vasoflux, a Novel 
Anticoagulant, and Heparin as Adjunctive 
Therapy to Streptokinase for Acute Myocardial 
Infarction 1106- 128 l 373A 
Recanalization of Total Coronary Occlusions Using 
the Sonicross Low Frequency Ultrasound 
Catheter 844.4*41A 
Safety Aspects of Azimilide in Patients With an 
Implantable Cardioverter Defibrillator: 
One-Year Follow-Up 1141.94*135A 
Simulated Real-Time Myocardial Contrast 
Echocardiography at a Low Mechanical Index 
Using Intravenous Definity 1144.280460A 
The Cholesterol Absorption Inhibitor SCH58235 
and Lovastatin Synergistically Lower Plasma 
Cholesterol and Inhibit the Development of 
Atherosclerosis 104456*252A 
Ion channels 
8.Br-cGMP Reverses lsoproterenol Induced 
Changes of Cardiac Single L-Type Calcium 
Channel Gating 1210.97* WA 
Amiodarone Blocks the Late Sodium Current in 
Isolated Ventricular Myocytes of Explanted 
Failed Human Hearts 1030-96-978 
Amiodarone Inhibits Cardiac ATP-Sensitive K+ 
Channels 1030-93 l 97A 
Ischemia Tolerance of the Neonatal Rabbit Heart: 
The Role of the KATP Channel 1192-166 l 
518A 
Stretch Stimulates Phosphoiipase C Activity and 
Increases Intracellular Calcium Ion Levels in 
Neonatal Cardiomyocytes 1161.142*214A 
Swimming Is a Gene-Specific Arrhythmogenic 
Trigger for Inherited Long QT Syndrome 91 O-2 
l 160A 
Ion currents 
Acute Effects of Dronedarone on Potassium Currents 
in Isolated Rabbit Ventricular Myocytes: 
Comparison With Amiodarone 1030.990 9SA 
Amiodarone Inhibits Cardiac ATP-Sensitive K+ 
Channels 1030-93 l 97A 
Decreased B-Adrenegic Sensitivity of Ventricular 
L-Type Calcium Current in Infarct-Induced 
Hypertrophy in Rats Is Related to Reduced 
B-Adrenergic Receptor Density 836-2 l 356A 
Effects of HIV Glycoprotien 120 on Cell 
Contractions and L-Type Ca2+ Channel Current 
in Rabbit Ventricular Myocytes 1184.1540 
225A 
Reduced B-Adrenergic Responsiveness of Calcium 
Inward Currents in Human Atria1 Myocytes of 
Patients With Heart Failure X83-6* 147A 
Ischemia 
Activation of Protein Kinase C in the Ischemic and 
in the Nonischemic Area After Left Anterior 
Descending Ligation Is Blocked by Pretreatment 
With Ramiprilate 1206-1420 233A 
Altered Segmental Compression/Expansion 
Crossover: A Sensitive indicator of Acute 
SUBJECT INDEX 663A 
Myocardial lschemia as Assessed by 
Noninvasive Strain Rate Imaging 88%2*475A 
Angiotensin Converting Enzyme Inhibition 
Improves Endothelial Dysfunction and 
Myocardial lschemia 1023.440 246A 
Apex to Base Position of an Infarct Is a Major 
Determinant of Its Size in Relation to the Risk 
Zone 1126.106.37SA 
Are Cardiac Risk Factors Predictive in Low Risk 
Emergency Department Chest Pain Patients 
Who Have Chest Pain? 1127-135*379A 
Beat-to-Beat QT Variability Identifies Myocardial 
Ischemia 1031-71 l 1OlA 
C-Reactive Protein as a Useful Marker for Acute 
Coronary Syndrome Manifested With Acute 
Chest Pain 1149-68-3888 
Clinical Importance of ST Segment Elevation 
During Dobutamine Stress Echocardiography in 
Patients With an Old Myocardial Infarction 
1101-30*439A 
Correlation Between Endocardial Voltage Mapping 
and Myocardial Perfusion: Implications in the 
Assessment of Myocardial Ischemia 1094-1200 
183A 
Correlation Between Myocardial Perfusion 
Abnormalities Detected With Intermittent 
Imaging Using Intravenous Petiuorocarbon 
Microbubbles and Radioisotope Imaging During 
High Dose Dipyridamole Stress Echo 1077-30 
425A 
Detection of Myocardial Ischemia Using Additional 
Left Posterior and Right Precordial Leads 
During Exercise Electrocardiography 1139-121 
.210A 
Detection of Regional Myocardial lschemia Using 
an Implantable Cardioverter Defibrillator Lead 
Set 1141-96*135A 
Different Antiischemic Effect of Estrogen and 
Testosterone in Men and Women With Coronary 
Artery Disease 1045.460255A 
Does Symptom Onset in the Morning Help Predict 
the Diagnosis of Acute Cardiac Ischemia? 
1194.137*405A 
Effects of Sustained-Release Diltiazem on Circadian 
Pattern of Ischemia During Daily Life 
1196.105*409A 
Emergency Catheterization Immediately After 
Coronary Artery Bypass Grafting for Extensive 
Ischemia 1060.1350350A 
Glucose Transport and GLUT-4 Content Within 
Chronically Ishemic Myocardium 1191-5 * 
4798 
Heat Production of Atherosclerotic Plaques and 
Inflammation Assessed by the Acute Phase 
Proteins in Acute Coronary Syndromes 
1005.169*358A 
Influence of Electrical Stimulation on Subtotally 
Mobilized Latissimus Dorsi Muscle 1185.1240 
22lA 
Intravenous Testosterone Has No Effect on 
Cardiovascular and Ventilatory Responses to 
Exercise in Elderly Men With Coronary Artery 
Disease 1050-122*173A 
Is Dobutamine Superior to Dipyridamole in 
Evaluating the Severity and Reversibility of 
Defects Using Tc-99m Sestamibi SPECT 
Imaging in Patients With Coronary Artery 
Disease? 884-3 l 473A 
Ischemia Detection by Means of a Subcutaneous 
Electrode Array 1211.59*159A 
Ischemic Mitral Regurgitation in the Setting of 
Hibernating Myocardium: Preliminary Results 
in a Porcine Model 1126-l 02 l 377A 
Left Atria1 Contractile Function During Left 
Ventricular Ischemia With and Without Left 
Atrial Ischemia 1143.5*458A 
Myocardial Conditioning via Mechanical 
Channeling Plus Healing Limits Ischemic 
Consequences of Acute Coronary Occlusion 
1105.134.3698 
Myocardial Salvage in Patients With Non-ST 
Elevation Myocardial Infarction: Results Using 
Technetium-99m Sestamibi Myocardial 
Perfusion Imaging 1079-36*430A 
KEY: Abstract title, Session-abstract number l page number 
664A SUBJECT INDEX 
Myocardial Strain Doppler: A Sensitive New 
Method for Detection of Ischemia During 
Off-Pump Coronary Bypass Surgery 1214.34. 
490A 
Normalization of Coronary Flow Reserve After 
Coronary Stenting and al- and ti- Adrenergic 
Antagonists 1067-55*261A 
Percutaneous Endocardial Gene Therapy: Patterns of 
In-Viva Gene Expression Related to Regional 
Myocanlial Delivery 1020- 111 l 6A 
Perfusion Defects of Multiple Vessel Territories on 
Exercise SPECT Thallium Imaging Predict 
Long-Term All-Cause Mortality 858.5 l 455A 
Persistent Chest Pain in Women at Six-Week 
Follow-Up: The NHBLI-Sponsored WISE 
Study 1104-13.5468 
Prognostic Significance of Transient Ischemic 
Dilation of the Left Ventricle in Normal 
Dual-Isotope Myocardial Perfusion SPECT 
1034-29 l 416A 
Prolonged Cardiomyocyte Apoptosis in the Remote 
Myocardium Is Associated With Left 
Ventricular Remodeling After Experimental 
Myocardial Infarction 1059.1030349A 
Quantification of Regional Subendocardial Function 
During Ischemia and Low Dose Dobutamine 
Using Tissue Doppler Subendocardial Velocity 
Gradient 1056-37*424A 
Quantitative Three-Dimensional Left Ventricular 
Shape Changes Associated With Acute 
Myocardial Infarction: Clinical Correlation of 
Shape Change and Function at Outcome 849.5 
l 443A 
Recurrent Ischemia and Clinical Outcome After 
Thrombolysis for Myocardial Infarction: 
Observations From InTIME II 873.5 l 386A 
Recurrent Ischemia During Continuous Multilead 
Electrocardiogramischernia Monitoring 
Identifies Patients With Unstable Angina at High 
Risk and Subsequent Cardiac Events. 
M&-Analysis of Three Studies Involving 995 
Patients 908-3 l 410A 
Reduction in Myocardial Ischemia During Acute 
Coronary Ischemia Using Intravenous 
Oxygenated Perfluorocarbon Exposed Sonicated 
Dextrose Albumin Microbubbles 885-l l 475A 
Reduction in Stress Myocardial Ischemia by Basic 
Fibroblast Growth Factor (rFGF-2) in Severe 
Ischemic Heart Disease 879-4*74A 
Regional Intramyocardial Vascular Endothelial 
Growth Factor Gene Transfer and Expression 
Using a Fluoroscopically Guided 
Catheter-Based Technique 879-5 l 74A 
Regional Left Ventricular Function by Angiography: 
What Is Normal and What Is Not? Classification 
by Computer-Assisted Discriminant Analysis 
1002.167*54OA 
Regional Myocardial Perfusion With Entire Heart 
Coverage During Stress Contrast Enhanced 
Magnetic Resonance Imaging Detects High 
Grade Coronary Stenosis in Patients 904.5. 
4858 
Regional Sympathetic Denervation and Myocardial 
Perfusion Disturbance Are Related Phenomena 
Preceding Wall Motion Abnormalities in 
Chagas’ Cardiomyopathy 1184.151 l 224A 
Right Ventricular Dysfunction During 
Dobutamine-Atropine Stress Echocardiography 
Correlates With Global Left Ventricular 
Dysfunction and Multivessel Coronary Artery 
Disease 1055.32*423A 
ST-Segment- and Bradycardia-Based Prediction of 
Imminent Cardiac Death in a Conscious Canine 
Model With Healing Infarction and Acute 
Ischemia 1187-93 l 149A 
Standard Tests to Assess Heparin,Efficacy May Not 
Accurately Reflect Anticoagulation 1037-108 l 
344A 
Surface Gradient Method Detects Exercise-Induced 
Ischemia on Multichannel 
Magnetocardiographic Mapping 1061.131 l 
3538 
Sustained Symptomatic and Exercise Improvements 
at Six Months Following Percutaneous Direct 
Myocardial Revascularization Guided by 
Biosense Left Ventricular Mapping in Patients 
With Refractory Ischemic Syndromes 83-6* 
5468 
Tagged Magnetic Resonance Imaging Can Qualify 
Regional Functional Variation During 
Dobutamine Stress in Subjects With Coronary 
Stenoses 1123.35*453A 
The Antiischemic Effect of Chronic Testosterone 
Replacement in Men Is Not Related to Its 
Peripheral Conversion Into Estrogens 1045.48. 
255A 
Tie-Varying Hazard Rates in Diabetic and 
Nondiabetic Patients With Normal 
Dipyridamole Stress Myocardial SPECT in 
Suspected Coronary Artery Disease 1034-31 l 
416A 
Tissue Doppler Echo Tracking System Can Detect 
Subendocardial Ischemia Even at Rest 885.5* 
4768 
Transmural Dispersion of Repolarization Recorded 
During Acute Myocardial Ischemia in In Situ 
Canine Hearts 1187.94.1498 
Value of Combined Myocardial Perfusion and 
Functional Analysis in Magnetic Resonance 
Imaging for the Detection of Regional 
Myocardial Ishemia 1006.175.4488 
Ischemia, preconditioning 
Cardiac High Energy Phosphates in Human 
Ischemic Preconditioning Assessed by Magnetic 
Resonance Spectroscopy 1123.34*452A 
C&lioprotective Effects of Preconditioning Are 
Mediated Through Both Protein Kinase 
C-Dependent and Independent Pathways 836-3 
03568 
Differential Regulation of Bcl-2, P53, AP-1 and 
NFkB on Cardiomyocyte Apoptosis During 
Ischemic Preconditioning 1059-104*349A 
Geranylgeranylacetone Induces Pharmacological 
Preconditioning in Rat Cardiac Myocytes as a 
Chaperon Inducing Reagent 899.2*401A 
Ischemic Preconditioning Mast Cell Histamine 
Release: Microdialysis of Isolated Rat Hearts 
1044.54.251A 
Myocardial Protection in Humans During Sequential 
Coronary Angioplasty Is Not Due to Collateral 
Recmihnent 1105.138037OA 
Persistent Translocation of Protein Kinase C and 
Activation of Adenylyl Cyclase Are Not 
Essential for Ischemic Preconditioning 
1105-132.368A 
Prevention of Ischemic Preconditioning in Diabetic 
Patients With Coronary Artery Disease Treated 
With Sulfonylureas 1016.105.3398 
The Effects of Ischemic Preconditioning on 
Adenosine Dearninase and Kinase Activities in 
the Canine Heart 899-3 l 401A 
Warm Up Angina Protects Against Ischemia and 
Arrhythmias in the Absence of Collateral Flow 
1126.103*37SA 
Warm-Up Phenomemon Is Lost in Elderly Patients 
With Coronary Artery Disease 1073-1260 181A 
Ischemia, reperfusion 
Accuracy and Feasibility of Technetium-99x1 
Tetrofosmin Myocardial Perfusion Imaging to 
Detect Spontaneous Recanalization in Patients 
With Acute Anterior Myocardial Infarction 
1079.37*430A 
Attenuation of Tumor Necrosis Factor-Alpha by 
Ultrasound-Targeted Antisense Oligonucleotide 
1105-136.3698 
Cardioprotective Effects of Preconditioning Are 
Mediated Through Both Protein Kinase 
C-Dependent and Independent Pathways X36-3 
l 356A 
Carvedilol Limits Infarct Size via 
Adenosine-Dependent Mechanisms in Dogs 
1059-106.3508 
Detection of Residual Coronary Stenoses by 
Assessing Coronary Flow Reserve Using 
99mTc-N-NOET Vasodilator Stress Imaging 
Early After Coronary Reperfusion in a Canine 
Model of Infarction 91 l-5 l 4938 
JACC February 2000 
Differential Regulation of Bcl-2, P53, AP-1 and 
NFkB on Cardiomyocyte Apoptosis During 
Ischemic Preconditioning 1059-104*349A 
Does Demand Ischemia Trigger Myocardial 
Hibernation? 1126-104 l 378A 
Early Changes of Coronary Resistance After 
Coronary Angioplasty Predicts Reversible 
Post-Ischemic Dysfunction in Anterior Acute 
Myocardial Infarction: Serial Assessment With 
Transthoracic Coronary Doppler 
Echocardiography 885-3 l 475A 
Effect of Caspase-3 Inhibitor on Myocyte Apoptosis 
and Left Ventricular Remodeling in the 
Ischemia-Reperfused Rat Heart 1059-107. 
350A 
Genetically Engineered Mice Overexpressing 
ab-Crystallin Exhibit Protection Against 
Myocardial Ischemia Reperfosion Injury 899-l 
l 4OlA 
Geranylgeranylacetone Induces Pharmacological 
Preconditioning in Rat Cardiac Myocytes as a 
Chaperon Inducing Reagent 899-2 l 401A 
Intracoronary Enalaprilat in Patients With Acute 
Myocardial Infarction 1038.135*346A 
Lecithin&d Copper, Zinc-Superoxide Dismutase 
Reduced the Infarct Size in Rats With 
Myowdial Ischemia: Repetiusion Injuries 
1105.137.3708 
MX68, a New Derivative of Methotrexate, Limits 
Infarct Size via Adenosine-Dependent 
Mechanisms in Dogs 1105-139.3708 
Predictors of Outcome After Transmyocardial 
Revasculatization 1017.140*342A 
PrognoxTM (99mTechnetiumHL91) Can Identify 
Hypoxic, Viable Regions in 
Ischemic-Rep&used Myocardium With Infarct 
911.6*493A 
Recurrent Ischemia and Clinical Outcome After 
Thrombolysis for Myocardial Infarction: 
Observations From InTIME II 873.5 03868 
Reduced Density of Sarcoplasmic Reticulum 
Calcium Release Channel in Human Ischemic 
and Rep&used Myocardium 1126.108 03798 
The Effects of Ischemic Precbnditioning on 
Adenosine Deaminase and Kinase Activities in 
the Canine Heart 899-3 l 401A 
Upregulation of Inducible Hem-Oxygenase-1, 
Generator of Carbon Monoxide, in the 
Post-Infarction Myocardium Is Dependent on 
the Presence of Nitric Oxide 899-5 l 402A 
Kawasaki disease 
Long-Term Consequences of Coronary Aneurysms 
After Kawasaki Disease: Vascular Wall 
Morphology and Endothelium Function 
1146-161*513A 
Re-Treatment for Immune Globulin-Resistant 
Kawasaki Disease: A Comparative Study of 
Additional Immune Globulin and Steriod Pulse 
Therapy 1146-164.5148 
Soluble Forms of P-, and E-Selectin in Children 
With Immune Globulin-Resistant K&w&i 
Disease 1146-162.5148 
Kidney 
Omega-3 Fatty Acids Improve Blood Pressure 
Control in Hypertensive Heart Transplant 
Recipients 1010.1680231A 
Predicting Factors of Increased Cardiac Troponins in 
Chronic Hemodialysis Patients 1016.1060 
339A 
Subcutaneous Brain Natiuretic Peptide 
Administration in Symptomatic Human Heart 
Failure: A Novel Therapeutic Strategy for 
Congestive Heart Failure 909.2*24OA 
The Superior Renal and Humoral Actions of Acute 
Dual NEP/ACE Inhibition by Vasopeptidase 
Inhibitor Versus ACE Inhibition Alone in 
Experimental Mild Heart Failure: Properties 
Mediated via Potent&ion of Endogenous 
Cardiac Natriuretic Peptides 842-l l 270A 
KEY: Abstract title, Session-abstract number l page number 
JACC February 2000 
Laser 
Detection of Vulnerable Atheroma by Laser-Induced 
Fluorescence 1022.54* 244A 
Determining the Thermal Heterogeneity of a Model 
Vessel Wall by Pulsed Laser Irradiation: An 
Experimental Attempt to Detect Vulnerability of 
Atherosclerosis 862-4 * 5’2A 
Device Influence on Outcome in the Treatment of 
In-Stent Restenosis With and Without 
Radiation: A Subanalysis From the WRIST 
Study 1063-112.218 
Electromechanical Characterization of Treatment 
Response to Laser Myocardial 
Revascularization Guided by Left Ventricular 
Mapping 1177.115*8OA 
Low Energy Laser Irradiation Reduces Formation of 
Scar Tissue Following Myocardial Infarction 
1038.136*346A 
Low-Power Red Laser Light Promotes Proliferation 
of Cardiomyocytes In Vitro 1087-I 19 8 37A 
Myocardial Innervation After Percutaneous 
Myocardial Laser Revascularization 1196-103 * 
408A 
Raman Spectroscopy Provides Characterization of 
Human Atherosclerotic Plaque Composition In 
Vivo X62-5 * 52A 
Rotational Atberectomy, Excimer Laser Angioplasty, 
or Balloon Angiopiasty for Therapy of In-Stent 
Restenosis’? 1198-I 19*89A 
The Impact of Direct Percutaneous Myocardial 
Laser Revascularization (Biosense DMR) on 
Myocardial Perfusion and Function as Assessed 
by Gated SPECT Myocardial Perfusion 
Imaging: Results of the Phase I Multicenter 
DMR Trial 87 I- 1 e 3838 
LlXhCyt~§ 
A Recombinant Soluble P-Selectin Glycoprotein 
Ligand-1 Chimera Has a Thrombolytic Effect in 
a Rat Model of Thrombosis 111 l-42 l 280A 
Altered CD18 Leukocyte integrin Expression and 
Function in the Acute Coronary Syndromes 
105134*337A 
Differences Between Unstable: Angina and Coronary 
Angioplasty in Platelet and Leukocyte 
Activation 1194-14Om406A 
Effect of a Recombinant Soluble P-S&&in 
Glycoprotein Ligand-1 Chimera on Restenosis 
Following Atria1 Injury by Repeat Angioplasty 
in Pigs 1042-I 11 e 16A 
Is Endotoxin a Trigger in Congestive Heart Failure 
Patients With Acute Cardiogenic Pulmonary 
Edna? 1183.150*224A 
Lymphocyte Count in Peripheral Blood Improves 
Risk Stratification in Unstable Angina Patients 
1005175*360A 
Noninvasive Assessment of Inflammation Using 
Ultrasound Detection of Phagocytosed 
Microbubbles 850-I -4448 
Percutaneous Transluminal Coronary Angioplasty 
Results in Stimulation of Monocyte but Not 
Eosinophil-Specific Chemotaxis 1065-l 150 
24A 
Role of Oral Blockade of Platelet Glycoprotein 
lIbinIa on Neutrophil-Platelet Interactions in 
Patients With Acute Coronary Syndromes 
1037.102-3438 
Soluble Forms of P-, and E-Selectin in Children 
With Immune Globulin-Resistant Kawasaki 
Disease 1146-162*514A 
The Prognostic Role of Relative Lymphocyte 
Concentration in Patients With Heart Failure and 
Low Ejection Fraction 1183-l 49.2248 
Vessel Wall Passivation to Platelets and Neutrophils 
Is Not Complete One Month After Stenting 
10X6-91*36A 
Lipid modifying agents 
Air Force/Texas Coronary Atherosclerosis 
Prevention Study (AFCAPS/TexCAPS): Effect 
of Lovastatin Treatment on Risk Subgroups 
Defined by Framingham Risk Equations 
1009.167*313A 
Complementary, Additive Benefit of Clopidogrel 
and Lipid-Lowering Therapy in Patients With 
Atherosclerosis 906-5 *326A 
Early and Striking Mortality Reduction After Acute 
Coron;uy Syndromes Following Lipid Lowering 
Therapy 908-5 l 411A 
Effect of Simvastatin Treatment on Postprandial 
Ypertriglyceridemia in Type 2 Diabetes Mellitus 
Patients With Combined Hyperlipidemia 
1009.172.3158 
Effects of Atorvastatin on Fasting and Postprandial 
Plasma Lipoproteins in Postinfarction Patients 
With Combined Hyperlipidemia 1009.1740 
315A 
High Dose Simvastatin Treatment Reduces 
Apolipoprotein B Production in Patients With 
Diabetic Dyslipidemiaa 906-3 l 325A 
Impact of the Results of the Landmark 4s Lipid 
Lowering Trial on Prescribing Habits for an 
Elderly Population 1009.170*314A 
Implications of Statin Use on the Health Burden and 
Economic Costs of Acute Coronary Syndromes 
Without ST Elevation: Prospective Registry of 
Acute Ischaemic Syndromes (PRAIS) in the 
United Kingdom 853.6*551A 
Improvement of Cholesterol Levels by a Structured 
and Standardized Cholesterol Physiology and 
Diet Education Program 1159.21 l 31OA 
Is Cholesterol Reduction as Effective in the Elderly? 
1117-153*198A 
Is Use of a Statin Agent at the Time of Presentation 
for Acute Myocardial Infarction Associated 
With a Favorable Outcome? 1009-171 l 314A 
Lipoprotein Lipase and Hepatic Lipase Activities 
Modulate Progression of Coronary 
Atherosclerosis and the Effectiveness of Lipid 
Lowering Therapy 1046.22 l 257A 
New Combination Niacin/St&in Formulation Shows 
Pronounced Effects on Major Lipoproteins and 
Is Well Tolerated 906.4*326A 
Nonlipid Lowering Effects of Statin Medication in 
Patients With Coronary Heart Disease 1046-I 1 
l 256A 
Pravastatin and Glucose Intolerance: Evidence for a 
Protective Treatment Effect in the West of 
Scotland Coronary Prevention Study 1202.580 
330A 
Prediction of Postprandial Triglyceride-Rich 
Lipoprotein Response From Fasting 
Triglyceride Levels 1136.20*299A 
Rapid Improvement of Endothelial Function After 
Lipid-Lowering Therapy With Cerivastatin 
Within Two Weeks 1046.9 l 256A 
Reduction of LDL-Cholesterol and Elevation of 
HDL-Cholesterol in Subjects With Primary 
Hypercholesterolemia by SCH 58235: Pooled 
Analysis of Two Phase II Studies 1046-21 l 
257A 
Simvastatin Increases HDL-C and Apolipoprotein 
A-I Levels Significantly More Than Atorvastatin 
1009.373.3158 
Statins Enhance Flow Dependent Vasodilation in the 
Human Skin Circulation: A New Approach to 
Monitor Vascular Function During 
Cardiovascular Therapy 1092-21 l 277A 
The Influence of Short-Term Therapy With 
Simvastatin on Inflammatory Profile in 
Hypercholesterolemic Patients 1046.12 l 256A 
Lipoproteins 
Cardiovascblar Risk Profile in the HIV/HAART 
Lipodystrophy (HAL) Syndrome 1136-I 8 l 
299A 
Cholesterol Reduction Through Weight Loss Is Not 
Influenced by Dietary Protein Source 1159-23 l 
310A 
Cytomegalovirus Infection of Human Macrophages 
Induces Increased Expression of Scavenger 
Receptor CD36 Gene and Cell-Surface 
Glycoprotein 841.2*268A 
Effects of Atorvastatin on Fasting and Postprandial 
Plasma Lipoproteins in Postinfarction Patients 
With Combined Hyperlipidemia 1009.1740 
315A 
High Affinity Extracellular Matrix Retention of LDL 
and HDLtE Is Mediated by Biglycan 
Glycosaminiglycans 1203-10 l 331A 
SUBJECT INDEX 665A 
High Dose Simvastatin Treatment Reduces 
Apolipoprotein B Production in Patients With 
Diabetic Dyslipidemiaa 906.3 l 325A 
Hypertriglyceridemia Is a Risk Factor for Arterial 
Endothelial Dysfunction in Asymptomatic 
Westernized Chinese 1023-41 l 245A 
Lipoprotein (a), a Predictor of Coronary Artery 
Remodeling: An Intravascular Ultrasound Study 
1132.113*59A 
Lipoprotein Lipase and Hepatic Lipase Activities 
.Modulate Progression of Coronary 
Atherosclerosis and the Effectiveness of Lipid 
Lowering Therapy 1046-22 l 257A 
Lipoprotein(a) and Risks of Stroke, Fatal Coronary 
Heart Disease, and Mortality in Older Adults: A 
Prospective Shady 861.4*289A 
Low Serum Cholesterol Levels Independently 
Predict Heart Failure Mortality: Immunological 
Importance of Lipoproteins? 1203-9 l 330A 
Myocardial Blood Flow in Young Adults: Predictors 
and the Effect of HMG-CoA Reductase 
Inhibition 1046.10*256A 
National Guidelines May Not Accurately Reflect 
Atherosclerosis Risk in Women as Defined by 
Electron Beam Tomography 1145.35 l 462A 
Plasma Lipoprotein (a) Is Predictive of a History of 
Vascular Disease but Not the Risk of Carotid 
Atherosclerosis X41-30269A 
Prediction of Postprandial Triglyceride-Rich 
Lipoprotein Response From Fasting 
Triglyceride Levels 1136.20*299A 
Procoagulant Risk Factors for Atherosclerosis: The 
Coronary Artery Bypass Risk Assessment 
(CARA) Study 1136.17.298A 
Receiver Operating Characteristic Curve Analysis of 
the Ability of Apolipoprotein (a) Isoform 
Polymorphism and Serum Lipoprotein (a) 
Levels to Predict the Risk of Coronary Heart 
Disease in Men 1202-51 l 328A 
Relations of Lipoprotein Subclass Levels and LDL 
Size to Reduction in Coronary Atherosclerosis 
in the PLAC-I Trial 1136-2 1 l 299A 
Role of ET-1 in Foam Cell Formation by Human 
Macrophages In Vitro 1178.58*317A 
Simvastatin Increases HDL-C and Apolipoprotein 
A-I Levels Significantly More Than Atorvastatin 
1009-173*315A 
The Association of FERHDL With Gender, Age, 
Body Mass Index, and Coronary Artery Disease 
(CAD) 1159.19.309A 
The Direct Effects of Can&, Olive, and Fish Oils on 
Endothelial Function X60-6 l 288A 
The Effect of Pravastatin on Myocardial Blood Flow 
in Young Healthy Adults 1034.39.4188 
Threshold for Effect of Triglycerides and LDL-c on 
Lipoprotein (a) 1136-23 l 300A 
Lipoproteins, HDL 
Comparing Treatment Success With Statins: Results 
From the Atorxstatin Comparative Cholesterol 
Efficacy and Safety Study (ACCESS) 1009.169 
l 314A 
Coronary Plaque Regression Over Twelve Months Is 
Correlated With Increase in High-Density 
Lipoprotein Cholesterol Levels During Therapy 
1046.23 *257A 
Effects of Low Dose Simvastatin and Hormone 
Replacement Therapy on Serum Lipids in 
Postmenopausal Women With 
Hypercholesterolemia 1202-56.33OA 
Inhibition of Vascular Cell Adhesion Molecule 
Expression by High Density Lipoproteins 
106%12*263A 
New Combination Niacin/Statin Formulation Shows 
Pronounced Effects on Major Lipoproteins and 
Is Well Tolerated 906-4 *326A 
Patients With Coronary Artery Disease Homozygous 
for the B-Allele of High Density Lipoprotein 
Paraoxonase (PONI) Exhibit Reduced 
HDL-PONI Arylesterase Activities of HDL 
Subfractions HDL2 and HDL3 1159-22*31OA 
Simvastatin Increases HDL-C and Apolipoprotein 
A-I Levels Significantly More Than Atorvastatin 
1009-173.3158 
Triglycerides Influence Mortality Primarily in the 
Selting of Elevated LDL: Cleveland Clinic 
KEY: Abstract title, Session-abstract number l page number 
666A SUBJECT INDEX 
Post-CABG Eight Year Follow-Up 1159.170 
309A 
Lipoproteins, LDL 
A Correlation Between Plasma Oxidized Low 
Density Lipoprotein (Ox-LDL) Levels and 
C-Reactive Protein Levels in Patients With 
Acute Myocardial Infarction 861.6*29OA 
Antioxidant Nutrient Supplementation and Brachial 
Reactivity in Patients With Coronary Artery 
Disease 1023-42 l 245A 
Antisense Directed at Endothelium Oxidized LDL 
Receptor LOX-l Inhibits Apoptosis in Human 
Coronary Artery Endothelial Cells 1134-50. 
295A 
Cholestagel, A Novel, Highly Potent, Polymeric Bile 
Acid Sequestrant Significantly Lowers LDL 
Cholesterol 1046-24*258A 
Effects of Low Dose Simvastatin and Hormone 
Replacement Therapy on Serum Lipids in 
Postmenopausal Women With 
Hypercholesterolemia 1202-56;33OA 
Immunolocalization of Oxidized 
Phosphatidylcholine and Apolipoprotein B in 
the Progression of Human Coronary 
Atherosclerotic Plaques 1068-10.2638 
Is Cholesterol Reductiod as Effective in the Elderly? 
1117-153.1988 
Lipid Peroxidation Product 4-Hydroxy-2-Nonenal 
Acts Synergistically With Serotonin in Inducing 
Vascular Smooth Muscle Cell Proliferation 
1068.9*262A 
National Guidelines May Not Accurately Reflect 
Atherosclerosis Risk in Women as Defined by 
Electron Beam Tomography 1145.35*462A 
Threshold for Effect of Triglycerides and LDL-c on 
Lipoprotein (a) 1136-23 l 300A 
Thromboxane A2 Potent&es Mitogenic Effects of 
Mildly Oxidized Low Density Lipoproteins on 
Vascular Smooth Muscle Cells 841-4*269A 
Toll-Like Receptor-4 Is Expressed in Human 
Coronary Atherosclerotic Plaques and 
Upregulated by Oxidized Low Density 
Lipoprotein in Macrophages 1066.48*260A 
Triglycerides InAuence Mortality Primarily in the 
Setting of Elevated LDL: Cleveland Clinic 
Post-CABG Eight Year Follow-Up 1159.170 
309A 
Longitudinal studies 
Age-Time-Estrogen Interactions in Longitudinal 
Changes in Systolic Blood Pressure in 
Postmenopausal Women 913-5 l 3348 
Coronary Flow Reserve Predicts Mortality in 
Patients With Suspected Myocadial Ischemia 
and Normal Coronary Arteries 871-4*384A 
Do the Major Coronary Heart Disease Risk Factors 
Predict Long-Tam Coronary Heart Disease 
Mortality in Young Men? 861-3 l 289A 
Effect of Race in Outcomes After Heart 
Transplantation 1029.120~ 167A 
Not So Benign Short-and Long-Term Prognosis of a 
Non-Q Wave Myocardial Infarction Following 
Thrombolytic Therapy 1084-134.3668 
Predictive Value of the Annual Electrocardiogram 
1163.124*22OA 
Pulse Pressure Rises Exponentially With Age by 
Longitudinal Analysis 847-2 l 192A 
Reduction in Mortality With Aggressive Multiple 
Risk Factor Interventions in Younger Patients 
With Symptomatic Coronary Artery Disease 
1171-15.5568 
Risk Factors, Ethnicity, and Type of Treatment 
Predict Need for Late Repeat Revasculaization 
in Patients Presenting for Treatment of Coronary 
Artery Disease 1125-16*552A 
Subclinical Atherosclerosis Detected by Lumbar 
Aortic Calcification Is an Important Predictor of 
Congestive Heart Failure 1115-1440 194A 
The Effect of Hospital Volume on Long-Term 
Outcome After Percutaneous Transluminal 
Coronary Angioplasty 1040-82 l 12A 
Macrophages 
Arteriogenic Potency of CC- and CXC-Chemokines 
Produced by Monocytes 1092.17 l 276A 
avb3 Integrin Receptor Blockade Reduces 
Restenosis and Macrophage Infiltration With a 
Reduction in Cellular Adhesion Molecule 
Expression Following Balloon Angioplasty in 
the Atherosclerotic Rabbit 1155.115 l 71A 
C-260T Polymorphism in the Promoter of the CD14 
Monocyte Receptor Gene Is Associated With 
Myocardial Infarction in Japanese Population 
1015.133*337A 
Chemokine Expression Profile of Human Monocytes 
After Stimulation With LPS: New Insight by 
Gene-Arrays 1134.58 l 297A 
Creating Lipid-Rich Lesions in Porcine Coronary 
Arteries: A Novel Model of Vulnerable Plaque 
1133.480295A 
Determining the Thermal Heterogeneity of a Model 
Vessel Wall by Pulsed Laser Irradiation: An 
Experimental Attempt to Detect Vulnerability of 
Atherosclerosis 862-4 l 52A 
Estrogen and Progesterone but Not Tamoxifen 
Inhibit Oxidized Low Density Lipoprotein 
Induced Matrix Metalloproteinase-9 in Cultured 
Human Macrophages 846-6.3688 
Galectin-3 Accumulation in Foam Cells of 
Atherosclerotic Lesions and Lipid Loaded 
Mouse Peritoneal Macrophages 1133-41 l 293A 
In Viva Physiologic Heating of Rabbit 
Atherosclerotic Plaques Induces Macrophage 
Apoptosis: A New Approach to Plaque 
Stabilization 1022-55 l 244A 
Is Arteriogenesis Inducible When Collateral Arteries 
Are Already Recruited? 1092-23 l 27SA 
Local and Systemic Hemostatic and Fibrinolytic 
Effects of h&a-Arterial Desmopressin In Viva 
in Humans: Role of Monocyte Activation 
1201-41 l 326A 
Microsphere Loading Monocytes Are Potential 
Vectors for Therapeutic Arteriogenesis 852-20 
2798 
Novel TXAZ Receptor Blockade, BAY u 3405, 
Prevents MCP-l,Expression, Macbrophage 
Infiltration, and Plaque Instability in an 
Atherosclerotic Rabbit Model 1045-19 l 253A 
Oxidized Low Density Lipoprotein (Ox-LDL) Is 
Associated With Plaque Inflammation and 
Destabilization in Human Coronary 
Atherosclerotic Lesions 1005..168*358A 
Role of ET-l in Foam Cell Formation by Human 
Macrophages In Vitro 1178-58 l 317A 
T-Lymphocytes in Initial Coronary Lesions Are 
Associated With the Development of Clinical 
Restenosis in Patients With Unstable Angina 
1155.113*70A 
The Adventitia of Atherosclerotic Coronary Arteries 
Frequently Contains Chlymydia Pneumoniae 
887-3*312A 
Toll-Like Receptor-4 Is Expressed in Human 
Coronary Atherosclerotic Plaques and 
Upregulated by Oxidized Low Density 
Lipoprotein in Macrophages 1066.48 l 260A 
Magnetic resonance imaging 
A New Nonobstructive Intravascular Magnetic 
Resonance Imaging Probe for High Resolution 
In Viva Imaging of Atherosclerotic Plaques 
1190-3 l 479A 
Advantages in Diagnostics of Using Magnetic 
Resonance Tomography and Color-Coded 
Duplex Ultrasound Prior to Carotid 
Desobliteration 1190-4 l 479A 
Analysis of Atria1 Motion Using Maggetic 
Resonance Imaging 1123-39 l 454A 
Angiotensin II Receptor Antagonism Alone Does 
Not Limit Post-Infarction Left Ventricular 
Remodeling 1059-102.3498 
Aortic Distensibility Is Severely Reduced and 
Correlates With Exercise Intolerance in Older 
Patients With Diastolic and Systolic Heart 
Failure 847-l 9 192A 
Aortic Stiffness Is Affected in Matfan Patients 
Without Aortic Dilation 1146.165 l 514A 
Arterial Flow-Mediated Dilatation Is Linearly 
Proportional to Vascular Wall Shear Stress: 
Endothelial Function Assessed by Phase 
Contrast Magnetic Resonance Angiography 
414.3*553A 
Assessment of Leg Arterial Vasodilatory Capacity in 
Elderly Heart Failure Patients and Normals 
JACC February 2000 
Using Phase Contrast Magnetic Resonance 
Imaging 847-3 l 192A 
Assessment of Regional Cardiac Function From 
Tagged Magnetic Resonance Imaging Using 
Harmonic Phase (HARP) Software 1002.1690 
540A 
Assessment of Ventricular Function and Pulmonary 
Regurgitation After Total Repair of Tetralogy of 
Fallot During Supine Physical Exercise by 
Ultra-Fast Magnetic Resonance Imaging 859-5 
l 509A 
Biplane, Omniplane, and Paraplane Analysis for 
Accurate Right Ventricular Volume 
Measurement: A Comparison With Magnetic 
Resonance Imaging 1122.290451A 
Brain Nahiuretic Peptide in Hypertrophic 
Cardiomyopathy Caused by Sarcomeric Gene 
Mutations: A Marker for Poor Outcome? 845-3 
l 191A 
Cardiovascular Function in the Obese: Insights From 
Cardiac Magnetic Resonance Imaging 1078-27 
l 427A 
Cardiovascular Magnetic Resonance Only Requires 
Small Sample Sizes in the Study of Heart 
Failure 1078.26*427A 
Comparison of Left Ventricular Functional Analysis 
in Heart Failure by Echocardiography, 
Radionuclide Ventriculography, and Magnetic 
Resonance: Implications for Research and 
Clinical Practice 1078.25 04278 
Complete Evaluation of Left Ventricular Volume and 
Mass in Less Than 5 Minutes With Real-Time 
Interactive Cardiac Magnetic Resonance 
Imaging System 806-3 l 464A 
Correspondence of BIOSENSE-Guided Endocardial 
Catheter Maps With Magnetic Resonance 
Imaging: Influence of Number of Locations 
Sampled 888-2 l SlA 
Delayed-Enhancement Magnetic Resonance 
Imaging for Fast and Accurate Assessment of 
Myocardial Viability: Comparison With 
Combined Cine, Tagging and First-Pass 
Perfusion Techniques in 102 Patients 806-5 l 
4658 
Detection of High-Grade Restenosis After Coronary 
Angioplasty Using Noninvasive 
Contrast-Enhanced Magnetic Resonance 
Imaging and Electron Beam Computed 
Tomography in 105 Patients 1033.25*415A 
Detection of Salvaged Myocardium by Contrast 
Enhanced Magnetic Resonance Imaging 806-4 
l 465A 
Determination of Regional Myocardial Blood Flow 
by Magnetic Resonance Imaging in Comparison 
to Positron Emission Tomography 904-3 l 4848 
Enhanced Diagnostic Accuracy to Predict 
Improvement of Left Ventricular Ejection 
Fraction Post-Revascularization by Sequential 
Thallium-201 Imaging and Dobutamine 
Echocardiography 1079-34*429A 
Evaluation of Aortic Valve Stenosis by Magnetic 
Resonance Imaging Compared to Results From 
Transesophageal Echocardiology and Cardiac 
Catheterization 1123-37 l 453A 
Evaluation of Global Left and Right Ventricular 
Function During Supine Physical Exercise by 
Ultra-Fast Magnetic Resonance Imaging 
1010.171*232A 
Evidence of Arterial Wall Inflammation by Magnetic 
Resonance Imaging in Patients With Preclinical 
or Established Atherosclerosis 877.2*302A 
Fast Automated Assessment of Regional Left 
Ventricular Function From Tagged Cardiac 
Images by Harmonic Phase Magnetic 
Resonance Imaging 806-l l 464A 
Four-Dimensional Magnetic Resonance Imaging of 
Congenital Heat Disease 859-205088 
Gender-Specific Cardiac Phenotypic Differences 
Detected by Magnetic Resonance Imaging in 
Hypeatrophic Cardiomyopathy Caused by 
Sarcomeric Gene Mutations 1096.158 l 190A 
High Diagnostic Accuracy of Parametric Magnetic 
Resonance Perfusion Maps for the Detection of 
KEY: Abstract title, Session-abstract number l page number 
JACC February 2000 
Coronary izrtety Disease in Comparison With 
Position Emission Tomography and X-Ray 
Coronary Angingraphy 904.2*484A 
High Resolution Magnetic Resonance Imaging in a 
Novel Porcine Model of Complex 
Atherosclerosis: TIW, T’2.711, and PDW 
Characteristics of Atherosclerotic Plaque 
Components 1190-Z * 479A 
In Viva Quantification of Atherosclerotic Plaque 
Composition by Noninvasive High Resolution 
MRI in Rabbits: A Histopathological 
Correlation 1190.1*47XA 
Left Atrial Volume Measurement by Real-Time 
Three-Dimensional Echocardiography 1100-X l 
4318 
Left Ventricular Ejection Fraction Following Acute 
Myocardial Infarction: Echo, MUGA and 
MRl-Preliminary Results “m the MARRVEL 
Study 806-Z * 464A 
Magnetic Resonance Imaging and 
Echocardiographic Assessment of Pulmonary 
Insufficiency Following Surgical Repair of 
Tetralogy bf Fall@ 1007.175*512A 
Magnetic Resonance Real-Time Imaging of Left 
Ventricular Function: Comparison With 
Conventional Magnetic Resonance Imaging and 
Echocardiogmphy 107X-28*4278 
Nicotine Is an Agent of Angiogenesis: Role of Nitric 
Oxide and Prostacyclin 408-3 l 5458 
Noninvasive Coronary Angiography Using 
Contrast-Enhanced Magnetic Resonance 
Imaging and Electron Beam Computed 
Tomography: Comparison of the 
Contrast-to-Noise Ratio 1033.26 l 415A 
Noninvasive Measurement of Blood Flow in the Left 
Anterior Descending Artery and Great Cardiac 
Vein 1201.4X*3288 
Noninvasive, Quantitative Detection of Left 
Ventricular Wall Dysfunctional Areas in Patients 
With Ischemic Cardiomyopathy Using Magnetic 
Resonance Imaging With Tissue Tagging and 
Finite Element Modeling 1115-142*193A 
Oxidative Metabolism, Glucose Utilization, 
Perfusion, and Contract& Reserve in Patients 
With Chronic Ischemic Left Ventricular 
Dysfunction 1079-29 * 4288 
Quantification of Flow Velocity and Volume With 
Real-Time Cardiovascnlar Magnetic Resonance 
1123.40*454A 
Regional Myocardial Infarct-Related Edema Is 
Visualized by STIR Magnetic Resonance 
Imaging and Correlates With Circumferential 
Strain in Anterior Myocwdial Infarction 
1123-33 l 452A 
Regional Myocardial Perfusion With Entire Heart 
Coverage During Shzss Contrast Enhanced 
Magnetic Resonance Imaging Detects High 
Grade Coronary Stenosis in Patients 904-5 * 
4858 
Relations Between Echocardiographic and Magnetic 
Resonance. Imaging in Hypertensive Patients 
With Electrocardiographic Left Ventricular 
Hypertrophy: The LIFE Study 1123-36 l 453A 
Serial Noninvasive In Viva Magnetic Resonance 
Imaging Monitors Progression and Regression 
of Individual Atherosclerotic Lesions in a 
Rabbit Model 830-l 04328 
Tagged Magnetic Resonance Imaging Can Qualify 
Regional Functional Variation During 
Dobutamine Stress in Subjects With Coronary 
Stenoses 1123-35 -453A 
Targeted Magnetic Resonance Contrast Agent for 
Detection of Thrombus 1111.43 l 280A 
The Backscattered Doppler Power Times Velocity 
Integral at the Vena Contracta for Direct 
Quantification of Regurgitant Volume Flow: 
Clinical Validation Versus Magnetic Resonance 
Imaging 1169-33 l 471A 
Transmyocardial Laser Revascularization (TMLR): 
Preservation of Global and Diastolic Function in 
Chronic Ischemia 1017.138*342A 
Transmyocardial Laser Revascularization Improves 
Regional Wall Motion in Remote and Chronic 
Ischemic Myocardium 904-6 l 4858 
Value of Combined Myocardial Perfusion and 
Functional Analysis in Magnetic Resonance 
Imaging for the Detection of Regional 
Myocardial Ishemia 1006.175=448A 
Magnetic resonance spectroscopy 
Cardiac High Energy Phosphates in Human 
Ischemic Preconditioning Assessed by Magnetic 
Resonance Spectroscopy 1123-34*452A 
Evaluation of Valvular Regurgitation: Real-Time 
Color Flow Magnetic Resonance Imaging 
Compared to Echo 1123-3X l 4538 
Medical record systems, computerized 
Making Cardiac Databases More Clinically Useful 
by Combining “Roll Forward” Update 
Programming With Scanning Technology 
1505-2.5608 
Secure and Accessible Electronic Medical Records: 
Setting Up Your Own Reliable, Low-Cost 
Web-Based System 1503-l l 554A 
The Veterans Administration’s Multimedia Hospital 
Workstation With Text, Images, and Cine: A 
Cardiologist Looks at T&medicine 1503-2 l 
55SA 
Tramtelephonic Patient Entry of Results From Home 
Prothrombin Time Testing Into a Centralized 
Anticoagulation Clinic Database 1501.2*545A 
Membrane potentials 
Myocardial Contractility Modulation Using a 
Nonexcitatory Electrical Signal 11X6-71 *148A 
Metabolism 
A Common Variant of the AMPDl Gene Predicts 
Improved Survival in Patients With Coronary 
Artery Disease 1084-127*365A 
Cardiac High Energy Phosphates in Human 
Ischemic Preconditioning Assessed by Magnetic 
Resonance Spectroscopy 1123-34 l 452A 
Glucose Transport and GLUT-4 Content Within 
Chronically Ishemic Myocardium 1191-j l 
479A 
Prognosis of Patients With Cardiac Fabry Disease: 
Commuison With Classical Tvoe 113X-158. 
209A 
__ 
Segmental Motility and Regional FDG-Uptake With 
Severe Coronary Heart Disease 1079.39*43OA 
The Impact of Aging on Myocardial Intermediary 
Metabolism 847-40 193A 
The Myocardial Metabolic Response to 
Catecholamines Is Dependent Upon the 
Substrate Environment 1191-25 l 481A 
The Skeletal Muscle Intrinsic Mitochondrial 
Oxidative Capacity Is Preserved in Severe Heart 
Failure 1183-143.2228 
Upregulation of Inducible Heme-Oxygenase-l , 
Generator of Carbon Monoxide, in the 
Post-Infarction Myocardium Is Dependent on 
the Presence of Nitric Oxide X99-5 l 402A 
Microcirculation 
1 XFDG-PET, ZOlTI-SPECT Findings and 
Histopathological Characteristics of Syndrome 
X 1191..31.482A 
A 201TI Scintigraphic Evidence of 
Trimetazidine-Mediated Improvement of 
Coronary Microcirculation in Patients With 
Chronic Stable Angina 1196.106 l 409A 
Angiographic No-Reflow During Angioplasty 
Portends Impaired Six-Week Perfusion and 
Functional Recovery: A Dipyridamole Tc99m 
Sestamibi Gated SPECT Imaging Study 
10X3-141 *364A 
Improved Power Doppler Imaging of Normal 
Myocardial Contrast Using a New Dual-Frame 
Trigger Harmonic Angio Algorithm 1032-X l 
414A 
Improvement in Myocardial Contrast Opacification 
Patterns After Myocardial Infarction: Their 
Relation to Myocardial Viability 1032-7 l 414A 
Microvascular Reactivity, Blood Pressure, and 
Survival Are Improved in Septic iNOS-Deficient 
Knockout Mice X86-6 l 312A 
Noninvasive Assessment of Inflammation Using 
Ultrasound Detection of Phagocytosed 
Microbubbles 850-l l 444A 
Oral Folic Acid Treatment Improves Endothelial 
Function in Patients With 
Hyperhomocysteinemia 868-5 l 291A 
SUBJECT INDEX 667A 
Simulated Real-Time Myocardial Contrast 
Echocardiography at a Low Mechanical Index 
Using Innavenous Definity 1144.28*460A 
The Interrelationship Between Myocardial Fibrin, 
Serum Soluble Intercellular Adhesion 
Molecule-l, Cardiac Troponin 1, and 
Subsequent Transplant Coronary Artery Disease 
1185.120-227A 
Transient Hypertension Directly Impairs 
Endothelium-Dependent Vasodilation in Human 
Resistance Arteries 913.6*335A 
Mitral regurgitation 
A New In Viva Model Providing a Direct Gold 
Standard for Mitral Regurgitant Flow 
Quantification: Application to Validate a New 
Doppler Method 1001.172*524A 
Altered Glycosaminoglycan Distribution in 
Myxomatous Mitral Valves 1070-63*527A 
Animation of Mechanical Complications in 
Experimental Ischemic Heart Disease: A New 
Technique for Three-Dimensional Cardiac 
Imaging 1172-1040 3958 
Cardiac Specific Sympathetic Nervous System 
Activation Relates to Hemodynamics and Right 
Ventricular Performance in Mitral Regurgitation 
lOOl-167.5238 
Determinants of Ischemic Mitral Regurgitation: Are 
the Papillary Muscles In or Out of the Ring? 
1001-16X*5238 
In Viva Visualization of the Three-Dimensional 
Shape of the Proximal Flow Convergence Zone 
and the Vena Contracta: A Qualitative Study 
Using Three-Dimensional Color Doppler 
Echocardiography llOO-3.436A 
Ischemic Mitral Regurgitation in the Setting of 
Hibernating Myocardium: Preliminary Results 
in a Porcine Model 1126.102*377A 
Natural History of Right and Left Ventricular Size 
and Function in Patients With Asymptomatic 
Chronic Severe Nonischemic Mitral 
Regurgitation 1001-171~5248 
Outcome of Mitral Valve Prolapse: A Large 
Population-Based Study 1070-65 l 52SA 
Relationship Between the Acoustic Propagation 
Properties of the Mitral Valve and the Severity 
of Mitral Regurgitation in Patients With Cardiac 
Amyloidosis lOOI-169*523A 
Surgery for Myxomatous Mitral Regurgitation: 
Trends Over an Eleven-Year Period 83 1 1 l 
5288 
The Backscattered Doppler Power Times Velocity 
Integral at the Vena Contracta for Direct 
Quantification of Regurgitant Volume Flow: 
Clinical Validation Versus Magnetic Resonance 
Imaging 1169-33 l 471A 
The Role of Mitral Regurgitation and Ventricular 
Function on Pulmonary Venous Waves in 
Patients With Atrial Fibrillation 1143-3 *45SA 
Mitral valve 
Altered Glycosaminoglycan Distribution in 
Myxomatous Mitral Valves 1070-63 *527A 
Association Between Mitral Annulus Calcification 
and Peripheral Arterial Atherosclerotic Disease 
1112.24 l 285A 
Evidence of Ongoing Inflammation in Chronic 
Rheumatic Mitral Valve Disease 1047-64’ 
5278 
Five-Year Follow-Up After Mitral Valve 
Replacement With a Cryopreserved Homograft 
lOOl-174*524A 
Impact of Three-Dimensional Echocardiography in 
Diagnosis and Management of Mitral Valve 
Disease: A Prospective Surgical Validation 
1070.64*52SA 
In Vivo Visualization of the Three-Dimensional 
Shape of the Proximal Flow Convergence Zone 
and the Vena Contracta: A Qualitative Study 
Using Three-Dimensional Color Doppler 
Echocardiography 1100-3 *436A 
Is the Use of Complex Techniques for Mitral Valve 
Repair Justified by the Long-Term Results? 
X31-2.5298 
Relationship Between the Acoustic Propagation 
Prop&es of the Mitral Valve and the Severity 
KEY: Abstract title, Session-abstract number l page number 
668A SUBJECT INDEX 
of Mitral Regurgitation in Patients With Cardiac 
Amyloidosis 1001.169.5238 
Short-Term Results of Left Ventricular Assist and 
Comprehensive Medical Management as Bridge 
to Recovery Therapy for Advanced Heart 
Failure 890-Z l 229A 
The Relationship Between Severity of Mitral 
Annular Calcification and Aortic Stenosis 
1182.64 l 534A 
The Relative Impact of Atria1 Fibrillation on Left 
and Right Atrial Size in Patients Following 
Mitral Valve Replacement 1209.73 l 156A 
The Spectrum of Parachute Mitral Valve: 
Morphologic Descriptors and Outcome 
1215-161 l 521A 
Thromboembolic Complications Following Surgery 
for Mitral Regurgitation: Need for an 
Aggressive Prevention 1114-65 l 531A 
Mitral valve prolapse 
Ehlers-Da&s Syndrome Is Not Associated With 
Significant Echocardiographic Abnormalities 
1146.166*515A 
Outcome of Mitral Valve Prolapse: A Large 
Population-Based Study 1070.65 -5288 
Surgery for Myxomatous Mitral Regurgitation: 
Trends Over an Eleven-Year Period 83 l-l. 
528A 
The Prognostic Role of Arrhythmias in Mitral Valve 
Prolapse: Results of a lo-Year Prospective 
Follow-Up 1070-66-5288 
Mitral valve stenosis 
Can the Results of Stress Doppler Echocardiography 
Predict Symptomatic Improvement in Patients 
Undergoing Percutaneous Mitral Balloon 
Valvotomy 1212-8*487A 
Comparative Indications, Baseline Characteristics, 
and Results of Percutaneous Mechanical Mitral 
Commissurotomy in Western and Developing 
Countries lOOI-175.5258 
Dobutamine Stress Echocardiography, 
Cardiopulmonary Exercise Test, and Exhaled 
Nitric Oxide in Patients With Pure Mitral 
Stenosis 1047-66*527A 
Echocardiographic Mitral Valve Area Using the 
Proximal Isovelocity Surface Area Method in 
Patients Undergoing Balloon Mitral 
Valvuloplasty 1167-2 l 467A 
Evidence That Mitral Valve Area Derived by 
Continuity Equation Method Is Not Affected by 
Alterations in Cardiac Output 1167-l 04678 
Long-Term Results of Mitral Balloon Valvotomy in 
Pregnancy 1001.176.5258 
Safety and Feasibility of Percutaneous Mitral 
Valvotomy With the Metallic Commissurotome 
in Patients With a High Echocardiographic 
Score 1047.65.527A 
Serial Echocardiographic and Clinical Follow-Up in 
Medicare-Aged Patients Undergoing 
Percutaneous Balloon Mitral Commissurotomy 
1163.123*220A 
Molecular biology 
Anabolic Steriods Induce Dose-Dependent 
Apoptotic Cell Death in Adult Ventricular 
Myocytes In Vitro 1048.144*169A 
Analysis of Repair of Ultra Violet Induced DNA 
Damage in Transcriptionally Active and Inactive 
Genes in Rat Cardiac Fibroblasts and Terminally 
Differentiated Myocytes 1161.143.215A 
Antisense Directed at Endothelium Oxidized LDL 
Receptor LOX-l Inhibits Apoptosis in Human 
Coronary Artery Endothelial Cells 1134.500 
2958 
Aortic Smooth Muscle Cells Chemotaxis Is 
Promoted by a New Tenascin-C Isoform 
1133.42 l 293A 
Are Sporadic Cardiac Myxomas a DNA 
Repair-Deficient Heaa Disease? 1184.159. 
226A 
Cardiac Adenylyl Cyclase Isotypes V and VI Are 
Differentially Regulated B-Adrenergic 
Stimulation in Stable Transfected Smooth 
Muscle Cells 1044-53 l 251A 
Cardiovascular Basic Helix-Loop-Helix Factor-l : A 
Novel Transcriptional Repressor Expressed 
Preferentially in the Developing and Adult 
Cardiovascular System 41 l-3 l 549A 
Chronic Angiotensin Converting Enzyme Inhibition 
Restores the Responsiveness of Cardiac 
Mitogen-Activated Protein Kinase in Rats With 
HeartFailure 1161.1440215A 
Coordinated Regulation of Cell Cycle Withdrawal 
During Cardiogenesis 1161.145*215A 
Cytomegalovims Infection of Human Macrophages 
Induces Increased Expression of Scavenger 
Receptor CD36 Gene and Cell-Surface 
Glycoprotein 841-Z-2688 
Developmental Changes in Calcium Regulatory 
Protein Gene Expression in the Human Heart 
1215-164-5218 
Effect of Different Therapeutic Ultrasound 
Frequencies in Preventing Intimal Hyperplasia 
Following Balloon Injury in Pigs Treated With 
Intravenous Antisense Bound to Perfluorocarbon 
Albumin Microbubbles 1169.360472A 
Effect of Matrix Metalloproteinase Inhibitors on 
Atherogenesis 842-4 l 270A 
Evidence of Ongoing Inflammation in Chronic 
Rheumatic Mitral Valve Disease 1047-64 l 
5278 
Frequency of Viral Persistence in End-Stage Dilated 
Cardiomyopathy 1028.158*166A 
Increased Furin mRNA Expression Precedes Matrix 
Metalloprotease-2 Activation During Sustained 
Flow Changes in Rabbit Arteries 1092-18 l 
2778 
Mammalian Suppressor of sgv-1 (MSSl), a Putative 
Transcription Factor and Differentiation Related 
Gene, Is Upregulated in Explant Derived 
Compared With Enzyme Dispersed Human 
Aortic Vascular Smooth Muscle Cells In Vitro 
1110.112.49A 
Novel Basic Helix-Loop-Helix Proteins Expressed 
in Heart Repress Transcription by Recruiting 
mSin3 and NCoR 411.4*549A 
Novel Induction of Heat Shock Proteins by Magnetic 
Field Stress in Myocytes In Vitro and In Viva 
1161-148.2168 
Oxidative Stress in Ethanol-Induced Cardiomyocyte 
Apoptosis 1048.145 l 169A 
Possible Molecular Mechanisms Responsible for the 
Beneficial Effects of Physical Training on 
Cardiac Function During Development of Heart 
Failure 1206-145*234A 
Regulation of TNF-Induced Vascular Endothelial 
Cell Apoptosis by Racl: A Model for the Pro- 
and AntiApoptotic Effects of Reactive Oxygen 
Species 41 l-5 l 5498 
Role of Glycogen Synthase Kinase-3b in 
Cardioyocyte Hypertrophy 1215.163*521A 
Serum Levels of Circulating Adhesion Molecules 
Reflect the Severity of Coronary Atherosclerosis 
1061-133.3548 
Soluble Forms of P-, and E-S&&in in Children 
With Immune Globulin-Resistant Kawasaki 
Disease 1146-162*514A 
Sp-1 Dependent Expression of the Cardiac Troponin 
T (cTNT) Gene in Avian Embryonic Myocytes 
Can Be Compensated for by the MEF-2 Site of 
the cTNT ‘Cardiac Element’ 1161.L47*216A 
Stretch-Induced Activation of Cardiac JaMSTAT 
Pathway Is Augmented in the Rat Hypertensive 
Hearts: Role of Endogenous Angiotensin II 
1068-11 l 263A 
Systemic and Myocardial Expression of Brain 
Natriuretic Peptide After Adenoviral-Mediated 
Gene Transfer Using a New Catheter-Based 
Approach 1206.144.234A 
The Role of Genetic Reprogramming in a Canine 
Model of Chronic Atrial Fibrillation: Alterations 
in Gene Expression of Markers of Hypertrophy 
and Calcium Homeostasis Proteins 883-l l 
146A 
Transcription Factor Control of Myogenic 
Differentiation in a Myogenic Model Cell Line 
1161.146*215A 
Transforming Growth Factor Beta 1 (TGF-bl) 
Induces a Growth Factor Cascade That Results 
in Extracellular-Regulated Kinase (ERK) and 
JACC February 2000 
P38 Mitogen-Activated Protein Kinase 
Activation in Endothelial Cells 1134-53 l 296A 
Vascular Injury Induces Posttranscriptional 
Regulation of the Id3 Gene 41 l-l l 548A 
Monitoring, physiologic 
Ischemia Detection by Means of a Subcutaneous 
Electrode Array 1211.59.159A 
Monoclonal antibodies 
Early Neutrophil Recruitment and Intimal 
Hyperplasia: Studies in a Murine Model of 
Femoral Artery Transluminal Injury 1092.220 
2788 
Immunolocalization of Oxidized 
Phosphatidylcholine and Apolipoprotein B in 
the Progression of Human Coronary 
Atherosclerotic Plaques 1068-10 l 263A 
Noninvasive Detection of Transplant Vasculopathy 
Using Indian-1 11 Tagged 2D3 Antibody in a 
Swine Model 1185.123*227A 
The Adventitia of Atherosclerotic Coronary Arteries 
Frequetitly Contains Chlymydia Pneumoniae 
887-3 l 312A 
Morphogenesis 
Coordinated Regulation of Cell Cycle Withdrawal 
DuringCardiogenesis 1161-145*215A 
Transcription Factor Control of Myogenic 
Differentiation in a Myogenic Model Cell Line 
1161.146*215A 
Muscle, skeletal 
A Lamin A/C Gene Mutation Associated With 
Dilated Cardiomyopathy With Variable Skeletal 
Muscle Involvement 855.60202A 
Relationship Between Exercise Capacity and 
Peripheral Vessel Sympathetic Function 
Determined With 123 
I-Meta-Iodobenzylguanidine (MIBG) 1050.124 
l 174A 
The Skeletal Muscle Intrinsic Mitochondrial 
Oxidative Capacity Contributes to Determine 
Exercise Capacity in Normal Subjects 
1050.123 l 174A 
The Skeletal Muscle Intrinsic Mitochondrial 
Oxidative Capacity Is Preserved in Severe Heart 
Failure 1183.143*222A 
Muscle, smooth 
avB3 Integrin-Mediated Synergy in the Promotion of 
Human Smooth Muscle Cell Migration by 
Platelet Derived Growth Factor and the Matrix 
Proteins Vitronectin or Osteopontin 1178.55 l 
317A 
Exochelin Prevents Neointima Formation After 
Coronary Artery Balloon Injury in a Porcine 
Model 1065-116.258 
HMG-CoA Reductase Inhibitors Affect the 
Fibrinolytic System of Human Vascular Smooth 
Muscle Cells In Vitro 886-40 311A 
Low Versus High Dose Radiation Has Divergent 
Effects on Special Mouth Care Migratory and 
Adhesive Behavior 826.2*28A 
Mammalian Suppressor of sgv-1 (MSSl), a Putative 
Transcription Factor and Differentiation Related 
Gene, Is Upregulated in Explant Derived 
Compared With Enzyme Dispersed Human 
Aortic Vascular Smooth Muscle Cells In Vitro 
1110.112.498 
Successful Nonviml Gene Transfer Using a Novel 
Thermosensitive Gel Stent Coating 1110-l 13 l 
49A 
The Endothelial Cell-Specific Angiogenic Factor 
Dell Mediates Smooth Muscle Cell Adhesion 
and Migration 841-l -2688 
Thromboxane A2 Potent&es Mitogenic Effects of 
Mildly Oxidized Low Density Lipoproteins on 
Vascular Smooth Muscle Cells 841.4*269A 
Vascular Injury Induces Posttranscriptional 
Regulation of the Id3 Gene 411-l l 548A 
Myocardial contraction 
A Rapid Bedside Test for Brain Natriueretic Peptide 
Accurately Delineates Both Systolic and 
Diastolic Dysfunction in Patients Referred for 
Echocardiography 1027.146.164A 
Altered Left Ventricular Inotropic Reserve and 
Mechanoenergetics Early in the Development of 
HeartFailure lOlO-1760233A 
KEE Abstract title, Session-abstract number l page number 
JACC February 2000 
Altered Segmental Compression/Expansion 
Crossover: A Sensitive Indicator of Acute 
Myocardial Ischemia as Assessed by 
Noninvasive Strain Rate Imaging 885-20 475A 
Anabolic Steroids Improve Myocardial Performance 
in Dilated Hearts in Failure 1162.159=219A 
Change in Systolic Function and Midwall Mechanics 
After One Year of Antihypertensive Treatment: 
The LIFE Study 1025-21 l 249A 
Depressed Tolerance to Fluorocarbon-Simulated 
Ischemia in Failing Rat Myocardium Due to 
Impaired Intracellular CA2+ Modulation 
1126-107*379A 
Effects of Candesartan and Enalapril on 
Contractility, Intracellular Ca2+ Handling, and 
Myofibrillar Ca2+ Responsiveness in Failing 
Myocardium of Postinfarction Rats 1206.149 * 
2358 
Effects of Carvedilol Versus Probucol on Survival, 
Left Ventricular Function in Morphology in 
Ischemic Hezt Failure in Rats 1059.1050349A 
Fast Automated Assessment of Regional Left 
Ventricular Function From Tagged Cardiac 
Images by Harmonic Phase Magnetic 
Resonance Imaging 806-l -4648 
Hyperkinesis of Noninfarcted Myocardial Regions 
by Echocardiography: Relation to Coronary 
Artery Stenosis 1054.7.4208 
Improved Left Ventricular Function and Reduced 
Peripheral Resistance After Long-Term Exercise 
Training in Patients With Chronic Heart Failure: 
The Leipzig Heart Failure Training Trial 901.6 
*231A 
Improved Responsiveness to Beta-Adrenergic 
Stimulation in Trabeculae From LVAD 
Supported Hearts 803.2*199A 
Myocardidial Contractility Modulation Using a 
Nonexcitatory Electrical Signal 1186.710 148A 
Myocardial Functional Recovery Early After 
Minimally Invasive Coronarv Surperv: A 
Tramesophageal Echocardiigrapgic study 
X01-4*355A 
Myocardial Strain Doppler: A Sensitive New 
Method for Detection of Ischemia During 
Off-Pump Coronary Bypass Surgery 1214.340 
49OA 
Right Ventricle Strain Rate: A New Way of 
Characterizing Right Ventricular Myocardium 
1056-39.424A 
Temporal Change of Myocardial Capillary Flow 
After Attempted Reperfusion in Acute 
Myocardial Infarction 1032.2*413A 
The Positive Inctropic Effects of Hydrostatic 
Pressure Are Buffered by the Endocardial 
Endothelim via Prostaglandins 1071-148.1768 
Value of Combined Myocardial Perfusion and 
Functional Analysis in Magnetic Resonance 
Imaging for the Detection of Regional 
Myccardial Ishemia 1006-175 04488 
Myocardial hibernation 
13N-Ammonia Myocardial Uptake but Not Blood 
Flow Identifies Regions With Positive 
Contractile Reserve to Low-Dose Dobutamine 
1079-33-4298 
Assessing Myocardial Viability Using NOGA Left 
Ventricular Mapping System in a Chronic 
Ischemic Porcine Model: A Correlation With 
Histology and Thallium Scintigmphy 1079.38 l 
430A 
Coronary Bypass Surgery in Patients With a 
Prolonged History of Medically Treated 
Ischemic Heart Disease, Decreased Left 
Ventricular Function, and Relatively Low Extent 
of Myocardial Viability by Positron Emission 
Tomography (PET and Revascularization: Th 
1079.32.429A 
Does Demand Ischemia Trigger Myocardial 
Hibernation? 11%104*378A 
Electroanatomical Left Ventricular Mapping 
(NOGA) for Prediction of Functional Recovery 
1095142*185A 
Glucose Transport and GLUT-4 Content Within 
Chmnically lshemic Myocardium 1191.50 
4798 
Hibernating Myocardium Diagnosed With 
Nonfluoroscopic Electromechanical (NOGA) 
Mapping: A Comparison With Dobutamine 
Stress Echocardiography 888-l l 81A 
Ischemic Mitral Regurgitation in the Setting of 
Hibernating Myocardium: Preliminary Results 
in a Porcine Model 1126- 102 l 3778 
Nitrate-Enhanced Tc-99m Sestamibi Single Photon 
Emission Computed Tomography Is Comparable 
to Tl-201 for Detection of Myocardial Viability 
and for Predicting Outcome in Patients With 
Hezt Failure 1006-173 l 447A 
NOGA Mapping of the Endocardial Surface 
Subtended by Chronic Total Occlusions With 
and Without Collateral Circulation 888-3 l SlA 
Regional Left Ventricular Response to Low-Dose 
Dobutamine Infusion During ECG-Gated 
Tc-99m Sestamibi Single Photon Emission 
Computed Tomography Image Acquisition 
Accurately Predicts Global Left Ventricular 
Function After Revascularization in Patients 
With 1006.167*446A 
The Extent of Ischemic and Nonischemic Viable 
Tissue Predicts the Degree of Recoverv of Left 
Ventricular Dysfunction Post Revascu~arization 
1079-31 l 428A 
Myocardial infarction, pathophysiology 
A Correlation Between Plasma Oxidized Low 
Density Lipoprotein (Ox-LDL) Levels and 
C-Reactive Protein Levels in Patients With 
Acute Myocardial Infarction 861.60290A 
ACE Inhibition and AI1 Blockade Following 
Experimental Myocardial Infarction: Effects on 
Ventricular Hypertrophy, Remodeling, and 
Function 1162.153.2178 
Activation of Tissue Factor-Dependent Coagulation 
Pathway in Patients With Acute Myocardial 
Infarction 1194.138*406A 
Admission Heart Rate Is a Useful Tool for Risk 
Stratification of Patients With Acute Myocardial 
Infarction in the Reperfnsion Era 1173.141 l 
3988 
An Algorithm Based on Clinical and Angiographic 
Criteria for Selecting a Glycoprotein llbfllla 
Inhibitor During Percutaneous Coronary 
Intervention 1199-87.908 
Angiographic Characteristics Associated With the 
Development of Q-Wave Myocardial Infarction 
11.50.95.3918 
Angiographic iManifestations of Coronary Artery 
Disease Presenting as Acute Coronary 
Syndrome in Patients With Cocaine Abuse 
1127-140.3818 
Angiographic Myocardial Blush Grade Relates to 
Intravenous Myocardial Contrast Echo and 
Coronary Flow Reserve for Assessment of 
Reperfnsion After Myocardial Infarction 
1173-135*397A 
Apex to Base Position of an Infarct Is a Major 
Determinant of Its Size in Relation to the Risk 
Zone 1126-106-3788 
Assessment of Myocardial Perfusion by Intravenous 
Administration of Levovist: A Comparison With 
2OlTI Single Photon Emission Computed 
Tomography 1077.5*426A 
Beyond TIMI- Flow: The Importance of Restored 
Myocardial Perfusion for Survival in High Risk 
Patients Undergoing Primary or Rescue PTCA 
900-4 l 403A 
C-260T Polymorphism in the Promoter of the CD14 
Monocyte Receptor Gene Is Associated With 
Myocardial Infarction in Japanese Population 
1015.133*337A 
Can T-Wave Normalization in Infarct-Related 
Electrocardiographic Leads During Exercise 
Testing Predict the Viability and Extent of 
Improvement of Wall Motion of Dysfunctioning 
Myocardium After Coronary Revascularization 
in Patients With Q-Wave Infarction? 1031-680 
1OOA 
Clinical Outcome Remains Poor in Diabetics With 
Myocardial Infarction Despite Early Fibrinoltyic 
Therapy: Findings From InTIME II 1195-1300 
407A 
SUBJECT INDEX 669A 
Clinical Safety and Efficacy of the PercuSurge 
Guardwire in the Saphenous Vein Graft 
Angioplasty Free of Emboli (SAFE) Study 
844-6 l 41A 
Clinical Significance of Antegrade Flow to Infarct 
Zone Before Primary Percutaneous 
Transluminal Coronary Angioplasty in Q-Wave 
Acute Myocardial Infarction 1060.137*351A 
Clinical Significance of ST-Segment Elevation in 
Lead Vl in Acute Inferior Myocardial infarction 
1031-62.998 
Common Genetic Variants of the Thrombomodulin 
Gene as a Risk Factor for Myocardial Infarction 
1201.42*327A 
Coronary Artery Calcification Extent Is Directly 
Related to Clinical Stability in Patients With 
Coronary Artery Disease 877-5 l 303A 
Deceleration Time of Diastolic Coronary Blood 
Flow Velocity in Patients With Acute Anterior 
Myocardial Infarction Can Predict Regional Left 
Ventricular Wall Motion Recovery: Assessment 
by Transthoracic Doppler Echocardiography 
1054-5 l 420A 
Diagnosis of Right Ventricular Infarction by Doppler 
Total Ejection Isovolume Index 1054-3 l 419A 
Differences Between Unstable Angina and Coronary 
Angioplasty in Platelet and Leukocyte 
Activation 1194.1400406A 
Different Circadian Pattern in the Onset of Acute 
Myocardial Infarction in African-Americans 
1148.136.387A 
Echocardiographic Determinants of Prognosis After 
Acute Myocardial Infarction: Beyond Ejection 
Fraction 1148.1350386A 
Effect of ACE Inhibitor and AT 1 Blocker on 
Myocardial Expression of TNF-a in Post 
Myocardial Infarction Ventricular Remodeling 
1071.142*175A 
Effect of Adrenergic Blockade on Myocardial 
Collagen Type I/III Ratio and Cytokine 
Expression Post Myocardial Infarction 
1071.143.175A 
Elevated CK-MB Following Coronary Intervention 
in Patients With Acute Coronary Syndromes Is 
Associated With a Four-Fold Increase in 
Mortality: Results From the GUSTO-L% and 
PURSUIT Trials 843-5 -4OA 
Elevated Levels of C-Reactive Protein in Patients 
With Acute Myocardial Infarction Are a 
Predictor of Mortality and Heart Failure but Not 
of New Coronary Events 1149.69 * 3898 
Impact of Nitrate Administration on the TIM1 Frame 
Count and TIM1 Flow Grades in the Setting of 
Acute Myocardial Infarction 1173-137*397A 
Improved Detection of Microvascular Integrity by 
Delayed Compared to Early Intermittent 
Myocardial Contrast Echocardiography Early 
After Acute Myocardial Infarction 1006.169 l 
446A 
Incidence and Prognosis on Non-Q Wave 
Myocwdial Infarction in the Thrombolytic Era: 
Insights From ASSENT II 1150-73 l 39OA 
increased Serum Matrix Metalloproteinase-9 
Expression in Postmenopausal Women on 
Estrogen Therapy 877.4.3038 
Influenza Vaccination and Reduced Risk of 
Recurrent Association of Myocardial Infarction 
1015.131.3378 
Is C-Reactive Protein a Marker for First and 
Recurrent Acute Coronary Events in Very 
Different Subsets of Stable Ischemic Heart 
Disease? 887.403138 
Is the Diagnostic Catheterization in Acute 
Myocardial Infarction Therapeutic? Rate of 
Opening of Closed Arteries With Diagnostic 
Injections Following Thrombolytic 
Administration in TIMI 10B and 14 1083.1370 
3638 
Is the Morning Peak of Acute Myocardial 
Infarction’s Onset Due to Sleep Related 
Breathing Orders? A Prospective Study 
1194.141*406A 
Ischemic Myocardial Injury in the Acute Coronsuy 
Syndromes: The Role of Elevated Plasma 
Homocysteine Concentrations 1194.139*406A 
KEY: Abstract title, Session-abstract number l page number 
670A SUBJECT INDEX 
LATIN (Lipid Assessment Trial in an Italian 
Network) 1159.18 l 309A 
Long-Term Prognostic Value of a Rapid Troponin T 
Bedside Test in Patients With Acute Coronary 
Syndromes 1084.128*365A 
Loss of the Relationship Between Refractory Period 
and Reentry Period in the Epicardial Border 
Zone of Hearts With Healed Infarcts: The Role 
of Gap Junctional Connexins 1186.740 149A 
Lower Prevalence of Specific Allele at the DRB 1 
MHC Class II Locus (DR3) in Young 
Myocardial Infarction Patients Compared to 
Older Subjects 1172.103*394A 
Marked Reduction of Insulin-Like Growth Factor-l 
in Acute Myocardial Infarction 836-l l 355A 
Myocardial Contract Echocardiography With 
Continuous Infusion of Optison and Variable 
Pulsing Intervals: Experience With Fist 200 
Cases Undergoing 99mTc-Sestamibi-SPECT 
867-l l 456A 
Myocardial Salvage in Patients With Non-ST 
Elevation Myocardial Infarction: Results Using 
Technetium-99m Sestamibi Myocardial 
Perfusion Imaging 1079-36 l 430A 
Plasma F2-Isoprostanes Are a Marker of Oxidative 
Stress Which Are Elevated in Patients With 
Unstable Coronary Syndromes 1194-l 33 l 
404A 
Prediction of Ultimate Infarct Size Despite Persistent 
Total Coronary Occlusion: A Study Using 
Myocardial Contrast Echocardiography 850-40 
444A 
Predictors of Microvascular Intergrity After 
Rep&used Acute Myocardial Infarction: 
Effects of Pressure-Derived Fractional Collateral 
Flow 1173.139.3988 
Prior Aspirin Use Is a Univzuiate, but NOT a 
Multivariate Predictor of One Year Mortality in 
10,302 Patients With Acute Coronary 
Syndromes: Results From OPUS-TIM1 16 
1151-97.3918 
Prognosis of Viable Myocudium Early After Acute 
Myocardial Infarction: Relation to Indicators of 
Left Ventricular Systolic Dysfunction 892-20 
4838 
Prospective Study of Pathogen Burden and Risk of 
Myocaxiial Infarction and Cardiovascular Death 
846-l -3678 
Quantitative Angiographic Measurement of 
Absolute Coronary Blood Flow and Its Relation 
to Mortality in Acute Myocardial Infarction 
1173-132*396A 
Quantitative Assessment of Infarct Size In Vivo by 
Myocardial Contrast Echocardiography in Acute 
Myocaxdial Infarction Model of the Rat 
1213-25*488A 
Quantitative Assessment of Left Ventricular 
Myocardial Viability Using Systolic Mitral 
Annular Descent Velocity: A Study With 
Dobutamine Stress Pulsed Tissue Doppler 
Imaging 892-4 l 483A 
Regional Myocwdial Infarct-Related Edema Is 
Visualized by STIR Magnetic Resonance 
Imaging and Correlates With Circumferential 
Strain in Anterior Myocardial Infarction 
1123-33.4528 
Relative Prognostic Importance of Preserved 
Antegrade Coronary Blood Flow Before 
Compared to After Angioplasty in Patients 
Undergoing Primary Percutaneous Trsnsluminal 
Coronary Angioplasty 1083-138*363A 
Risk of Arrhytbmic Mortality in High-Risk Patients 
Does Not Change With Time Course in the First 
Two Years After Myocardial Infarction: A 
Secondary Meta-Analysis 856-6*375A 
Role of Oral Blocka+ of Platelet Glycoprotein 
IIb/IIIa OF Neutrophil-Platelet Interactions in 
Patients With Acute Coronary Syndromes 
1037-102*343A 
Routine Heparinization During Coronary 
Arteriography: Is It Still Indicated? 1107.77 l 
42A 
Seasonal Variation of Myocardial Infarct Size in 
Humans 1150-72 l 3898 
Serial Versus Single-One-Point Cardiac Troponin T 
Measurements for Estimation of Myocardial 
Infarct Size-a Histoanatomical Study in 
Experimental Myocardial Infarction 1172.1020 
394A 
Soluble Matrix Metalloprotease (MMP).9 Levels in 
Systemic and Coronary Circulation in Patients 
With Variant Angina and Acute Coronsry Artery 
Syndrome 1148-140*388A 
Strain Rate Imaging Can Accurately Identify Infarct 
Segments in Patients With Myocardial 
Infarction: A Clinical Study 91%2*494A 
Temporal Evolution of the Contractile State of 
Neighboring Myocardium in the Early Phase of 
Acute Myocaxlial Infarction 1105.133 03688 
The Incidence of Late Stent Thrombosis Without the 
Use of Brachytherapy 1176.840778 
Three-Dimensional Echocardiographic 
Quantification of Left Ventricular Remodeling 
After Acute Myocardial Infarction 1144.260 
460A 
Time Course of Coronary Flow Reserve Recovery in 
Infarct- Related and Remote Vascular Areas 
Following Acute Myocardial Infarction 
1200.111.928 
Time Course of Early Elevation of Tissue Inhibitor 
of Matrix Metalloproteinase 1 (TIMP-1) 
Following Acute Myocardial Infarction 
1148.137.3878 
Time-to-Balloon Dependence of Coronary Flow 
Velocity Reserve After Primary Angioplasty in 
Patients With Anterior Acute Myocardial 
Infarction 899-4-4018 
Use of Body Surface Mapping in Diagndsis of Acute 
Myocardial Infarction in Patients With Chest 
Pain and Left Bundle Branch Block 1031.670 
1OOA 
Validation of Real-Time Three-Dimensional 
Echocardiography for Quantifying Left 
Ventricular Volumes in the Presence of a Left 
Ventricular Aneurysm: In Vitro and Clinical 
studies 1095.143*186A 
Myocardial infarction, treatment 
A Novel Noninvasive Short Hospital Stay Strategy 
for Low Risk Myocardial Infarction: Six-Month 
Follow-Up 103X-1400347A 
A Randomized Trial of Thrombolysis Versus 
Transfer for Primary PTCA in High Risk Acute 
Myocardial Infarction Patients: Results of the 
AIR PAM1 Trial 8643 l 376A 
A Simple Model for Prediction of Mortality in Acute 
Myocardial Infarction: Observations From 
InTIME II 1173-1400398A 
A Simple Tool 4s a Strong Predictor of Long-Term 
Mortality After Acute Myocardial Infarction in 
the Recanalization Era: Predischarge Exercise 
Test 874-4 l 214A 
Abciximab Improves Microvascular Function After 
Rescue Percutaneous Coronary Intervention: A 
TIMI 14 Substudy 843-6*4OA 
Angiographic No-Reflow During Angioplasty 
Portends Impaired Six-Week Petfusion s,nd 
Functional Recovery: A Dipyridamole Tc99m 
Sestamibi C&ted SPECT Imaging Study 
10X3-141*3648 
Angiotensin II Receptor Antagonism Alone Does 
Not Limit Post-Infarction Left Ventricular 
Remodeling 1059.102*349A 
Baroreflexsensitivity and Heart Rate Variability Arc 
Independent Risk Indicators for One-Year 
Mortality in Patients After Acute Transmural 
Myocardial Infarction and Individually 
Optimized Therapy: Results of the Post-Infarct 
Risk Stratification Study (PIR 880-3 l 145A 
Benefit Versus Bleeding Complications After 
Thrombolysis for Acute Myocardial Infarction 
in Patients With History of Gastroduodenal 
Ulcers 873-4 l 386A 
Beta Blocker Treatment for Acute Myocardial 
Infarction in Patients With Clinical Evidence of 
Heart Failure: Evidence From the GUSTO Trials 
864-4 l 3768 
Beyond TIMI- Flow: The Importance of Restored 
Myocardial Perfusion for Survival in High Risk 
JACC February 2000 
Patients Undergoing Primary oi Rescue PTCA 
900-4 l 403A 
Blush Grade Is a Stronger Predictor of Four Week 
Left Ventricular Function Than Intravenous 
Myocardial Contrast Echocardiography and 
Coronary Flow Reserve 1213.32*490A 
Cardiogenic Shock After Acute Myocardial 
Infarction in the Elderly: The Michigan 
Cooperative Cardiovascular Project Experience 
1116-123.1968 
Chest Pain and Myocardial Infarction: Is It Time to 
Redefine the Classical Clinical Presentation? 
Observations From the NRMI 2 1127.137 l 
380A 
Chest Pain Emergency Units and Their Impact on 
Processes of Care and Outcome: Observations 
From the National Registty of Myocardial 
Infarction 864-6 l 3778 
Clinical Outcome Remains Poor in Diabetics With 
Myocardial Infarction Despite Early Fibrinoltyic 
Therapy: Findings From InTIME Il 11‘95.1300 
407A 
Comparison of Antiplatelet Effects of Clopidogrel, 
Aspirin, and their Combination in Patients 
Following Myocardial Infarction 1151-98 l 
391A 
Contemporary Use of Evidence-Based Therapies in 
High Risk Groups After Myocardial Infarction 
1038.138*346A 
Diabetes Mellitus in Cardiogenic Shock 
Complicating Acute Myocardial Infarction: 
Report From the SHOCK Registry 1116..120* 
196A 
Divergent Effects of “Discretional” Versus 
“Mandated” Stenting on Acute Myocardial 
Infarction Survival in Women 1130-88 l 56A 
Do Different B-Blockers Cause Different Mortality 
Effects Following a Myocardial Infarction? 
1202-53*329A 
Do Proximal Right Coronruy Artery Lesions in 
Acute Myocwdial Infarction Benefit From 
Stenting? The Stent PAM1 Randomized Trial 
900-5 l 403A 
Do Transplanted Cardiomyocytes Augment Global 
Left Ventricular Function in Infarcted Rat 
Heart? 1172-101 l 394A 
Does Cardiologist Subspecialization Affect the 
Cost-Effective Management of Acute 
Myocardial Infarction Patients Undergoing 
Pre-Discharge SPECT? 88469474A 
Early ACE Inhibitor Treatment Is Associated With 
Improved Short-Term Survival in Diabetics 
After Acute Myocardial Infarction 103%1370 
346A 
Early and Striking Mortality Reduction After Acute 
Coronary Syndromes Following Lipid Lowering 
Therapy 908-5 l 411A 
Effect of End-of-Month Admission on Discharge 
Quality Parameters for Acute Myocardial 
Infarction Patients 1104-14.5478 
Effect of End-of-Month Admission on Length of 
Stay for Acute Myocardial Infarction Patients 
1058.14*543A 
Effect of Managed Care Market Share on Treatment 
of Fee-for-Service Patients With Myocardial 
Infarction 833.4*268A 
Effects of Carxdilol Versus Probucol on Survival, 
Left Ventricular Function in Morphology in 
Ischemic Heart Failure in Rats 1059-105*349A 
Enoxaparin Pharmacokinetics and 
Phxmacodynamics After Intravenous Bolos 
Administration Alone and at Initiation of a 
Subcutaneous Dosing Regimen 1106.1290 
3738 
Exercise-Induced Negative U Waves in Precordial 
Leads as a Marker of Ischemic but Viable 
Myocardium in Patients With Recent Anterior 
Myocardial Infarction 1016.104*338A 
Explaining the Relationship Between Age, 
Cardiogenic Shock, and Outcomes: 
Echocardiographic Observations From the 
SHOCK Trial 1163-1’22.219A 
Functional Capacity Following Emergency 
Revascularization in Cardiogenic Shock 
KEY: Abstract title, Session-abstract number l page number 
JACC February 2000 
Patients: Preliminzuy Results From the SHOCK 
Trial 873.2*385A 
Gender-Based Differences in Treatment and 
Mortality of Acute Myocardial Infarction 
1038-139.347A 
Higher aPTTs Associated With Worse Outcomes 
After Thrombolytic Therapy With 
Reduced-Dose Heparin: Results From 
ASSENT-Z 1106105*372A 
Hirudin Significantly Reduces Ischemic Events 
Following Coronary Intervention for Acute 
Coronary Syndromes 843-3 l 39A 
Home Is Where the Heart Is: Hospital in the Home 
Management ofMyocardia1 Infarction 
1060~136.3518 
Hospital Characteristics and Treatment of Acute 
Myocardial Infarction: Role of Ownership and 
Teaching Status 833-3 l 267A 
Impact of Quality Improvement Initiative on 
Long-Term Compliance to Key Quality of Care 
Indicators After Acute Myocardial Infarction 
1171.13*555A 
Impact of the Results of the Landmark 4S Lipid 
Lowering Trial on Prescribing Habits for an 
Elderly Population 1009.170-3148 
Improved Survival Following Acute Myocardial 
Infarction Complicated by Cudiogenic Shock 
With Left Ventricular Assist Device/Transplant 
Support: A Study Comparing Aggressive 
Intervention With Conservative Treatment 
890-3 02298 
In-Hospital Outcomes Following Percutaneous 
Transluminal Coronary Angioplasty Versus 
St& Placement for Acute Myocardial 
Infarction: New York State Experience 1040-75 
*llA 
Incidence, Risk Factors, and Clinical Outcome of 
Stroke After Acute Myocardial Infarction in 
Clinical Practice 873-3 l 385A 
Influence of Gender on In-Hospital Outcomes of 
Patients Undergoing Primary Percutaneous 
Transluminal Coronary Angioplasty for Acute 
Myocardial Infarction: New York State 
Experience 878.2*72A 
Initial Experience With Angiojet Mechanical 
Tbrombectomy in the Treatment of Acute 
Myocardial Infarction 1062-79 *19A 
Interim Results of the Tirofiban Given in the 
Emergency Room Before Primary Angioplasty. 
(TIGER-PA) Pilot Study 1106-102 *371A 
InTIME-Zb: Omission of Heparin Bolus Lowers 
Rate of Intracranial Hemorrhage With 
Lanoteplase 1195-129.4078 
Intracoronary Enalaprilat in Patients With Acute 
Myocardial Infarction 1038.135*346A 
Intravenous Atria1 Natriuretic Peptide Prevents Left 
Ventricular Remodeling in Patients With 
Anterior Acute Myocardial Infarction 1038.128 
l 345A 
Is the Quality of Care in Octogenarians With Acute 
Myocardial Infa-ction Optimal? 1147-15*554A 
Is There a Benefit of Early Angiography in ST 
Segment Depression Myocardial Infarction? An 
Observational Study 900.6.4038 
Is Use of a Statin Agent at the Time of Presentation 
for Acute Myocardial Infarction Associated 
With a Favorable Outcome? 1009-171 l 314A 
Left Ventricular Ejection Fraction Following Acute 
Myocardial Infarction: Echo, MUGA and 
MRI-Preliminruy Results From the MARRVEL 
Study 806-Z * 464A 
Longer Thmmbolysis Door-to-Needle Times Are 
Associated With Increased Mortality in Acute 
Myocardial Infarction: An Analysis of 85,589 
Patients in the National Registry of Myocardial 
Infarction 2+3 864-l l 3768 
Low Energy Laser Irradiation Reduces Formation of 
Scar Tissue Following Myocardial Infarction 
1038-136.3468 
Low-Molecular-Weight Heparin in Acute Coromuy 
Syndrome: Evidence for Superior or Equivalent 
Efficacy Compared to Unfractionated Heparin? 
1037.106*344A 
Marked Delay in Presentation of Native American 
Patients With Acute Myocardial Infarction 
1127-139.3808 
Mortality With Coronary Artery Bypass Grafting for 
Non-Q Myocardial Infarction: Results From the 
1996 New York State Cardiac Surgery Database 
103%141*347A 
Multivessel Percutaneous Coronary Interventions 
During Acute Coronary Syndromes Appear to 
Be Safe in the Glycoprotein IIblIIIa Antagonist 
Era 837-3 l 357A 
Noninvasive Transthoracic Low Frequency 
Ultrasound Greatly Augments Thrombolysis in 
a Canine Model of Acute Myocardial Infarction 
1195-128*407A 
One-Year Follow-Up After Primary Coroniuy 
Intervention for Acute Myocardial Infarction in 
Diabetic Patients: STENT PAM1 Trial Results 
878-4 l 72A 
Percutaneous Coronary Intervention for Non-ST 
Elevation Myocardial Infarction: A Repoa From 
the NHLBI Dynamic Registry 843-l l 39A 
Physician Characteristics and Variation in Treatment 
for Acute Myocardial Infarction 833-l l 267A 
Platelet Activation as a Potential Mechanism of GP 
IIb/IIIa Inhibitor-Induced Thrombocytopenia 
1106.103*371A 
Platelet Glycoprotein lIb/IIIa Receptor Blockade 
After Failed Thrombolysis Is Associated With 
Risk of Bleeding 1106.101 l 371A 
Predictors of Delay From Emergency Room to 
Catheterization With Primary Percutaneous 
Transluminal Coronary Angioplasty for Acute 
Myocardial Infarction 1062-82.208 
Prevalence of Coron;uy Artery Disease in Black and 
White Patients With Acute Myocaniial 
Infarction 1150-93.3908 
Primary Angioplasty Without Surgical Back-Up at 
All: Results of a Five-Year Experience in a 
Community Hospital in Europe 1083-1390 
364A 
Primary Percutaneous Transluminal Coronary 
Angiopiasty in Patients With Acute Myocardial 
Infarction and Prior Coronary Artery Bypass 
Grafting 1062-80*19A 
Ptimy Percutaneous Transluminal Coronary 
Angioplasty With and Without Stent 
Implantation in 671 Patients With Acute 
Myocardial Infarction Complicated by 
Cardiogenic Shock: Results of the ALKK 
Primary-PTCA Registry 1083-135 l 363A 
Primary Stenting Versus Balloon PTCA for the 
Treatment of Acute Vein Graft Occlusion in 
Myocardial Infarction: Ln-Hospital Results From 
the Brazilian Coronary Interventional Registry 
(CENIC) X43-2*39A 
Prior Bypass Surgery Protects the Diabetic Patient in 
the Setting of Spontaneous Q-Wave Myocardial 
Infarction 1150.71.3898 
Prior Myocardial Infarction or Angina and the Risk 
From Acute Myocardial Infarction: 
Observations From InTIME II 1150-74 l 390A 
Randomized Comparison of Vasoflux, a Novel 
Anticoagulant, and Heparin as Adjunct& 
Therapy to Streptokinase for Acute Myocardial 
Infarction 1106.1280 3738 
Recurrent Ischemia and Clinical Outcome After 
Thrombolysis for Myocardial Infarction: 
Observations From InTIME II 873-5 l 386A 
Relative Prognostic Importance of Preserved 
Antegrade Coronary Blood Flow Before 
Compared to After Angioplasty in Patients 
Undergoing Primary Percutaneous Transluminal 
Coronary Angioplasty 1083-138 l 363A 
Repelfusion Therapy Among Paced Patients With 
Acute Myocardial Infarction 1173.131 l 396A 
Reversible Left Ventricular Regional Dysfunction 
Following Radiofrequency Ablation in Chronic 
Myocardial Infarction 1098-93 l 119A 
Seasonal Variation of Myocardial Infarct Size in 
Humans 1150-72*389A 
Selective Inhibition of Factor Xa Is More Efficient 
Than Heparin at Facilitating Coronary 
SIJJSJECT INDEX 671A 
Thrombolysis in a Canine Model 1106.127 l 
373A 
Severity of Left Ventricular Dysfunction After Acute 
Myocardial Infarction: Long-Term Moaality 
With Optimized Medical Treatment in Clinical 
Practice 1072.156*178A 
Should Survivors of Myocardial Infarction Be 
Screened for Risk of Sudden Death? A 
Cost-Effectiveness Analysis 853-5 l 55OA 
ST Resolution at 90 and 180 Minutes in Patients 
With Acute Myocardial Infarction Treated With 
Lanoteplase or Alteplase: Results of the 
InTIME- Electrocardiogram ST Resolution 
Substudy 1195.127*407A 
Stent PAMI: Are Excellent Outcomes Achieved 
Only by Experienced Sites? 1083-136.3638 
Stent PAMI: Twelve-Month Results and Predictors 
of Mortality 900-l l 4OZA 
Temporal and Regional Differences in Therapy for 
Reinfarction Following Tbmmbolysis: Results 
From GUSTO I and ASSENT II 873-6.3868 
The ENACT Study 1060- 140 l 352A 
The Relationship of Primary Angioplasty Volume 
and Survival Among Interventional Hospitals in 
the National Registry of Myocardial Infarction 
1062.83*20A 
Time Course and Prognostic Implications of 
QT-Interval Dynamicity and Variability After 
Successful Repelfusion by Primary 
Percutaneous Transluminal Coronary 
Angioplasty 1173.133 03968 
Tolerance and Safety of Can&or, a Novel Purin 
Receptor Antagonist, Used as a Platelet 
Aggression Inhibitor in Acute Coronary 
Syndrome 1037-101*343A 
Treatment of Paced Patients With Acute Myocardial 
Infarction 1165.lOO* 143A 
Value of Classic and New Risk Indicators for 
Identifying Patients at High Mortality Risk: 
Results of the Post-infarct Risk Stratification 
Study (PIRS) X80-5 l 145A 
Very Early PTCA of Infarct Arteries With TIM1 3 
Flow Is Associated With Improved Clinical 
Outcomes 900-3 l 403A 
What Should Be Done Acutely for Patients With 
Noninvasive Evidence of Spontaneous 
Reperfusion in Acute Myocardial Infarction? 
864-5 l 3778 
Myocardial stunning 
Absolute Myocardial Blood Flow to Stunned 
Myocardimn Is Normal in Patients With 
Coronary Artery Disease 1079-35 l 429A 
Angiographic No-Reflow During Angioplasty 
Portends Impaired Six-Week Perfusion and 
Functional Recovery: A Dipyridamole Tc99m 
Sestamibi Gated SPECT Imaging Study 
1083.141 l 364A 
Cardioprotection, During Ischemia-Reperfusion in 
the Dog, Induced by Chronic Angiotensin II 
Type 1 Receptor Blockade Involves Enhanced 
Angiotensin II Type 2 Receptor and Protein 
Kinase C Protein Expression 841-5 l 269A 
Combined Low Dose Dobutamine-Nitrate 
Echocardiography in Comparison of 
Dobutamine Alone for Identifying Viable 
Myocardium 1212-7.4878 
Comparison Between Low-Dose Dobutamine 
Echocardiography and Echocardiography 
During Glucose-Insulin-Potassium Infusion for 
the Detection of Myocardial Viability Post 
Infarction 892-l 04838 
Depressed Tolerance to Fluorocarbon-Simulated 
Ischemia in Failing Rat Myocardium Due to 
Impaired Intracellular CA2+ Modulation 
1126-107*379A 
Detection of Salvaged Myocardium by Contrast 
Enhanced Magnetic Resonance Imaging 806-4 
l 465A 
Does Demand Ischemia Trigger Myocardial 
Hibernation? 1126-104.3788 
Enhanced Angiotensin II Type 2 Receptor mRNA 
and Protein Expression During Cardioprotection 
Induced by Receptor Blockade During 
Ischemia-Reperfusion in Isolated Working Rat 
Hearts 1206-143.2348 
KEY: Abstract title, Session-abstract number l page number 
672A SUBJECT INDEX 
Mechanism of Myocardial Dysfunction in the 
Presence of Chronic Coronary Stenosis and 
Normal Resting Myocardial Blood Flow 
1055.29*422A 
Myocardial Functional Recovery Early After 
Minimally Invasive Coronary Surgery: A 
Transesophageal Echocardiographic Study 
801-4-3558 
Prognosis of Viable Myocardium Early After Acute 
Myocardial Infarction: Relation to Indicators of 
Left Ventricular Systolic Dysfunction 892.20 
483A 
Temporal Change of Myocardial Capillary Flow 
After Attempted Reperfusion in Acute 
Myocardial Infarction 1032-2*413A 
Transient Exposure of Nicotine Attenuates the 
Severity of Canine Myocardial Stunning via 
al-Adrenergic Receptor Activation and 
Augmentation of Ecto 5’. Nucleotidase Activity 
1105.135.3698 
Myocarditis 
Apoptosis and Inducible Nitric Oxide Synthase in 
Acute Chagasic Myocarditis 1184.153 02258 
Coxsackie B Virus RNA Replication in the 
Myocardium of Patients With End-Stage 
Idiopathic Dilated Cardiomyopathy 1028.157 l 
166A 
Detection of Anti&” and Antimyosin Antibodies in 
Acute Coron;uy Syndromes: Clinical 
Associations and Prognostic Implications of 
Humoral Immune Response 1082-108*362A 
Inducible Nitric Oxide Synthase Contributes to 
Development of Mutine Chagasic 
Cardiomyopathy 1184-152*225A 
Myocardium 
Acute Myocardial Infarction Morbidity After 
Previous Revascularization: Prediction Using 
Neural Networks 1504-l l 556A 
Assessment of Myocardial Petiusion by Intravenous 
Administration of Levovist: A Comparison With 
201Tl Single Photon Emission Computed 
Tomography 1077-5 l 4268 
Catheter-Based Transendocardial Injection of 
Adenoviral VEGF121 Offers Equivalent Gene 
Delivery and Protein Expression Compared to a 
Surgical-Based Transepicardial Injection 
Approach 879-2 l 73A 
Combined Assessment of Myocardial Perfusion and 
Left Ventricular Function for the Evaluation of 
Patients With Breast Cancer Undergoing 
Radiation Therapy 1191-27 l 4SlA 
Coordinated Regulation of Cell Cycle Withdrawal 
During Caxliogenesis 1161.145*215A 
Correlation Between Endocardial Voltage Mapping 
and Myocardial Perfusion: Implications in the 
Assessment of Myocardial Ischemia 1094.120 l 
183A 
Differential Expression of Proinflammatory 
Cytokines in Endotoxin-Treated Isolated Adult 
Cardiac Myocytes and Cardiac-Derived 
Fibroblast 1203-11 l 331A 
Doppler Tissue Velocity Improves the Sensitivity 
and Specificity of Wall Motion Analysis of the 
Basal Inferior Wall 1144-31 l 461A 
Effect of ACE Inhibitor and AT 1 Blocker on 
Myocardial Expression of TNF-a in Post 
Myocardial Infarction Ventricular Remodeling 
1071.14’2.175A 
Electromechanical Characterization of Treatment 
Response to Laser Myocardial 
Revascularization Guided by Left Ventricular 
Mapping 1177.115*8OA 
Endocardial Electromechanical Mapping to Assess 
Myocardial Viability: A Comparative Receiver 
Operating Characteristic Analysis With 
Radionuclide Perfusion Imaging 888.4*81A 
Intracardiac Echocardiography Permits High Spatial 
Resolution for Percutaneous Local Myocardial 
Delivery Using a Needle Injection Catheter 
1020.109*5A 
Mechanical Unloading Versus Neurohumoral 
Stimulation on Myocardial Structure and 
Endocrine Function In Viva X03-3 l 200A 
Myocardial Conditioning via Mechanical 
Channeling Plus Healing Limits Ischemic 
Consequences of Acute Coronary Occlusion 
1105-134-3698 
Myocardial Innervation After Percutaneous 
Myocardial Laser Revascularization 1196.103 l 
408A 
Novel Induction of Heat Shock Proteins by Magnetic 
Field Stress in Myocytes In Vitro and In Viva 
1161-148.2168 
PrognoxTM (99mTechnetium-HL91) Can Identify 
Hypoxic, Viable Regions in 
Ischemic-Reperfued Myocardium With Infarct 
911.604938 
Reactive Oxygen Species Activate ~38 
Mitogen-Activated and C-Jun N-Terminal 
Kinase (JNK) Signaling Cascades in Myocytes, 
and Synergizes With Cytokines to Induce 
Myocyte Apoptosis 1048.1500 170A 
Retention of Myocardial Injectate After Direct 
Surgical or Catheter-Based Needle 
Administration 870-l l 60A 
Suppression of Cardiac Myocyte Hypertrophy by 
Adenoviral Gene Transfer of Cyclic 
GMP-Dependent Protein Kinase 803-5 l 200A 
Systemic and Myocardial Expression of Brain 
Natriuretic Peptide After Adenoviral-Mediated 
Gene Transfer Using a New Catheter-Based 
Approach 1206-144.2348 
Targeted Gene Delivery to the Left Ventricular 
Myocardium Using Ultrasound-Triggered 
Microbubble Destruction 850-2*444A 
Transcription Factor Control of Myogenic 
Differentiation in a Myogenic Model Cell Line 
1161-146.2158 
Transmyocaxdial Laser Revascularization (TMLR): 
Preservation of Global and Diastolic Function in 
Chronic Ischemia 1017-138.3428 
Transmyocardial Laser Revascularization Improves 
Regional Wall Motion in Remote and Chronic 
Ischemic Myocardium 904-6 l 485A 
Upregulation of Inducible Heme-Oxygenase- 1, 
Generator of Carbon Monoxide, in the 
Post-Infarction Myocardiun Is Dependent on 
the Presence of Nitric Oxide X99-5 l 402A 
Myoglobin 
A Critical Pathway for Chest Pain Patients Allow 
Acute Triaging Within 90 Minutes of 
Presentation to the Emergency Room 1127-136 
l 379A 
Myosin 
Detection of Ant&tin and Antimyosin Antibodies in 
Acute Coronary Syndromes: Clinical 
Associations and Prognostic Implications of 
Humoral 1mm”ne Response 1082-108.3628 
Diagnostic Implications of Raised Smooth Muscle 
Myosin Heavy Chain Levels in Acute Aortic 
Dissection 1091.12-2768 
Natriuretic peptides, atria1 
Anabolic Steroids Improve Myocwdial Perfomxmce 
in Dilated Hearts in Failure 1162-159-2198 
Beneficial Effects of Vasopeptidase Inhibition on 
Mortality and Morbidity in Heart Failure: 
Evidence From the Omapatilat Heart Failure 
Program 909-l l 240A 
Chronic Endothelin A Receptor Antagonism 
Improves Vasorelaxations to Natriuretic 
Peptides in Atherosclerosis 1178.53 l 316A 
Comparison of the Prognostic Value of Cardiac 
I-123 Metaiodobenzylguanidine and 
Neurohumoral Factors in Patients With 
Congestive Heart Failure 119 1-7 l 480A 
Doppler Index and Plasma Level of Atria1 
Natriuretic Hormone Are Improved by 
Optimizing Atrioventricular Delay in 
Atriovenhicular Block Patients With Implanted 
DDD Pacemakers 1165.96 l 142A 
Efficacy of Combination Therapy With Ahial 
Natriuretic Peptide and Nitroglycerin In Patients 
With Congestive Heart Failure 1049-156*172A 
Elevated Levels of Sen~m C-Reactive Protein May 
Predict Prognosis of Patients With Chronic 
Heart Failure 1095.144*186A 
Intravenous Atria1 Natriuretic Peptide Prevents Left 
Ventricular Remodeling in Patients With 
Anterior Acute Myocardial Infarction 1038-128 
l 3458 
JACC February 2000 
Mechanical Unloading Versus Neurohumoral 
Stimulation on Myocaxlial Stmcture and 
Endocrine Function In Viva 803-3 l 2OOA 
Nesiritide Therapy for Decompensated Congested 
Heart Failure Is Not Proarrhythmic 1049-155. 
172A 
Neuohormonal Effect of Vasopeptidase Inhibition 
With Omapatrilat in Hypertension 1045-17 l 
252A 
Neurohumoral Response During Exercise in Healthy 
Controls and Patients With Chronic Heart 
Failure 107 1-144 l 175A 
Omapatrilat Improves Volume Homeostasis in 
Chronic Heart Failure 1010.173 l 232A 
Plasma Atrial Natriuretic Peptide, Cyclic Guanosine 
Monophosphate, and Endothelin Response to 
Omapahilat in Heart Failure 1137-144*206A 
Plasma Brain Natiuretic Peptide Response to 
Exercise Is Augmented in Patients With Left 
Ventricular Dysfunction and Heart Failure 
1049.153*171A 
Regulation of Systolic and Diastolic Function by 
Endogenous cGMP in Experimental Heart 
Failure 865-l l 204A 
Salutary Effect of Exogenous Atrial Nat&r&c 
Peptide on Left Ventricular Relaxation in 
Patients With Left Ventricular Hypertmphy 
1049-157*172A 
Subcutaneous Brain Natriuretic Peptide 
Administration in Symptomatic Human Heart 
Failure: A Novel Therapeutic Strategy for 
Congestive Heart Failure 909-2-2408 
Systemic and Myocardial Expression of Brain 
Natiuretic Peptide After Adenoviral-Mediated 
Gene Transfer Using a New Catheter-Based 
Approach 1206.144*234A 
The Cardiac Hormone BNP Is a Marker for Left 
Ventricular Hypertrophy in Dialysis Patients 
1049.154*171A 
The Superior Renal and Humoral Actions of Acute 
Dual NEP/ACE Inhibition by Vasopeptidase 
Inhibitor Versus ACE Inhibition Alone in 
Experimental Mild Heart Failure: Properties 
Mediated via Potentiation of Endogenous 
Cardiac Natriwetic Peptides 842-l l 270A 
Nitrates/Nitroglycerin 
Chronic Long-Term Nitrate Therapy: Any 
Cytogenetic Effect in Humans? 1044-55 l 251A 
Combined Low Dose Dobuttine-Nitrate 
Echocardiography in Comparison of 
Dobutamine Alone for Identifying Viable 
Myocardium 1212-7*487A 
Efficacy of Combination Therapy With Atria1 
Natriuretic Peptide and Nitroglycerin In Patients 
With Congestive Heart Failure 1049.156 l 172A 
Endothelial Nitric Oxide Synthase Is a Site of 
Superoxide Synthesis in Endothelial Cells 
Treated With Glyceryl Trinitrate 1044-57 l 
252A 
Glutathione-Mediated Biotransformation of Glyceryl 
Trinitrate to Nitric Oxide: A Potential Role for 
Peroxynihite in Nitrate Tolerance in Patients 
With Unstable Angina 1156-44 l 304A 
hnprovement of Right Ventricular Function After 
Acute Vasodilator Administration Is Critical for 
Risk Stratification of Patients With Severe Heart 
Failure and Pulmonary Hypertension 1115-148 
l 195A 
Nitric oxide 
Apoptosis and Inducible Nitric Oxide Synthase in 
Acute Chagasic Myocarditis 1184.153*225A 
Apoptosis in Skeletal Muscle of Patients With 
Chronic Heart Failure: Role of Inducible Nitric 
Oxide Synthase and IL-lb Expression 
104X-149*170A 
Asymmetric Dimethylarginine Inhibits Vascular 
Endothelial Growth Factor Synthesis by 
Cytokine-Stimulated Vascular Smooth Muscle 
Cells 1157.54*307A 
B-Adrenergic Blockade in Developing Heart Failure: 
Effects on Myocardial Inflammatory Cytokines, 
Nitric Oxide, and Remodeling lOlO-167*231A 
KEY: Abstract title, Session-abstract number l page number 
JACC February 2000 SUBJECT INDEX 673A 
Basic Fibroblast Growth Factor Inhibits 
Lipopolysaccharide-Induced Apoptosis in 
Cardiac Myocytes 836-4*356A 
Cerivastatin Inhibits Inducible Nitric Oxide Synthase 
and Ameliorates End-Organ Damage in Rats 
With Hinh Hmnan Hvoertension 842-5 l 271A 
Chronic Long-Term Nitrate Therapy: Any 
Cytogenetic Effect in Humans? 1044-55 l 25lA 
Cyclo:Oiygenase Inhibitor Diclofenac Improves 
Chlamydia Pneumoniae-Induced Endothelial 
Dysfunction 1022-56 l 244A 
Differential Association of Endothelial Nitric Oxide 
Synthase Gene Polymorphism With Acute 
Coronary Syndrome, but Not With Variant 
Angina 1194.134*405A 
Dobutamine Stress Echocardiography, 
Cardiopulmonary Exercise Test, and Exhaled 
Nitric Oxide in Patients With Pure Mitral 
Stenosis 1047-66*§27A 
Effect of Inhaled Nitric Oxide on Exercise 
Pulmonary Pressure in Patients With Pulmonary 
Hvuertension 1113-51*2X58 
Effectsbn Synthetic Progestin on Nitric Oxide 
Bioactivity and Markers of Inflammation in 
Healthy Postmenopausal Women 1045-49 l 
25!+A 
Elevated Plasma Level of Asymmetric 
Dimethylarginine (ADMA) Is Associated With 
Coronary Artery Disease Independent of the 
Traditional Atherosclerotic Risk Factors 
1022-50 l 2438 
Endothelia! Nitric Oxide Synthase Gene 
Polymorphism Is Positively Associated With 
In-St& Restenosis 1041.880 14A 
Endothelial Nitric Oxide Synthase Is a Site of 
Superoxide Synthesis in Endothelial Cells 
T&ted With Glyceryl Trinitratc 1044-57 * 
2528 
Endothelin-I Suppresses Nitric Oxide Induced 
Caspase-3 Activation and Antagonizes 
Apoptosis in Cardiomyocytes 1048.147*170A 
Endothelin-1, Nitric Oxide Metabolites, Left 
Ventricular Mass, and Hemodynamic Responses 
to Vasoconstrictive Stress in Normotensive 
Youth 1181.22*321A 
Glutathione-Mediated Biotransformation of Glyceryl 
Trinitrate to Nitric Oxide: A Potential Role for 
Peroxynitrite in Nitrate Tolerance in Patients 
With Unstable Angina 11%44*304A 
Hypercholesterolemiais Associated With Impaired 
Aerobic Capacity in Patients With Dilated 
Cardiomyopathy: Normalizing Effects of 
Chronic Exercise Training 102%159* 166A 
Improvement in Endothelium~Dependent Function 
in Patients With Class II & IlI Angina by a 
Medical Food 1196.102 *408A 
Inactivation of Nitric Oxide by Superoxide Is a 
Mechanism Leading to Age-Related Endothelial 
Dysfunction 1092-19.2778 
Inducible Nitric Oxide Svnthase Contributes to 
Development of Muhne Chagasic 
Cardiomyopathy 1184.l52*225A 
Influence of Aging on Vascular Effects of Thrombin: 
Role of Endothelium-Derived Nitric Oxide and 
Vasoconstictive Prostaglandins 1089-41 l 271A 
Inhibition of I&tent Plaque Formation by Inducible 
Nitric Oxide Synthase-Lipoplex-Mediated Gene 
Therapy in a Pig Femoral Artery Stent Model 
852-6 e 28OA 
L-NMMA (a Nitric Oxide Synthase Inhibitor) Is 
Effective. in the Treatment of Cardiogenic Shock 
X90-4 * 229A 
Left Ventricular Assist Device Preserves Nitric 
Oxide Dependent Control of Mitochondrial 
Respiration in Failing Human Hearts 1116-121 
l 196A 
Left Ventricular End Diastolic Wall Stress and 
Endomyocardial Inducible Nitric Oxide 
Synthase Gene Expression in Human Dilated 
Cardiomyopathy 865-2-2048 
Microvascular Reactivity, Blood Pressure, and 
Survival Are Improved in Septic iNOS-Deficient 
Knockout Mice 886-6*312A 
Neither Previous Chlamydia Pneumoniae Infection 
nor Elevated C-Reactive Protein Are Associated 
With Endothelial Dysfunction in Healthy Young 
Adults 1201.43 l 327A 
Nicotine Is an Agent of Angiogenesis: Role of Nitric 
Oxide and Prostacyclin 408-3 l 545A 
Nitric Oxide Synthase Inhibition Improves Coronary 
Microcirculatory Function in Patients With 
Coronary Artery Disease 1191.30*482A 
Oral Consumotion of Pumle Graoe Juice Inhibits 
Platelet l%nction and’Incr&es Platelet-Derived 
Nitric Oxide Release 832-5 *267A 
Oral Folic Acid Treatment Improves Endothelial 
Function in Patients With 
Hvuerhomocvsteinemia X68-5*291A 
Primary Platelet hitric Oxide Resistance and 
Oxidative Stress in Patients With Chronic Heart 
Failure 1183-l 42 l 222A 
Pulmonary Vascular Response to Priming With 
Inhaled Nitric Oxide Durinc Hvoeroxia. 
Normoxia, and Hypoxia 894-3 l 322A 
Rapid Improvement of Endothelial Function After 
Lipid-Lowering Therapy With Cerivastatin 
Within Two Weeks 1046-9*256A 
Regulation of Systolic and Diastolic Function by 
Endogenous cGMP in Experimental Heart 
Failure 865-l l 204A 
Short Polymers of Arginine Inhibit Myointimal 
Hyperplasia: Efficient Intracellular 
Translocation and Activation of Nitric Oxide 
Synthesis 411-2 l 548A 
Short-Term Endurance Exercise Training Enhances 
Endothelium-Dependent Vasodilation in Health) 
Premenooausal Women 1073-121 l 179A 
Smoking Is Associated With Increased Plasma 
Asymmetric Dimethylaxginine (ADMA) Levels 
in &ents With Type 2 Diabetes Mellitus 
1201-45.3278 
Statins Enhance Flow Dependent Vasodilation in the 
Human Skin Circulation: A New Approach to 
Monitor Vascular Function During 
Cardiovascular Therapy 1092-21 l 277A 
Tetrahydrobioptelin Restores Endothelial Function 
in Human Coronary Arteries In Vivo 1023-470 
246A 
The Effects of Oral Methionine and Homocysteine 
on Endothelial Function X60-5 l 288A 
The Influence of Short-Term Theraov With 
Simvastatin on Inflammatory P&de in 
Hypercholesterolemic Patients 1046-12.2568 
The Rebponse to Inhaled Nitric Oxide in Adult 
Patients With Primarv Pulmonarv Hvaertension 
and Pulmonary Hypertension From Secondary 
Causes 1113.54.286A 
U-74 Inhibits the Cytokine Induced iNOS 
Expression via Elevation of I&? and Depression 
of NFkB in Cultured Endothelial Cells 
1071-146-1768 
Upregulation of Inducible Heme-Oxygenase- 1, 
Generator of Carbon Monoxide, in the 
Post-Infarction Myocardium Is Dependent on 
the Presence of Nitric Oxide 899-5 l 402A 
Norepinephrine 
Cardiac Specific Sympathetic Newous System 
Activation Relates to Hemodynamics and Right 
Ventricular Performance in Mitral Regurgitation 
1001.167*523A 
Catecholamine Sensitivity Changes With Time After 
Cardiac Transplantation 1185-121 l 2278 
Cytokines Only Slightly Increased Under Optimized 
Medical Treatment in Unselected Patients With 
Advanced Heart Failure Due to Coronary Artery 
Disease 1072-158 l 179A 
Decreased Submaximal Exercise Tolerance and 
Increased Sympathetic Activation in Response 
to Cold Exposure in Patients With Congestive 
Heart Failure 827-20181A 
Differential Prognostic Value of Neurohumoral 
Activation in Left Ventricular Dysfunction: 
Coronary Heart Disease Versus Dilated 
Cardiomvooathv in 428 Nonselected Patients 
i115-14j.i94ii 
Genetic Influences of Obesity and Blood Pressure 
Level 1069-210 2648 
Insulin Resistance in Chronic Heart Failure: 
TNF-Alpha, Norepinephrine, or Leptin-Related? 
1072.159.179A 
Neurohumoral Response During Exercise in Healthy 
Controls and Patients With Chronic Heart 
Failure 1071-144*175A 
Noninvasive Assessment of Exercise-Induced 
Alterations of the Conduit Artery Tone in 
Healthy Controls and Patients With Chronic 
Heart Failure: Relationship to Endothelin-1 and 
Norepinephrine 1071-150* 177A 
Reduction of Oxidative Stress by Trolox and 
Superoxide Dismutase Abolishes 
Norepinephrine-Induced Myocyte Apoptosis 
and B-Adrenergic Receptor Downregulation in 
Ferrets 1048.142.1688 
Usefulness of Iodine 123 Metaidobenzylguanidine 
Scintigraphy in Assessing Sympathetic 
Activation in Patients With Mild Heart Failure 
1072-157-1788 
Nutrition 
Adverse Effects of Dietary Fish Oil Supplementation 
Against Doxorubicin-Induced Cardiomyopathy 
1138-156*209A 
Cholesterol Reduction Through Weight Loss Is Not 
Influenced by Dietary Protein Source 1159-23 l 
310A 
Enhanced Reduction of Fasting Total Hoiocysteine 
Levels With Supraphysiological Versus Standard 
Multivitamin Dose Folic Acid Supplementation 
in Renal Transplant Recipients 1023-43 02458 
Improvement in Endotheliun-Dependent Function 
in Patients With Class Il & III Angina by a 
Medical Food 1196.102.4088 
Oral Consumption of Purple Grape Juice Inhibits 
Platelet Function and Increases Platelet-Derived 
Nitric Oxide Release 832-5 l 267A 
The Direct Effects of Canola, Olive, and Fish Oils on 
Endothelial Function 860.6*288A 
Obesity 
Cardiovascular Function in the Obese: Insights From 
Cardiac Magnetic Resonance Imaging 1078-27 
.427A 
Cholesterol Reduction Through Weight Loss Is Not 
Influenced by Dietary Protein Source 1159-23 * 
310A 
Effects of Obesity on Coronary Atherosclerosis, 
Vascular Remodeling, and Endothelial Function 
1090-51.2738 
Electron Beam CT-Determined Coronary Artery 
Calcium Is Correlated With Parameters of the 
Insulin Resistance Syndrome 1145.37 l 463A 
Genetic Influences of Obesity and Blood Pressure 
Level 1069-Z l 264A 
Importance of Obesity and Hypertension to the 
Relation Between Age and Left Ventricular 
Mass 1069.22 l 2658 
Increased Prognostic Value of Body Fat Adjusted 
Peak Oxygen Consumption in the Evaluation of 
Obese Patients With Chronic Heart Failure 
1139.124*211A 
Increases in Leptin Levels, Symnatbetic Drive. and 
Weight Gain in Obstructive Sleep Apnea 
1067-54*261A 
Left Ventricular Mass and Metabolic Syndrome: The 
HyperGEN Shldy 1069.19*264A 
Long-Term Effect of Weight Reduction on Arterial 
pressure at Rest and During Exercise in Obese 
Hypertensives 1025.23*250A 
Obesity and 24.Hour Blood Pressure Variation 
1069-23 0265A 
Obesity, a Cardiovascular Risk Factor, Is Associated 
With Tissue-Specific Activation of Renal 
Angiotensin Converting Enzyme Activity In 
Vivo: Evidence for a Regulatory Role of 
Engothelin 1133.45 l 294A 
The Association of FERHDL With Gender, Age, 
Body Mass Index, and Coronary Artery Disease 
(CAD) 1159.19*309A 
The Effect of Obesity on Long-Term Survival 
Following Coronary Bypass 112515*551A 
The Impact of Gender, Age, and Body Mass Index 
on the 24.Hour Efficacy of Antihypertensive 
Therapy 102522*249A 
KEY: Abstract title, Session-abstract number l page number 
674A SUBJECT INDEX 
Oncogelles 
Are Sporadic Cardiac Myxomas a DNA 
RepairDeficient Heart Disease? 1184-1590 
226A 
Outcomes assessment 
A New Score Svstem to Predict Maior 
Cardiovas&lar Events During &onary 
Stenting: Does AHA/ACC Lesion Type 
Classification Matter? 834.40298 
A Nonlinear Model for Moaality Prediction in 
Patients With Type A Acute A&c Dissection: 
A Study From the International Registry of 
Acute Amtic Dissection (IRAD) 1091-9 l 275A 
A Simple Intervention to Improve Physician 
Practices Regarding Antithrombotic Therapy in 
Patients With Atria1 Fibrillation 1051.67 l 102A 
A Simple Model for Prediction of Mortality in Acute 
Myocardial Infarction: Observations From 
InTIME II 1173.1400398A 
A Simple Mortality Risk Prediction Tool for 
Individual Patients Undergoing Percutaneous 
Coronary Interventions: A Report From the Blue 
Cross/Blue Shield of Michigan Cardiovascular 
Consortium (BMC2) 1193.14*557A 
A Trial to Improve Compliance With National 
Cholesterol Education Program Guidelines 
895-l l 558A 
Acute and Long-Term Outcomes for a New 
Generation Stent: Experience in 441 Patients 
With the Medtronic AVE GFX Stem 1176.88 l 
78A 
Acute and Long-Term Outcomes of Minimally 
Invasive Direct Coronary Artery Bypass 
(MIDCAB) Surgery: A Comparison to 
Single-Vessel Stenting of the Left Anterior 
Descending Artery 801-3 03548 
Acute Aortic Dissection in Women: Comparative 
Analysis Among Genders-Results From the 
International Registry of Acute Aortic 
Dissection (IRAD) 1112-23 l 284A 
Advanced Heart Failure Shared Clinical Experience 
Network (AHFSCENCE) Educational Program 
Improves Clinical and Economic Outcomes 
895-4 l 558A 
Adverse Cardiovascular Events Associated With the 
Use of Viagra 1147.13*553A 
Age Related Outcome for Patients Bridged to Heart 
Transplantation With HeartMate Left 
Ventricular Assist Devices 1116.122 l 196A 
Angiotensin-Converting Enzyme Inhibitor Use in 
Diastolic Heart Failure Is Associated With a 
Reduced RiskofDeath lOlO-172.2328 
Are Patients With Known or Suspected Coronary 
Artery Disease and Normal Stress Imaging 
Studies at Low Risk for Adverse Outcomes? 
Meta-Analysis of Stress Echocardiography and 
SPECT 1104.16*547A 
Aspirin and the Treatment of Heart Failure in the 
Elderly 1003-172.5418 
Biases in the Evaluation of Risk Associated With 
Cigarette Smoking Following Percutaneous 
Transluminal Coronary Angioplasty 1081.13 l 
5438 
Can Combined Indices of Diastolic and Systolic 
Myocardial Performance Reliably Predict 
Cardiac Allograft Rejection? X82-3*221A 
Can Long-Term Outcome in Acute Ischemic 
Syndromes Be Reliably Predicted by Abnormal 
Acute Electrocardiogram and Enzyme 
Abnormalities? 1084.129*365A 
Cardiac Mortality of Patients With Left 
Bundle-Branch Block Following Rest 
201Tl/Stress 99mTc-Sestamibi Dual-Isotope 
Myocardial Perfusion 858.6*456A 
Cardiogenic Shock After Acute Myocardial 
Infarction in the Elderly: The Michigan 
Cooperative Cardiovascular Project Experience 
1116-123.1968 
Carotid Stenting in Symptomatic Versus 
Asymptomatic Patients: Acute and Long-Term 
Clinical Outcomes 898-6 l 86A 
Clinical Significance of Antegrade Flow to Infarct 
Zone Before Primary Percutaneous 
Transluminal Coronary Angioplasty in Q-Wave 
Acute Myocardial Infarction 1060.137 l 351A 
Clinical Significance of Pulmonary Arteriovenous 
Malformations After Staging Bidirectional 
Cavopulmon~ Anastomosis 1007.171 l 511A 
Comparison of Intravascular Ultrasound Guided 
“Stent Like” Optimal Balloon Angioplasty and 
Stenting: Immediate and One-Year Clinical 
Outcomes 1130.90.56A 
Computer-Based Information Prompts Modify 
Physician Ordering 1505-l l 56OA 
Contemporary Use of Evidence-Based Therapies in 
High Risk Groups After Myocardial Infarction 
103%138*346A 
Coronary Angioplasty With Provisional Stenting in 
Dialysis Patients: In-Hospital and Six-Month 
Outcomes 1062.77 l 19A 
Cost-Comparison of Early Invasive Versus 
Noninvasive Treatment in Unstable Coronary 
Artery Disease: A Six-Months Follow-Up From 
the FRISC II Invasive Trial 837-5 l 358A 
Decision Analysis Comparing Treatment Strategies 
for Hypoplastic Left Heart Syndrome 1103-160 
l 502A 
Do Patients Undergoing Multivessel Interventions 
Have Worse Acute and Long Term-Outcomes? 
1193-15.5578 
Does Estimating Hospital Cost Require. Detailed 
Departmental Costing, or Are Whole Hospital 
Approaches Just as Good? 1216-15.559A 
Does Therapy With GP IIbIIIa Receptor Antagonists 
Improve Late Clinical Outcome Following 
Percutaneous Coronaly Intervention? A Report 
From the NHLBI Dynamic Registty 835-5 l 
31A 
Early Ant&rhythmic Therapy Is No Better Than 
Rate Control Therapy Alone for Suppression of 
Atrial Fibrillation After Cardiac Surgery 902-3 
l 154A 
Effect of End-of-Month Admission on Discharge 
Quality Parameters for Acute Myocardial 
Infarction Patients 1104.14*547A 
Effect of End-of-Month Admission on Length of 
Stay for Acute Myocardial Infarction Patients 
10%14*543A 
Effect of Race in Outcomes After Heart 
Transplantation 1029-120*167A 
Enhancing Implementation of Critical Care 
Pathways for Heart Failure: Lessons Learned 
From a Multicenter Trial 1003- 174 l 542A 
Epidemiology and Outcome of Aotiic Intramural 
Hematoma: A Me&Analysis of 123 Cases 
Reported in the Literature 1091-11.2768 
Estrogen Rep&em& Therapy Reduces Major 
Adverse Cardiac Events (MACE) in Post 
Menopausal Women After Intracoronary 
Stenting: A Long Term (>3 Years) Follow-Up 
807-3 l 301A 
Evolving Patterns of Coronary Stenting: Report 
From a Large National Database 1130.84*55A 
Expert Rating of Angioplasty in Europe 1193.130 
557A 
Home Is Where the Heart Is: Hospital in the Home 
Management of Myocardial Infarction 
1060.136*351A 
Hospital Characteristics and Treatment of Acute 
Myocaxlial Infarction: Role of Ownership and 
Teaching Status 833-3 l 267A 
Identification of High Risk Patients With Coronary 
Artery Disease 1058.13*542A 
Impact of an Emergency Department Cardiac 
Clinical Decision Unit on a Population of 
Patients With Episodic Chest Discomfort 
1127-138.3808 
Impact of New Onset Atrial Fibrillation on Quality 
of Life: Initial Findings of a Prospective, 
Multicenter Registry 1209-700 155A 
Impact of Quality Improvement Initiative on 
Long-Term Compliance to Key Quality of Care 
Indicators After Acute Myocardial Infarction 
1171-13*555A 
Incidence of Unexpected Death After Palliative 
Surgery for Hypoplastic Left Heart Syndrome 
851-1 l 504A 
Independent Prospective Validation of a Clinical 
Index to Predict Survival in Ambulatory Patients 
JACC February 2000 
Referred for Cardiac Transplant Evaluation 
1029.121 l 167A 
Influence of Gender on In-Hospital Outcomes of 
Patients Undergoing Primary Percutaneous 
Transluminal Coronary Angioplasty for Acute 
Myocardial Infarction: New York State 
Experience 878-2 l 72A 
Influence of Tbrombus on the Outcome of Coronary 
Interventions in the Current Era 1199.86*9OA 
Intravenous Atria1 Natriuretic Peptide Prevents Left 
Ventricular Remodeling in Patients With 
Anterior Acute Myocardial Infarction 1038.128 
l 345A 
Is the Quality of Care in Octogenarians With Acute 
Myocardial Infarction Optimal? 1147.15 l 554A 
It’s Quality Not Quantity That Counts! Operator 
Performance in Coronary Angioplasty: The 
Utility of One-Month Outcomes X35-4*318 
Long-Term Clinical Outcomes of Percutaneous 
Coronary Intervention in Patients With Severe 
Left Ventricular Dysfunction 1040.77.11A 
Long-Term Survival Following Surgical Versus 
Percutaneous Coronary Revascularization in 
Patients With Low and Preserved Ejection 
Fractions 835-2.318 
Longest Respiratory Rate Interval in Atrial 
Fibrillation Predicts Outcome of Subsequent 
Cardioversion: A Prospective Study 1052-94 l 
104A 
Low Event Rates in Patients With Viable 
Underperfused Myocardium Who Are Not 
Eligible for Revascularization: A VIVA 
Substudy 879-6 l 74A 
Modeling the Risk of Major In-Hospital 
Complications Following Percutaneous 
Coronary Intervention 835.3 l 31A 
More Malignant Than Cancer? Five-Year Survival 
Following a Fist Admission for Heart Failure in 
Scotland 1125.13*551A 
Mortality Differences Between ACE Inhibitor and 
Calcium Channel Blocker Treated Hypertensive 
Patients 913-l 03338 
Observed Protective Effect of Glycoprotein llb/llla 
Antagonists Against In-Hospital Death Stratified 
by Patient Risk 1199.88 l 91A 
Oral Amiodarone Prophylaxis and a Clinical 
Pathway Approach to Atrial Fibrillation 
Following Primary Coromuy Artery Bypass 
Graft Surgery: Preliminary Results of Phase II 
of the Postoperative Atria1 Fibrillation in 
Cardiac Surgery Study 895-3 l 5588 
, 
Outcome Study of Two Large Populations With 
Different Rates of Cardiac Interventions 
1040-83 l 13A 
P Wave Signal-Averaged Electrocardiogram Criteria 
in Predicting Early Recurrence of Atrial 
Fibrillation: A Prospective Study X57-5 l 131A 
Patient Characteristics and In-Hospital Outcomes 
Following Angioplasty of the Left Main 
Coronary Artery: New York State Experience 
1040-80 l 12A 
Patients With Patent Foramen Ovale: When Do We 
Seek Closure? 853-3 l 550A 
Population-Based Medication Profiling in Heart 
Failure: Treatment Related Outcomes From the 
R.E.A.C.H. Study 1003-175.5428 
Prediction of Myocardial Viability in Patients With 
Acute. Myocardial Infarction From Coronary 
Flow Velocity Patterns With Tram-Thoracic 
Doppler: Retrospective and Prospective Studies 
1006-170.4468 
Prediction of Operative Mortality Following Valve 
Replacement Surgery 83 1-5 l 529A 
Predictive Model of Mortality in Patients With Type 
A Acute Aortic Dissections: Results From the 
International Registry of Acute Aortic 
Dissection (IRAD) 905-2.3238 
Predictors of Cause-Specific Hospital Readmission 
in Men and Women With Congestive Heart 
Failure 1058.16.543A 
Predictors of Late Clinical Outcomes in Patients 
With Unstable Angina Undergoing Percutaneous 
Coronary Interventions 1062-75 l 18A 
KEY: Abstract title, Session-abstract number l page number 
JACC Febnmty 2000 
Predictors of Outcome After Transmyocardial 
Revascul%ization 1017-1409342A 
Preliminary Results From the Patency Outcomes and 
Economics of MIDCAB (POEM) Trial: 
Minimally Invasive Direct Coronary 
Revascularization Versus Conventional Bypass 
5urgery 1017-129.340A 
Present&ion, Clinical Findings, and Outcomes 
Among Patients With Acute Definitive 
ln~amural Hematoma: Results From the 
International Registry of Acute Aortic 
Dissection (IRAD) 905.30324A 
Quality of Life in Unstable Coronary Artery 
Disease-A Comparison of Early Invasive Versus 
Noninvasive Treatment: Six-Month Follow-Up 
From the FRISC II Invasive Trial 837-4*357A 
Quality of Lie With End-Stage Coronary Artery 
Disease il47-16*554A 
Quantitative Electrocardiographic Variables Predict 
Adverse Outcomes in Non-ST Elevation Acute 
Coronary Syndromes: Results From GUSTO IIb 
90%4*41OA 
Rehospitalization: An Outcome That Parallels Other 
Major Endpoints in Comparisons of Antiplatelet 
Therapy 1193-16*557A 
Revascultization of the Internal Mammary Artery 
Graft: In-Hospital and One-Year Outcomes 
1129.82* 54A 
Risk of Arhythmic Mortality in High-Risk Patients 
Does Not Change With Time Course in the First 
Two Years After Myocardial Infarction: A 
Secondary M&-Analysis 856-6 * 3758 
Risk of Early and Long-Term Events Following 
Coronary Stenting Are Not Predicted by 
Traditional Lesion Classification 834-5 l 3OA 
Serum Uric Acid Independently Predicts Future 
Mortality in Patients With Severe, 
Angiographically Defined Coronary Artery 
Disease 1112-19*284A 
Stem Implantation in Proximal Left Anterior 
Descending Coronary Disease Is Associated 
With Improved 30-Day, One and Three-Year 
Outcomes 1130~87*56A 
The Benefit of Spironolactone in the RALES Trial Is 
Not Primarily Due to Diuretic Effect 872-40 
212A 
The Cost Benefit of Implementing a Heart Failure 
Program 1207-156.2378 
The Cumulative Effects of Nistorical and Physical 
Examination Findings on the Prognostic Value 
of rhe Electrocardiogram 1031-69 0 1OOA 
The Detrimental Impact of Chronic Renal 
Insufficiency and Diabetes Mellitus on Late 
Prognosis After Percutaneous Coronary 
Interventions 878-6 *73A 
The Effect of Hospital Volume on Long-Term 
Outcome After Percutaneous Transluminal 
Coronary Angioplasty 1040-82 l 12A 
The Impact of Oral Antiplatelet Therapy on CK 
Release After Coronary Stent Implantation: A 
Comparison Between Ticlopidine and 
Clopidogrel 1153.118 l 67A 
The Incidence, Management, and Outcome After 
Coronruy Artery Perforation During 
Percutaneous Coronary Intervention: A Single 
Center Experience 108%76*32A 
The Influence of the BAR1 Diabetic Treatment Alert 
on Revascularization Selection Patterns: The 
National Cardiovascular Network Results 
1081.16*544A 
The Kansas City Cardiomyopathy Questionnaire 
Predicts Heart Failure Admissions and Death 
1003.173*541A 
The Prognostic Value of a Single Creatine 
Phosphokinase Measurement After 
Percutaneous Coronary Interventions 1107-76. 
42A 
Three-Year Survival in Patients With Multivessel 
Coronary Artery Disease and Peripheral 
Vascular Disease Undergoing Coronluy 
Revasculavization 1112-20 * 2848 
Tolerability and Side-Effect Profile of Beta-Blockers 
in Patients With Heart Failure: Differences 
Between Clioical Trial and Practice Setting 
1137.146.207A 
Urine Fibrinopeptide A as a Risk Factor for Cardiac 
Events Following Heart Transplantation 
1185-322*227A 
Use of Early Troponin 1 and Continous 12.Lead ST 
Segment Monitoring to Predict Need for 
Subsequent Urgent Revascularization for 
Refractory Unstable Angina 1082-101 l 361A 
Usefulness of Hypotension During Dobutamine 
Echocardiography in Predicting Perioperative 
Cardiac Events 1101.32.4398 
Volume Overload and Co-Morbid Conditions of 
Hospitalized Heart Failure Patients 1207.152 l 
2368 
What Impact Does the Type of Lesion (A,Bl,B2,C) 
Have on Cath Lab Clinical and Economic 
Outcomes? 1104.15*547A 
oxygen consumption 
Adjunctive Handgrip During Dobutamine Stress 
Echocardiography: Invasive Assessment of 
Myocardial Oxygen Consumption in Humans 
1212-5 l 4868 
Differences in Physical Performance in Right 
Atrium to Right Ventricular Conduit as 
Compared to Right Atrium to Pulmonary Avery 
Connection in Adult Patients With Modified 
Fontan Procedure 1035-166*498A 
EndotheIiom-Dependent and Independent Vascular 
Responses and Blood Flow in the Brachial 
Artery of Healthy Controls and Patients With 
Chronic Heart Failure: Relationship to Peak 
Oxygen Consumption and Left Ventricular 
Ejection Fraction 1071.149*177A 
Estimate of Metabolic Equivalent by Accelerometer 
or Minute Ventilation Sensors in Implanted 
Devices: Initial Observations 1050-125 l 174A 
Hypercholesterolemia Is Associated With Impaired 
Aerobic Capacity in Patients With Dilated 
Cardiomyopathy: Normalizing Effects of 
Chronic Exercise Training 1028-159 l 166A 
Increased Prognostic Value of Body Fat Adjusted 
Peak Oxygen Consumption in the Evaluation of 
Obese Patients With Chronic Heart Failure 
1139.124*211A 
Left Ventricular Assist Device Preserves Nitric 
Oxide Dependent Control of Mitochondrial 
Respiration in Failing Human Hearts 1116.121 
0 196A 
Plasma Brain Natriuretic Peptide Response to 
Exercise Is Augmented in Patients With Left 
Ventricular Dysfunction and Heart Failure 
1049-153.1718 
The Skeletal Muscle Intrinsic Mitochondrial 
Oxidative Capacity Contributes to Determine 
Exercise Capacity in Normal Subjects 
1050.123*174A 
Pacemaker, artiicid 
A Randomized Study on the Effects of Pacemaker 
Programming to a Lower Output on Pulse 
Generator Longevity 1075-95 l 112A 
Adjusted Pacemaker Implant Rates Are Lower in 
Women Than Men at All Ages: Is Gender Bias 
at Work? 1165-97 l 142A 
Cardiac Pacing Reduces Falls in Carotid Sinus 
Hypersensitivity: The SAFE-PACE Trial 
1165-9X.1424 
Cardiac Sympathetic Innervation Abnormalities in 
Patients Paced Chronically From the Right 
Ventricular Apex: An 1123 
Metaicbobelltozylquanidine (MlBG) Cardiac 
Scintigraphic Study 1165-99 l 142A 
Doppler Index and Plasma Level of Atrial 
Natriuretic Hormone Are Improved by 
Optimizing Atrioventricular Delay in 
Atrioventricular Block Patients With Implanted 
DDD Pacemakers 1165.960 142A 
Estimate of Metabolic Equivalent by Accelerometer 
or Minute Ventilation Sensors in Implanted 
Devices: Initial Observations 1050-125 l 174A 
Exercise Noise Seen by Pacemaker From Leads 
1075-96*112A 
Is Atria1 Lead Implantation During Atrial 
Fibrillation as Efficient as After Restitution of 
Sinus Rhythm? 1004-170* 108A 
SUBJECT INDEX 675A 
Long-Term Survival Following Permanent 
Pacemaker Implantation in Patients With 
Dilated Cardiomyopathy 1165-93 l 141A 
Outcome of Children With Fetal, Neonatal, or 
Childhood Diagnosis of Isolated Complete 
Heart Block: A Single Institution’s Experience 
of 30 Years 1192.165*518A 
Prevention of Atrial Fibrillation by Atrial Overdrive 
Stimulation at Rest in Patients With 
Symptomatic Sinus Node Disease 1004-173. 
108A 
Single-Center Experience With Transvenous 
Biventricular Pacing to Treat Advanced Heart 
Failure: Long-Term Clinical Results 839-l l 
116A 
Variations in Selection of Dual Chamber and Rate 
Responsive Pacemakers: Influence of 
Geographic Region and Physician Gender 
1165.95 l 141A 
Pacing 
A Randomized Study on the Effects of Pacemaker 
Programming to a Lower Output on Pulse 
Generator Longevity 1075-95 l 112A 
Acute Effect of Multisite Pacing With Different 
Atrioventricular Delays on the Noninvasive 
Doppler-Derived iMyocardia1 Performance Index 
X39-4*117A 
Alternate Atrial Pacing Sites Shorten Atria1 
Activation Time in Humans 1004.169 l 107A 
Atria1 Septal Pacing Decreases the Incidence of 
Atrial Late Potential in Patients With 
Paroxysmal Atria1 Fibrillation 1188-62 * 152A 
Cardiac Sympathetic Innervation Abnormalities in 
Patients Paced Chronically From the Right 
Ventricular Apex: An 1123 
Metaiobobentozylquanidine (MIBG) Cardiac 
Scintigraphic Study 1165-990 142A 
Comparison of Acute and Chronic Performance of 
Intramyocardial Versus Epicardial Steriod 
Eluting Ventricular Pacing Electrodes 1170-162 
l 516A 
Diagnostic Value of Thallium 201 Myocardial 
Perfusion in Permanent Paced Patients 1075-98 
.113A 
Dual Site Atria1 Pacing for Atria1 Fibrillation 
Prevention: Triggered or Inhibited Response to 
Ectopy? 1004.168.107A 
Dual-Chamber Implantable Cardiovefler 
Defibrillator Versus Single-Chamber 
Implantable Cardioverter Defibrillator: High 
Incidence of Device and Lead-Related 
Complications in Dual-Chamber Implantable 
Cardioverter Defibrillator 1119-96 l 127A 
Effect of Dual Site Right Ahial Pacing on Burden of 
Atrial Fibrillation in Patients With 
Drug-Refractory Atria1 Fibrillation 1004-175 l 
109A 
Effect of Vasopeptidase Inhibition With Omapatrilat 
in a Canine Model of Tachycardia-Induced 
Heart Failure 1206.146 l 234A , 
Exercise Noise Seen by Pacemaker From Leads 
1075-96*112A 
Impact of Dual Site Pacing on the Natural History of 
Symptomatic Atrial Fibrillation Recurrence in 
Patients Without Bradycardia 1004-176*109A 
Influence of Programmed Atriaventricular Delay on 
Left Ventricular Performance in Bivenhicular 
Pacing Systems for Treatment of Heart Failure 
839.2*116A 
Inter-At&l Conduction Delay Cannot Predict the 
Maintenance of Sinus Rhythm During Biahial 
Pacing in Patients With Permanent Atria1 
Fibrillation 1075-100 l 113A 
Is Overdrive Stimulation Therapy a Therapeutic 
Option in Pacemaker Patients With Paroxysmal 
Atria1 Fibrillation? First Worldwide Results of a 
New Dual Chamber Stimulator 828-l l 114A 
Left Ventricular Pre-Excitation Improves 
Mechanoenergetics of Patients With Dilated 
Cardiomyopathy and Ventricular Conduction 
Delay 90 l-2 l 230A 
Long-Term Benefit of Cardiac Resynchronization in 
Heart Failure Patients: The 12.Month Results of 
the InSync Trial 901.3.2308 
KEY: Abstract title, Session-abstract number l page number 
676A SUBJECT INDEX 
Monophasic Transmittal Flow Velocity Pattern With 
Less Increase in Heart Rate Indicates Left 
Ventricular Dysfunction 1212-l l 4858 
Noninvasive Determination of Optimal Pacing Site 
by Doppler Echocardiography in Comparison to 
Invasive Hemodynamic Testing: Results of the 
PATH-CHF Study 839.5 l 117A 
Pacing and Sensing Characteristics Within the 
Coronary Sinus and Great Cardiac Veins 839-3 
l 116A 
Prospective Evaluation of Clinical Criteria for the 
Diagnosis of Pacemaker Lead Infection 
1075-97 l 112A 
Reperfusion Therapy &nong Paced Patients With 
Acute Myocardial Infarction 1173.131.3968 
Responders and Nonresponders to Cardiac 
Resynchronization Therapy: Results From the 
InSync Trial 901.4.23OA 
Reversion and Maintenance of Sinus Rhythm in 
Patients With Permanent Atrial Fibrillation by 
Internal Cardioversion Followed by BiahiaJ 
Pacing 1004-171*108A 
Should All Patients Receive a Dual Chamber 
Device? Unanticipated Use of the Implantable 
Defibrillator as a Pacemaker 1119-95 l 127A 
Should Ethanol Septal Reduction Be Performed on 
Young Patients With Symptomatic Hypertrophic 
Obstmctive Cardiomyopathy? 1197-82 l 88A 
Transcranial Doppler Detection of Microemboli 
During Endocardial Biventricular Pacing in 
End-Stage Heart Failure 1165.94*141A 
Treatment of Paced Patients With Acute Myocardial 
Infarction 1165.100*143A 
Undesirable Change in Arterial Coronary 
Conductance With Right Ventricular Pacing 
1067-57 l 262A 
PathlOgy 
Apoptosis and Inducible Nitric Oxide Synthase in 
Acute Chagasic Myocarditis 1184.153 02258 
Assessment of Global Atrial Fibrillation 
Organization to Optimize the Timing of Ahial 
Defibrillation 408-5 l 546A 
Augmentation of Postnatal Neovascularization by 
Transplantation of Cord Blood Derived 
Endothelial Progenitor Cells 408-l l 5458 
Complete Reversal of Fatal Pulmon~ Hypertension 
in Rats by a Swine Elastase Inhibitor 408.2 l 
5458 
Familial Effort Polymorphic Ventricular 
Arrhythmias in Apparently Normal Heart Map 
to Chromosome lq42-q43 910-3 l 160A 
Histological and Immunohistochemical Myocardial 
Abnormalities in Early Familial Dilated 
Cardiomyopathy X55-5 l 202A 
Hypertrophic Cardiomyopathy and Premature Death 
in the Young: The Histological Characteristics of 
Patients Aged 21 Years and Under 845-4.191A 
Increase in Coronary Artery Matrix 
Met+Proteinases Induced by Intranasal 
Chlamydia Pnenmoniae Infection in a Mini-Pig 
Model 877-3 l 302A 
Increased Activity of Matrix Metalloproteinases in 
Floppy Aotic Valves 1026-64.5258 
Myocudial Rupture After Percutaneous Coronary 
Interventions 1085.77 l 32A 
Oxidized Low Density Lipoprotein (Ox-LDL) Is 
Associated With Plaque Inflammation and 
Destabilization in Human Coronary 
Atherosclerotic Lesions 1005-168 l 358A 
Plaque Substrate and Arterial Damage Are 
Predictors of Restenosis After Coronary 
Stenting in Humans 1019-91 l 4A 
Remodeling of Cardiac Collagen and Extracellular 
Matrix in Keshan Disease 113%157.2098 
Patient care 
Comparison of Point-of-Care and Standard 
Reference Laboratory PT/INR Testing in 
Patients on Routine Warfarin Therapy: An 
Engineering Work Process Flow Study 1216.14 
l 559A 
Defibrillator Shocks and Self-Perceived Quality of 
Life in the Antiarrhythmics Versus Implanted 
Defibrillators (AVID) Trial 891.40 153A 
Depression Following Acute Coronary Syndrome Is 
Associated With a High Risk for Recurrent 
Acute Ischemic Cardiac Events 115 I-96.391A 
Do Sealing Devices After Vascular Interventions 
Make a Difference in Clinical Practice? 
1085.79 l 33A 
Impact of a HCFAfMedicare Compliance Policy on 
Inpatient Cardiology Billing Practices and 
Faculty Productivity 1216-1605598 
Intraortic Balloon Counterpulsation in Patients With 
Cardiogenic Shock: The BENCHMARK 
Registry Experience 1116-124 l 197A 
Promoting Best Physician Practices: The Canadian 
Congestive Heart Failure Clinics Network 
1207-155.2378 
The Veterans Administration’s Multimedia Hospital 
Workstation With Text, Images, and Cine: A 
Cardiologist Looks at T&medicine 1503-20 
555A 
Treatment of Paced Patients With Acute Myocardial 
Infarction 1165.100*143A 
Undertreatment of Hyperlipidemia in Patients With 
Combined Coronary Artery Disease and 
Congestive Heart Failure 861-l 02898 
Pediatric cardiac surgery 
A Prospective Randomized Trial of Azathioprine in 
Children Receiving Cryopreserved Valved 
Allografts for Repair of Congenital Heart 
Defects 1103.161 l 502A 
Aortic Valve Repair for Congenital A&c 
Regurgitation: Precise and Varying Surgical 
Intervention Based on Preoperative Two- and 
Three-Dimensional Echocardiographic Imaging 
and Surgical Inspection 859-4 l 508A 
Contrast Echocardiography Versus Cardiac 
Catheterization for Detection of Pulmonruy 
Arteriovenous Malformations 1124.165 l 507A 
Coronv Artery Abnormalities in Patients With 
Anomalous Left Coronary Artery From the 
Pulmonary Artery: Redefinition of a Syndrome 
804-5 l 510A 
Decision Analysis Comparing Treatment Strategies 
for Hypoplastic Left Heart Syndrome 1103-160 
l 502A 
Device Influence on Outcome in the Treatment of 
In-Stent Restenosis With and Without 
Radiation: A Subanalysis From the WRIST 
Study 1063-112*21A 
Emergency Hospital Admission of Adults With 
Congenital Heart Disease: A Multicenter Study 
1103-164.5038 
Influence of Coronaxy Anatomy and 
Re-Implantation on the Long-Term Outcome of 
the Arterial Switch 851-505058 
Intermediate Term Follow-Up of the End-to-Side 
Aortic Anastomosis for Coax&&on of the Aorta 
851-3.5048 
Ischemia Tolerance of the Neonatal Rabbit Heart: 
The Role of the KATP Channel 1192.166. 
518A 
Ministemotomy for Repair of Congenital Heart 
Disease in Children 1103.1620 502A 
Preoperative Identification of Coronary Artery 
Origin and Distribution Is Unnecessary Prior to 
the Arterial Switch Operation 851.40 504A 
Prevalence and Progression of Neoartic Insufficiency 
Following Staged Reconstruction for 
HypoplasJic Left Heart Syndrome 1007.173 l 
512A 
Systolic and Diastolic Function in Univentricular 
Hearts of Left Ventricular Morphology Pre- and 
Post-Fontan 1103.166*503A 
The Fontan Operation in Adult Patients 1035.1640 
4988 
VenPro Contegra Pulmonary Valved Conduit: 
Preliminary Results From a Multicenter, 
European Trial 1103-163.5038 
Pediatric cardiology 
0.052” Coil Occlusion of a Moderate to Large Patent 
Ductus Arteriosus: Controlled Coil Delivery 
Using a Bioptome Through a Four French 
Sheath 1057.163*499A 
A Comparison of Tramesophageal and Intracardiac 
Induction of Atria1 Fibrillation in Children: 
KEY: Abstract title, Session-abstract number l page number 
JACC February 2000 
Implications in Wolff-Parkinson-White 
Syndrome 1170.1650516A 
A New Technique for Implantation of Large Stents 
Through Small Sheaths in Infants and Children 
With Branch Pulmonary Artery Stenoses 
1080.160*500A 
A Novel Combined Approach to Severe Pulmonary 
Atresia and Ventricular Septal Defect in Infancy 
Results in Improved Outcome 851.6*505A 
A Prospective Rando+ed Trial of Azathioprine in 
Children Receiving Cryopreserved Valved 
Allografts for Repair of Congenital Heart 
Defects 1103-161*502A 
Acute and Long-Term Follow-Up Results With the 
HELEX Septal Occulder in an Animal Model 
1057.161.498A 
Amtic Distensibility Predicts Exercise Arm/Leg 
Gradients and Hypertension in Repaired 
Coarctation of the Aorta 1135-9 l 297A 
Aortic Stiffness Is Affected in Marfan Patients 
Without Aortic Dilation 1146.165*514A 
Aortic Valve Repair for Congenital Aortic 
Regurgitation: Precise and Varying Surgical 
Intervention Based on Preoperative Two- and 
Three-Dimensional Echocardiographic Imaging 
and Surgical Inspection 859-4*508A 
Assessment of Ventricular Function and Pulmonary 
Regurgitation After Total Repair of Tetralogy of 
Fallot During Supine Physical Exercise by 
Ultra-Fast Magnetic Resonance Imaging X59-5 
l 509A 
Atrial Septal Defect Closure in Adult Patients With 
the Amplatzer ASD Occluder 1035-163.4978 
Autonomic Abnormalities After Tetralogy of Fallot 
Repair 1170..166.5178 
Characteristic Head-Up Tilt Responses of Pediatric 
Chronic Fatigue Syndrome 1067-51 l 26OA 
Comparison of Acute and Chronic Performance of 
Intramyocardial Versus Epicardial Steriod 
Eluting Ventricular Pacing Electrodes 1170-162 
l 516A 
Contrast Echocardiography Versus Cardiac 
Catheterization for Detection of Pulmonary 
Arteriovenous Malformations 1124.165 l 507A 
Coronary Artery Abnormalities in Patients With 
Anomalous Left Coroniuy Artery From the 
Pulmonary Artery: Redefinition of a Syndrome 
804-5 l 510A 
Doppler Evidence of Restrictive Right Ventricle 
Physiology in Late Follow Up of Adolescents 
With Repaired Tetralogy of Fallot: A 
Menaningful Finding? 804-4 l 510A 
Ehlers-Danlos Syndrome Is Not Associated With 
Significant Echocardiographic Abnormalities 
1146.166.515A 
Electroanatomical Mapping of Amhythmias in 
Children 1170.164.516A 
Emergency Hospital Admission of Adults With 
Congenital Heart Disease: A Multicenter Study 
1103.164*503A 
Esmolol Causes Paradoxical Supine Tachycardia 
Response in a Subgroup of Pediatric Chronic 
Fatigue: Disturbance of Adrenergic 
Ligand-Receptor Pathway in Blood Pressure 
Control? 1203.12 l 331A 
Extrasystolic and Post-Extrasystolic Beats Provide 
Unique Insight Into the Function of Single 
Ventricles in Children 1007.168 l 511A 
Flecainide and Sotalol: A New Combination 
Therapy for Refractmy Supravenhicular 
Tachycardia in Infants 1170-161 l 515A 
Four-Dimensional Magnetic Resonance Imaging of 
Congenital Heart Disease 859-2*508A 
Four-Dimensional Virtual Pictures: A New Method 
for Teaching Cardiac Embryology 1502-l l 
5488 
Image Digitization and File Compression Using the 
Motion Picture Expert’s Group (MPEG) 
Algorithm Does Not Affect Quantitative Echo 
Measurements in a Pediatric Population 1121-5 
l 449A 
Impact of Telemedicine on the Practice of Pediatric 
Cardiology in a Community Hospital Neonatal 
Unit 1124.162*506A 
JACC February 2000 
Initial Clinical Experience With Pediatric Real-Time 
Three-Dimensional Echocardiography X59-3 l 
508A 
Intermediate Term Follow-Up of the End-to-Side 
Aortic Anastomosis for Coarctation of the Aorta 
851-3*504A 
Inwmediate Term Outcome of Redilation of 
Endovascular Stents 903-3 *519A 
Left Ventricular Volume Analysis in Pediatric 
Patients: A Comparison of Real-Time 
Three-Dimensional Echocardiography With 
Cardiac Magnetic Resonance Imaging 1168-25 
l 469A 
Ministemotomy for Repair of Congenital Heart 
Disease in Children 1103.162*502A 
Myocardial Blood Flow and Flow Reserve After 
Coronary Reimplantation in Patients After 
Arterial Switch and Ross Operation 1007.169* 
511A 
Outcome of Children With Fetal, Neonatal, or 
Childhood Diagnosis of Isolated Complete 
Heart Block: A Single Institution’s Experience 
cf30Years 1192-165*51SA 
Outcome of Prenatally Diagnosed Congenital Heart 
Disease Detected Between 1993.1999 
1192.163*518A 
Prenatal and Postnatal Cardiac Functional 
Assessment in Patients With Family History of 
Cardiomyopathy 1146.163 *514A 
Preoperative Identification of Coronary Artery 
Origin and Distribution Is Unnecessary Prior to 
the Arterial Switch Operation 851.4*504A 
Prevalence and Progression of Neoartic Insufficiency 
Following Staged Reconstruction for 
Hypoplastic Left Heart Syndrome 1007-173. 
512A 
Pulsatile Work Efficiency of a Stented Aorta: A 
Model of Compliance Mismatch With 
Implications to Correction of Aortic Coarctation 
1080.161*500A 
Rapid Decrease of Right Ventricular Volume 
Overload Following Transcatheter Closure of 
Secundum Atrial Seoul Defects 1007.167. 
51OA 
Re-Treatment for Immune Globulin-Resistant 
Kawasaki Disease: A Comparative Study of 
Additional Immune Glob&n and Steriod Pulse 
Therapy 1146.164.514A 
Retrograde Transcatheter Coil Occlusion of 
Congenital Coronary Artery Fistulas in Young 
Children and Infants 1057-166*5OOA 
Serial Assessment of Coronary Flow Reserve in 
Pediatric Cardiac Transplant Recipients 
1208-123.2398 
Stent Dilation of Long Segment Coarctation of the 
Aorta 1080-162-5018 
Studies of Flow in Accurate Models of Early 
Embryonic Human Heart 1192.1610517A 
Sudden Cardiac Death in the Yonng: Japanese 
Nationwide Survey 1215.162*521A 
Sudden Death in Heterotaxy Syndrome 1007.1700 
5llA 
Systolic and Diastolic Function in Univentricular 
Hearts of Left Venbicular Morphology Pre- and 
Post-Fontan 1103.166*503A 
The Use of Flecainide in the Treatment of Fetal 
Supraventricular Tachycardia 1192-164e518A 
Three-Dimensional Echo Atria1 Septal Defect 
Diameters That Account for Septum Primurn 
Tissue Exceed Standard Two-Dimensional Echo 
Measurements: Possible Utility in Device 
Closure 840-5 *435A 
Transcatheter Device Closure of Ventricular Septal 
Defects With Amplatzer Device: Initial Results 
1057-165*500A 
Transcatheter Therapy for Patent Ductus Arteriosus 
in the Adult 1035.160*497A 
Transthoracic Encircling Overlapping and 
Monophasic Waveform Defibrillation in Infant 
and Pediatric Models 889-l *400A 
Use of Tissue Type Plasminogen Activator 
Thrombolysis to Restore Arterial Pulse 
Following Interventional and Diagnostic 
Cardiac Catheterization in infants and Small 
Children IOSO-164*501A 
Peptides 
A Rapid Bedside Test for Brain Natriueretic Peptide 
Accurately Delineates Both Systolic and 
Diastolic Dysfunction in Patients Referred for 
Echocardiography 1027.1460164A 
A Rapid Bedside Test for Brain Natriuretic Peptide 
Accurately Predicts Therapeutic Response and 
Clinical Outcomes in Patients Admitted With 
Decompensated Heart Failure 1049.151 l 171A 
A Rapid. Bedside Test for Brain Natriuretic Peptide 
Accurately Predicts Cardiac Function in Patients 
Referred for Echocardiography 1054-l l 419A 
Beneficial Effect of Spironolactone on Brain 
Natriuretic Peptide in Severe Congestive Heart 
Failure 1137.142 l 206A 
Brain Natriuretic Peptide in Hypertrophic 
Cardiomyopathy Caused by Sarcomeric Gene 
Mutations: A Marker for Poor Outcome? 845-3 
l 191A 
Effect of Camosine on Left Ventricular Systolic and 
Diastolic Performance Before and After 
Congestive Heart Failure 1162.158*218A 
Usefulness of a Rapid, Bedside Test for Brain 
Natriuretic Peptide in the Evaluation of Patients 
Presenting to the Emergency Room With 
Possible Congestive Heart Failure 1049.1520 
171A 
Pericarditis 
Increases of Cardiac Troponin I Compared to Creatin 
Kinase in Acute Pericarditis 1184-157*226A 
Prevalence of Effusive Constrictive Pericarditis 
Among Patients Diagnosed With Constrictive 
Pericarditis 11X4-156.2268 
Pericardium 
Echocardiographic and Clinical Features of Mixed 
Constrict&Restriction 840-404348 
Intracardiac Echocardiography Can Identify 
Pericardial EffusioniTamponade and Monitor 
Pexicardiocentesis: Experimental Studies 
1121-8.4508 
Intrapericardial Ethanol Delivery Inhibits 
Neointimal Proliferation After Porcine Coronary 
Overstretch X70-6 l 61A 
Post-Operative Cardiac Tamponade in the Modem 
Surgical Era: Analysis of 4561 Consecutive 
Patients After Open Heart Surgery 1184-158. 
226A 
Preclinical Safety of Transatial Access to the 
Normal Per&dial Space for Local Cardiac 
Drug Delivery During Aspirin Use and 
Pulmonary Hypertension 1177-I 1 I l 79A 
Reduction in QRS Voltage in Significant Pericardial 
Effusion-Reversibility After Pericardiocentesis 
and After Antiinflammatory Drug Treatment 
1031-72*101A 
Peripheral vasculature 
A Quantitative Study of Tobacco Addiction and 
Motivation to Quit Smoking in Patients With 
Peripheral Arterial Disease 1112-17*283A 
Angiographic Guidance Technique Dramatically 
Decreases Vascular Complications in 1,004 
Intraaortic Balloon Pump Cases 1024-l 1 l 2478 
Association Between Mitral Annulus Calcification 
and Peripheral Arterial Atherosclerotic Disease 
1112.24 *285A 
C677T Methylenehydrofolate Reductase (MTHFR) 
and Factor V Leiden Mutations in Patients With 
Premature Lower Extremity Atherosclerosis Are 
Associated With Systemic Cardiovascular 
Disease 1112.120283A 
Do Sealing Devices After Vascular interventions 
Make a Difference in Clinical Practice? 
10X5-79*338 
Effect of Estrogen and Progestin on Clinical 
Peripheral At&al Disease in Women With 
Coronary Heart Disease 905-5 l 324A 
Effect of Intramuscular Gene Transfer With 
VEGF121 on Endothelial Function in Patients 
With Peripheral Atherosclerotic Occlusive 
Disease 852-5 l 2798 
Effects of Cardiac Transplantation on 
Flow-Mediated Arterial Vasodilation of the 
Peripheral Vascnlature 1029.122* 167A 
SUBJECT INDEX 677A 
Evaluation of Flow Mediated Vasodilation in Upper 
and Lower Limbs of Patients With Congestive 
HeartFailure 1115.1500195A 
Femoral Vascular Access Complications Following 
Arteriotomy Closure Devices: A Comparison 
With Manual Compression After Percutaneous 
Coronary Interventions 10X5-82*33A 
Potential of Contrast Ultrasound Imaging in the 
Detection of Deep Vein 
Thrombosis-Experimental Studies in a Canine 
Model 11 SO-45 l 319A 
Prior Peripheral Vascular Disease and 
Cerebrovascular Disease Are Independent 
Predictors of Increased One-Year Mortality in 
Patients With Acute Coronary Syndromes: 
Results From OPUS-TIM1 16 908.2.410A 
Prospective Trial to Determine the Time of Pressure 
Bandage Application After Cardiac 
Catheterization 1024-12*248A 
Quantification of Flow Velocity and Volume With 
Real-Time Cardiovascular Magnetic Resonance 
1123.40*454A 
Statin Therapy Reduces Restenosis After 
Percutaneous Translmninal Angioplasty by 
Inducing Vascular Enlargement: An 
Intravascular Ultrasound Study 1009-168. 
314A 
The Kit Carson Approach to Chronic Total 
Occlusions of the SFA Biamino G 1064-920 
24A 
Three-Year Survival in Patients With Multivessel 
Coronary Artery Disease and Peripheral 
Vascular Disease Undergoing Coronary 
Revasculaxization 1112-20 l 284A 
Treatment of Post Catheterization Pseudoaneurysms 
With Ultrasound Guided Percutaneous 
Thrombin Injection 1024-10 l 247A 
Treatment of Pseudoaneurysms With Tbrombin 
Injection: Multicenter Experience 1024-9 l 
2478 
Vascular Complications in Patients Who Receive a 
Glycoprotein IIb/IIIa Inhibitor and Vascular 
Closure With the Perclose Device 1085.SO* 
33A 
Pharmacokinetics 
Enoxaparin Pharmacokinetics and 
Pharmacodynamics After Intravenous Bolus 
Administration Alone and at Initiation of a 
Subcutaneous Dosing Regimen 1106-1290 
3138 
Tissue and Myocardial Distribution of Intracoronary, 
Intravenous, Intrapericaxlial, and 
Intramyocardial 12%Labeled Basic Fibroblast 
Groivth Factor (bFGF) Favor Intramyocardial 
Delivery 83-2*1OA 
Unique Kinetics and Hemodynamics of Vascular 
Endothelial Growth Factor (rh VEGA) 
Following Intracoronary and Intravenous 
Infusion in Humans 879-3 *73A 
Pharmacology 
Abciximab Thrombocytopenia: Clinical Correlates 
and Outcomes 1199-91 l 91A 
Abciximab-Enoxaparin Interaction During 
Percutaneous Coronary Intervention: Results of 
the NICE 1 and 4 Trials 1199-92 l 92A 
Antimalarial Drug Halofantine Induces Ventricular 
Tachycardia in Patients With Long QT 
Syndrome Caused by a Mutation of the Cardiac 
Sodium Channel Gene SCNSA 1066.49.26OA 
Assessment of Global Atrial Fibrillation 
Organization to Optimize the Tiing of Attial 
Defibrillation 408-5 l 546A 
Augmentation of Postnatal Neovascularization by 
Transplantation of Cord Blood Derived 
Endothelial Progenitor Cells 408-l -5458 
avb3 Integrin Receptor Blockade Reduces 
Restenosis and Macrophage Infiltration With a 
Reduction in Cellular Adhesion Molecule 
Expression Following Balloon Angioplasty in 
the Atherosclerotic Rabbit 1155-l 15 l 71A 
Complete Reversal of Fatal Pulmonary Hypertension 
in Rats by a Serine Elastase Inhibitor 408-20 
545A 
KEE Abstract title, Session-abstract number l page number 
678A SUBJECT INDEX JACC February 2000 
Do Different B-Blockers Cause Different Mortality 
Effects Following a Myocardial Infarction? 
1202.53 l 329A 
Effect of Carnosine on Left Ventricular Systolic and 
Diastolic Performance Before and After 
Congestive Heart Failure 1162.158 l 218A 
Effects of Phosphodiesterase-5 Inhibition on 
Myocardial Ischemia in Patients With Chronic 
Stable Angina in Therapy With Beta-Blockers 
1016.108*339A 
Eptifibatide Inhibits the Function of GP IIb-IIIa on 
Unstimulated Platelets Without Causing Platelet 
Activation 1106.130.374A 
Population-Based Medication Profiling in Heart 
Failure: Treatment Related Outcomes From the 
R.E.A.C.H. Shxdy 1003.175.542A 
Reversible Cardiac Dvsfunction Associated With 
Zidovudine Exposure in HIV-Infected Children 
1146.1600513A 
Second Generation Oral IIbiIIIa Receptor Blockade: 
Phase II Experience With Roxifiban 1158-l 1 l 
30SA 
Selectivity and Negative Dromotropic Affect of an 
Al Adenosine Receptor Partial Agonist 
1140.72.134A 
Stent-Based Delivery of Sir&mu for the Prevention 
of Restenosis 1131-119*5SA 
The Antipsychotic Agents Thioridadne, 
Chlorpromazine, and Clozapine Block the 
Human-Ether-a-go-go Related Gene (HERG) 
Potassium Channel: Cellular Mechanism for 
Proarrhythmia 1030.97 l 9SA 
The Impact of Clinical Presentation on the Degree of 
Platelet Inhibition at Baseline and Following 
Glycoprotein IIbiIIIa Receptor Blockade in 
Patients Undergoing Percutaneous Coronary 
Intervention 1107.82*43A 
Tranilast Reduces Arterial Wall Cell Proliferation 
After Balloon Angioplasty in Pig Coronary 
Arteries 1065.119*25A 
Troglitazone Reduces the Atherosclerotic Lesion of 
Apo Lipoprotein E-Deficient Mice 1044.52. 
251A 
What Is the Appropriate Loading Dose of 
Clopidogrel Prior to Stent Implantation? Insights 
From a Platelet Inhibition Study 1158-90 307A 
Phosphodiesterase inhibitors 
Effect of Vesntinone on Circulating Cytokine 
Levels in Patients With Congestive Heart Failure 
863-6 l 204A 
Efficacy and Safety of Viagra (Sildenafil Citrate) in 
Men With Cardiovascular Disease and Erectile 
Dysfunction 1202.54*329A 
Incidence of Myocardial Infarction and Death in 53 
Clinical Trials of Viagra (Sildenafil Citrate) 
X07-6 l 302A 
Interaction of Sildenafil CAMP Mediated 
Vasodilation In Viva 1045-20.2538 
Physiology 
An Exaggerated Ventilatory Response to Exercise Is 
Related to Abnormal Exercise Hemodynamics 
in Patients With Chronic Heart Failure 
1095.147*187A 
Animation of Mechanical Complications in 
Experimental Ischemic Heart Disease: A New 
Technique for Three-Dimensional Cardiac 
Imaging 1172.1040395A 
Assessment of Global Ahial Fibrillation 
Organization to Optimize the Timing of Atria1 
Defibrillation 408-5 l 5468 
Assessment of Left Atrial End-Systolic Pressure 
Volume Relationship in an Aniial Model: A 
Real-Time Three-Dimensional 
Echocardiographic and Hemodynamic Study 
1169-34.4718 
Augmentation of Postnatal Neovascularization by 
Transplantation of Cord Blood Derived 
Endothelial Progenitor Cells 408-l 05458 
Central Alpha-2 Adrenoceptors Have No Role in the 
Pathogen&s of the Vasodepressor Component 
of Carotid Sinus Hypersensitivity 1067-52 l 
261A 
Complete Reversal of Fatal Pulmonary Hypertension 
in Rats by a Serine Elastase Inhibitor 408-Z* 
545A 
Diastolic Function From Trammitral Flow: 
Derivation and Validation of the Myocardial 
Velocity Gradient to Doppler E-Wave Relation 
1214.38.491A 
Diurnal Fluctuations in Atrial Fibrillatory 
Refractoriness in Humans 1210.100*15SA 
Left Atrial Contractile Function During Left 
Ventricular Ischemia With and Without Left 
Atrial Ischemia 1143.5 04588 
Preload and Beta-Receptor Induced Alterations in 
Ventricular Relaxation as Quantified by Tissue 
Doppler Echocardiography 912-6 l 495A 
Quantitiative General Theory for Periodic Breathing 
in Chronic Heart Failure and Its Clinical 
Implications 1095.146 l lS6A 
Relationship Between Reduced Pulmonary Diffusion 
Capacity and Excessive Vent&tory Response to 
Exercise in Patients With Chronic Heart Failure 
827-l l 1SlA 
SERCA-2 Expression Is Decreased in the Unloaded 
Heart In Viva 803-4 l 200A 
Sustained Improvement in Homocyst(e)ine Levels 
and Arterial Endothelial Function After 
One-Year Folic Acid Supplementation 868-6 l 
291A 
The Effects of Estrogen Replacement on Thrombus 
Formation in Elderly Women 1010-169 l 231A 
The Skeletal Muscle Intrinsic Mitochondrial 
Oxidative Capacity Contributes to Determine 
Exercise Capacity in Normal Subjects 
1050.123*174A 
Plaque 
360 Degrees Thermal Color Mapping of the 
Atherosclerotic Plaque by Means of a Special 
Thermography Catheter and Computer Software 
1088.111.3SA 
A New Nonobstructive Intravascular Magnetic 
Resonance Imaging Probe for High Resolution 
In Viva Imaging of Atherosclerotic Plaques 
1190.3 l 4798 
Adventitial Fibrosis and Inflammation Surrounding 
Atheroma: Implications for Different Arterial 
Remodeling in Stable and Unstable Plaques 
846-5 9 3688 
Assessment of Lipid Content of Atherosclerotic 
Plaque by Intravascular Ultrasound Using 
Fractal Analysis 108X-113 l 3SA 
Cigarette Smoking Increases Tissue-Factor 
Expression in Human and Murine 
Atherosclerotic Plaques 887-603138 
Comparison of Seven Methods of Calculating 
Plaque Volume From Intracoromuy Ultrasound 
Cross-Sections Using a Monte Carlo Simulation 
of Position Errors 1002-168 l 54OA 
Complement Activation in Active Coronary 
Atherosclerotic Plaque 1090-55 l 2748 
Creating Lipid-Rich Lesions in Porcine Coronary 
Arteries: A Novel Model of Vulnerable Plaque 
1133.4802958 
Detection of Simulated Vulnerable Plaque Using a 
Novel Near Infrared Spectroscopy Catheter 
108%112.3SA 
Detection of Vulnerable Atheroma by Laser-Induced 
Fluorescence 1022..54.2448 
Determining the Thermal Heterogeneity of a Model 
Vessel Wall by Pulsed Laser Irradiation: An 
Experimental Attempt to Detect Vulnerability of 
Atherosclerosis 862-4 l 52A 
Efficacy of Intravascular Ultrasound Radiofrequency 
Signal Analysis in Evaluation of Coronary 
Atherosclerotic Plaques Compared With 
Conventional Video Images 862-2*51A 
Enhanced Levels of Membrane-Bound CD40 Ligand 
on Platelets in Patients With Unstable Angina 
1037.105.3448 
Impact of Coronary Debulking Prior to Stenting 
Versus Conventional Stenting on Early 
Outcome: Initial IVUS Findings 907-l l 94A 
In Vivo Noninvasive Serial Monitoring of 
Atherosclerotic Progression and Regression 
With FDG-PET in a Rabbit Model 911.40493A 
In Viva Quantification of Atherosclerotic Plaque 
Composition by Noninvasive High Resolution 
MRl in Rabbits: A Histopathological 
Correlation 1190-l l 47SA 
Influence of Calcium on Coronary Dissection 
Following Cutting Balloon Angioplasty: An 
Intravascular Ultrasound Study 1043-l 19. ISA 
Novel TXA2 Receptor Blockade, BAY u 3405, 
Prevents MCP-1 Expression, Machrophage 
Infiltration, and Plaque Instability in an 
Atherosclerotic Rabbit Model 1045-19.2538 
Optical Coherence Tomography of Human Coronary 
Arteries: A New Imaging Modality to Visualize 
Different Components of Plaques 862.60528 
Soluble Matrix Metalloprotease (MMP)-9 Levels in 
Systemic and Coronary Circulation in Patients 
With Variant Angina and Acute Coronary Artery 
Syndrome 114X-140 l 3888 
The Angiotensin Receptor Blocker, Candesartan, 
Reduces Atherosclerosis in a Dose-Dependant 
Manner 1133-44*294A 
The Influence of De Now Atherosclerotic 
Remodeling on Luminal Narrowing Follows a 
Normal Distribution: An Intravascular 
Ultrasound Study 1109-l 17 l 47A 
Thermosensor Catheter: A Nitinol Shape Memory 
Basket Catheter to Measure Temperature of 
Vessel Wall With Continuous Blood Flow 
862-l l 51A 
Unstable Coronary Atherosclerotic Plaques: 
Intracoronruy Ultrasound Characteristics With 
In Viva Measurement of Culprit Lesion 
Temperature 862-3 l 52A 
Plasminogen activators 
Bradykinin-Induced Tissue Plasminogen Activator 
Release Is Enhanced by Angiotensin Converting 
Enzyme Inhibition but Not Angiotensin II 
Receptor Antagonism in Healthy Humans 
1023-45*2c16A 
Effect of Angiotensin AT1 Receptor Inhibition on 
Circulating Markers of Endothelial Dysfunction 
860-4 l 2888 
HMG-CoA Reductase Inhibitors Affect the 
Fibrinolytic System of Human Vascular Smooth 
Muscle Cells In Vitro 886-4.3118 
Induction of PAI-I Synthesis by Growth Factors in 
Human Arterial Smooth Muscle Cells Is 
Independent of the 4G/5G Polymorphism in the 
Promoter of the PAI- Gene 1111.41 l 2SOA 
Local and Systemic Hemostatic and Fibrinolytic 
Effects of Intra-Arterial Desmopressin In Viva 
in Humans: Role of Monocyte Activation 
1201-41.3268 
Modification of Growth Factor Induced Expression 
of Plasminogen Activator Inhibitor Type-l in 
Human Arterial Smooth Muscle Cells by 
Intracellular CAMP 886-2 l 311A 
Selective Inhibition of Factor Xa Is More Efficient 
Than Heparin at Facilitating Coronary 
Thrombolysis in a Canine Model 1106-127 l 
373A 
The Plasminogen Activator Inhibitor 1 Promoter 
Polymorphism Predicts Late Loss After 
Coronary Stenting 1152-80.658 
Use of Tissue Type Plasminogen Activator 
Thrombolysis to Restore Arterial Pulse 
Following Interventional and Diagnostic 
Cardiac Catheterization in Infants and Small 
Children 1080.164*501A 
Platelet inhibitors 
A Comparison of Clopidogrel to Ticlopidine 
Therapy for the Prevention of Major Adverse 
Cardiac Events at 30 Davs and Six Months 
Following Coronary St&t Implantation 
1153-119*67A 
A Potential New Indication for Thienopyridine 
ADP-Receptor Antagonist: In-Stent Restenosis 
897-3 l S4A 
A Prospective Multicenter Study to Determine the 
Optimal Level of Platelet Inhibition With 
GPIIb/IIIa Inhibitors in Patients Undergoing 
Coronary Intervention: The GOLD Study 
1107.83*44A 
Abciximab Administration During Angioplasty in 
Acute Coronary Syndromes 1199-85 l 90A 
Abciximab and l+mxaptin Administration During 
Elective High-Risk FICA in Patients With More 
KEY: Abstract title, Session-abstract number l page number 
JACC February 2000 
Than Three Days of Ticlopidine Pretreatment 
1199-90.91.4 
Abciximab Improves Microvascular Function After 
Rescue Percutaneous Coronary Intervention: A 
TIMI 14 Substudy 843.6*4OA 
Abciximab Reduces Early Mortality but Not Late 
Adverse Outcomes in Unselected Diabetics 
Undergoing Scent Implantation 1086.87 l 35A 
Abciximab Thrombocytopenia: Clinical Correlates 
and Outcomes 1199.91.91A 
Abciximab-Enoxaparin Interaction During 
Percutaneous Coronary Intervention: Results of 
the NICE 1 and 4 Trials 1199.92.92A 
Acute Antithrombotic Effect of a Front-Loaded 
Regimen of Clopidogrel on Arterial Tbrombus 
Formation in Patients With Atherosclerosis on 
Aspirin 832-l l 265A 
An Algorithm Based on Clinical and Angiographic 
Criteria for Selecting a Glycoprotein lIb/llla 
Inhibitor During Percutaneous Coronary 
Intervention 1199.87 l 90A 
Association of Presence and Intracmonary 
Thrombus and Troponin I Levels in Patients 
With Unstable Angina or NowQ-Wave 
Myocardial Infarction in PRISM-PLUS 
1082.106*362A 
Clinical and Therapeutic Profile of Patients 
Presenting With Acute Coronary Syndromes 
Who Do Not Have Significant Coronary Artery 
Disease 1039.131*347A 
Comparative Effects of Low Molecular Weight 
Heparin (With and Without Abciximab) and 
Unfractionsted Heparin on Antithrombin 
Activity During Coronary Angioplasty 1107-79 
.43A 
Comparison of Antiplatelet Effects of Clopidogrel, 
Aspirin. and their Combination in Patienls 
Following Myocardial Infarction 1151-9X* 
391A 
Detection of Platelet-Rich Coronary Thrombi Using 
a Novel Radionuclide Imaging Agent 
(Technetium 99m-DMP-444) in a Canine 
Model: Interaction With Abciximab 911-20 
492A 
Does Therapy With GP IIbIIIa Receptor Antagonists 
Improve Late Clinical Outcome Following 
Percutaneous Coronm Intervention? A Report 
From the NHLEI Dynamic Registry X35-50 
31A 
Elimination of Restenosis by Stenting After Plaque 
Reduction With Platelet Inhibitor Trial 
(ESPRIT): A Prospective Randomized Trial 
79-5.8A 
Eptifibatide Inhibits the Function of GP Lib-IIIa on 
Unstimulated Platelets Without Causing Platelet 
Activation 1106-130.3748 
Eptifibatide Reduces the Incidence of Coronary 
Events in Patients With Non-ST-Elevation Acute 
Coronary Syndromes Undergoing Early Cardiac 
Catheterization and Revascularization 
Regardless of Patient Gender 1037.104*343A 
Factors Influencing Outcome and Degree of Benefit 
With GP IIb/Illa Inhibition in Patients With 
Non-ST-Elevation Acute Coronary Syndromes 
X81-2*392A 
Increased Mortality With Oral Glycoprotein IIb/IlIa 
Antagonists: A Pooled Analysis of the Large 
Scale Oral Glycoprotein IIb/IIIa Trials 881-3 l 
393A 
Incremental Effects of Antiplatelet, Antithrombin, 
and Fibrinolytic Therapy on the Speed and 
Stability of ST-Segment Recovery After Acute 
MyocardialInfarction 1106.104.372A 
Initial Experience of Glycoprotein IIb/lIIa Inhibition 
With Abciximab During Carotid Stenting: A 
Safe Adjunctive Therapy 898-4 l 86A 
Interim Results of the Tirofiban Given in the 
Emergency Room Before Primary Angioplasty 
(TIGER-PA) Pilot Study 1106.102*371A 
Intravenous AR-C69931MX, a Novel P2T Platelet 
Receptor Antagonist, in Patients Undergoing 
Percutaneous Coronary Interventions: 
Preliminary Results From a Placebo or Active 
Controlled Trial 1087-l 16 *36A 
Lipid Peroxidation Product 4.Hydroxy-2.None& 
Acts Synergistically With Serotonin in Inducing 
Vascular Smooth Muscle Cell Proliferation 
1068-9.2628 
Marginal Cost-Effectiveness of GPIIB/lIIA 
Blockade Targeted to High-Risk Patients 
Undergoing Angioplasty 853-4 l 55OA 
Multivessel Percutaneous Coronary Interventions 
During Acute Coronary Syndromes Appear to 
Be Safe in the Glycoprotein IIb/IIIa Antagonist 
Era X37-3*357A 
Observed Protective Effect of Glycoprotein llb/llla 
Antagonists Against In-Hospital Death Stratified 
by Patient Risk 1199.88 l 91A 
Platelet Activation as a Potential Mechanism of GP 
IIbiIIIa Inhibitor-Induced Thrombocytopenia 
1106.103.371A 
Platelet GPIIb/lIIa Antagonist, Roxifiban in Hepaxin 
or Low Molecular Weight Heparin-Induced 
Thrombocytopenia 117X-56*317A 
Predictors of TIM1 r<= 2 Coronary Flow After 
Primary Angioplasty in Patients With Acute 
Myocardial Infarction 1062-81 l 20A 
Prior Peripheral Vascular Disease and 
Cerebrovascular Disease Are Independent 
Predictors of Increased One-Year Mortality in 
Patients With Acute Coronary Syndromes: 
Results From OPUS-TIM1 16 908-2 l 410A 
Prolonged Antiplatelet Therapy Prevents Late 
Thrombosis After Radiation Therapy in Patients 
With In-St& Restenosis 1022-53 l 243A 
Rapid Platelet Function Assessment Using Two 
Concentrations of Adenosine Diphosphate After 
Clopidogrel Loading Dose in Patients 
Undergoing Cardiac Catheterization 1107-X0* 
43A 
Rehospitalization: An Outcome That Parallels Other 
Major Endpoints in Comparisons of Antiplatelet 
Therapy 1193.16.557A 
Second Generation Oral IIb/TIIa Receptor Blockade: 
Phase II Experience With Roxifiban 1158-11 l 
30SA 
Short-Term Mortality Is Lower With Clopidogrel 
Than Ticlodpidine Following Coronary Artery 
Stenting 1153-116*66A 
Simultaneous Administration of Glycoprotein 
IIb/lIIa Inhibitors With Low-Molecular-Weight 
Heparins Does Not Augment the Release of 
Tissue Factor Pathway Inhibitor: Implications in 
the Management of Cardiovascular Patients 
1092.20 l 277A 
Striking Reduction and Mortality in Taget Vessel 
Revascularization With Stent-Abciximab in 
Diabetic Women 1086-88 l 35A 
Sustained Coronary Artery Recanalization With 
Adjunctive Infusion of a Novel PZl-Receptor 
Antagonist AR-C69931 in a Canine Model 
llll-47.2818 
The Antidepressant Nefazodone Inhibits 
Shear-Induced Platelet Aggregation 1111-49 l 
2828 
The Effect of Sib&ban, an Oral IIbfiIIa Platelet 
Receptor Antagonist, on Platelet Function in 
Patients With Chronic Renal Failure 115X-10- 
308A 
The Impact of Abciximab on Mortality After 
Multivessel Prophylactic Cranial Irradiation: A 
Striking Effect in Diabetes 1199.89 *91A 
The Impact of Clinical Presentation on the Degree of 
Platelet Inhibition at Baseline and Following 
Glycoprotein IIb/IIIa Receptor Blockade in 
Patients Undergoing Percutaneous Coronary 
Intervention 1107-82 *43A 
The Impact of Oral Antiplatelet Therapy on CK 
Release After Coronary Stent Implantation: A 
Comparison Between Ticlopidine and 
Clopidogrel 1153-l 18 l 67A 
Thrombocytopenia, Bleeding, and Thrombotic 
Events With Oral Glycoprotein IIb/IIIa 
Inhibition: Results From OPUS-TIM1 16 881-4 
*393A 
Thrombostatin, a PAR1 Inhibitor, Reduces Both 
Platelet Aggregation and Adhesion After 
KEY: Abstract title. Session-abstract number l page number 
SUEUECT INDEX 679A 
Arterial Wall Injury With Balloon Angioplasty 
1111.45.281A 
Thrombotic Stent Occlusion and Associated Major 
Adverse Cardiac Events Beyond the First Two 
Weeks After Coronary Stent Placement: 
Analysis of 3676 Patients With a Four-Week 
Ticlopidine Regimen 1153-l 17 l 66A 
Tirofiban and Heparin Are Synergistic With Low 
Frequency High Intensity Ultrasound for In 
Vitro Blood Clot Dissolution 1106-l 06 l 372A 
Tolerance and Safety of Cangrelor, a Novel Purin 
Receptor Antagonist, Used as a Platelet 
Aggression Inhibitor in Acute Coronary 
Syndrome 1037-101 l 343A 
Total Platelet Volume Is an Independent Predictor 
for Mortality Reduction in Patients Treated With 
Abciximab 1199.84 l 90A 
What Is the Appropriate Loading Dose of 
Clopidogrel Prior to Stent Implantation? Insights 
From a Platelet Inhibition Study 1158.9*307A 
Platelets 
A Recombinant Soluble P-Selectin Cilycoprotein 
Ligand-1 Chimera Has a Thrombolytic Effect in 
a Rat Model of Thrombosis 1111-42 *280A 
Abciximab Thrombocytopenia: Clinical Correlates 
and Outcomes 1199.91 l 9lA 
Antiplatelet Effect of Abciximab, Tirofiban, and 
Eptifibatide With Coronary Stent Placement 
1086-86*34A 
Comparative Effects of Abciximab and Integrilin on 
Platelets and Fibrin Formation in Native 
Nonanticoagulated Blood Under Flow 
Conditions 1106.131 l 374A 
Comparative Effects of Paroxetine and Nefazodone 
on Human Platelet Aggregation and Vascular 
Reactivity 832.402668 
Comparison of Antiplatelet Effects of Clopidogrel, 
Aspirin, and their Combination in Patients 
Following Myocardial Infarction 1151-98 - 
391A 
Detection of Platelet-Rich Coronary Thrombi Using 
a Novel Radionuclide Imaging Agent 
(Technetium 99m-DMP-444) in a Canine 
Model: Interaction With Abciximab 91 l-2 * 
492A 
Differences Between Unstable Angina and Coronary 
Angioplasty in Platelet and Leukocyte 
Activation 1194.140*406A 
Effect of a Recombinant Soluble P-Selectin 
Glycoprotein Ligand-1 Chimera on Restenosis 
Following Atlial Injury by Repeat Angioplasty 
in Pigs 1042-l 11 l 16A 
Endothelial Dysfunction Following Oral Methionine 
Is Not Mediated by an Increase in Free Radicals 
10X9-48 l 273A 
Lack of Thrombocytopenic Response After 
Low-Molecular-Weight Heparins Usage 1s Due 
to the Generation of Non-Functional 
Anti-Heparin-Platelet Factor 4 Antibodies 
1178-51*316A 
Losartan Therapy Reduces Thrombin-Receptor 
Agonist-Induced Platelet Aggregation 832-3 l 
266A 
Oral Consumption of Purple Grape Juice Inhibits 
Platelet Function and Increases Platelet-Derived 
Nitric Oxide Release 832-5 l 2678 
Platelet Activation as a Potential Mechanism of GP 
IIblIIIa Inhibitor-Induced Thrombocytopenia 
1106.103*371A 
Platelet GPIIbiIIIa Antagonist, Roxifiban in Heparin 
or Low Molecular Weight Heparin-Induced 
Tbrombocytopenia 1178.56 l 317A 
Platelet Inhibition by Sertraline and 
N-Desmethylsertraline: A Possible Missing 
Link to Explain Benefits of Selective Serotonin 
Reuptake Inhibitors in Depressed Patients After 
Acute Coronary Events 1111.48 l 282A 
Primary Platelet Nitric Oxide Resistwce and 
Oxidative Stress in Patients With Chronic Heart 
Failure 1183.142*222A 
Role of Oral Blockade of Platelet Glycoprotein 
IIb/IIIa on Neutrophil-Platelet Interactions in 
Patients With Acute Coronary Syndromes 
1037.102.3438 
680A SUBJECT INDEX JACC February 2000 
Serum Glucose but NorInsulin Modulates 
Platelet-Dependent Thrombosis in Patients With 
Coronary Artery Disease 1111-440 281A 
Standard Tests to Assess Heparin Efficacy May Not 
Accurately Reflect Anticoagulation 1037-108 l 
344A 
The Antidepressant Nefazodone Inhibits 
Shear-Induced Platelet Aggregation 1111-49 l 
282A 
Thrombocytopenia, Bleeding, and Thrombotic 
Events With Oral Glycoprotein IIb/IIIa 
Inhibition: Results From OPUS-TIM1 16 X81-4 
l 3938 
Tbrombostatin, a PAR1 Inhibitor, Reduces Both 
Platelet Aggregation and Adhesion After 
Arterial Wall Injury With Balloon Angioplasty 
1111.45*281A 
Tocopherols and Human Platelet Aggregation 842-3 
l 270A 
Vessel Wall Passivation to Platelets and Nentmphils 
Is Not Complete One Month After Stenting 
1086-91*36A 
Point-of-services 
A Prospective Multicenter Study to Determine the 
Optimal Level of Platelet Inhibition With 
GPIIbiIIIa Inhibitors in Patients Undergoing 
Coronary Intervention: The GOLD Study 
1107-83.448 
Comparison of Point-of-Care and Standard 
Reference Laboratory PTiINR Testing in 
Patients on Routine Wufarin Therapy: An 
Engineering Work Process Flow Study 1X6-14 
l 5598 
Rapid Platelet Function Assessment Using Two 
Concentrations of Adenosine Diphosphate After 
Clopidogrel Loading Dose in Patients 
Undergoing Cardiac Catheterization 1107-80 l 
43A 
Tramtelephonic Patient Entry of Results From Home 
Prothrombin Time Testing Into a Centralized 
Anticoagulation Clinic Database 1501-2*545A 
Potassium 
Acute Effects of Dronedamne on Potassium Currents 
in Isolated Rabbit Ventricular Myocytes: 
Comparison With Amiodarone 1030.99*98A 
Extracellular K+ Accumulation in Canine Right 
Atria During Rapid Rates and Atrial Fibrillation 
In Viva 883-40 146A 
Preexcitation 
Natural History of Wolff-Parkinson-White in 238 
Militzy Aviators: Long-Term Follow-Up of 22 
Years 1209.67 l 155A 
Pregnancy 
Four-Dimensional Virtual Pictures: A New Method 
for Teaching Cardiac Embryology 1502-l l 
548A 
Long-Term Results of Mitral Balloon Valvotomy in 
Pregnancy 1001.176*525A 
Pressure-volume relation 
Assessment of Left Atrial End-Systolic Pressure 
Volume Relationship in an Animal Model: A 
Real-Time Three-Dimensional 
Echocardiographic and Hemodynamic Study 
1169-34.4718 
Effect of Camosine on Left Ventricular Systolic and 
Diastolic Performance Before and After 
Congestive Heart Failure 1162.158*218A 
Effect of Increased Afterload on Left Ventricular 
Function in Mice 1094.1240 184A 
Multiple Frequency Volume-Conductance Catheter 
Provides True Volume in the Mouse Left 
Ventricle 1094.123.184A 
Prevention 
A High School Student’s Vascular Wall Is 
Associated With Hem Disease RiskFactors for 
Adults 1136-19.2998 
Aggregation of Metabolic Abnormalities, 
Overweight, and High Blood Pressure in Young 
Subjects Followed Up for a IO-Year Period: The 
Rio de Janeiro Study 1069.20*264A 
Air Force/Texas Coronary Atherosclerosis 
Prevention Study (AFCAPS/TexCAPS): Effect 
of Lovastatin Treatment on Risk Subgroups 
Defined by Framingham Risk Equations 
1009.367.313A 
Antioxidant Nutrient Supplementation and Brachial 
Reactivity in Patients With Coronary Afiery 
Disease 1023-42 l 245A 
Cardiovascular Risk: A Coronary Heart Disease 
Risk Calculator-Advisor 1504-20 556A 
Clinical Predictors of Poor Outcome in Women 
Recovering From Acute Coronary Syndrome 
1151.1000392A 
Depression in Heart Failure: Clinical Characteristics 
and Impact on Outcomes 1072-153 l 178A 
Dual Site Atrial Pacing for Atria1 Fibrillation 
Prevention: Triggered or Inhibited Response to 
Ectopy? 1004-168.107A 
Effects of Aerobic Training on Normotensive 
Subjects With Exaggerated Blood Pressure 
Response to Exercise 1025.24*25OA 
Fast Platelet Suppression by Lycine Acetylsalicylate 
in Chronic Stable Coronary Patients: Potential 
Clinical Impact Over Regular Aspirin for 
Coronary Syndromes 1196.104 l 408A 
Impact of Ramipril and Vitamin E on 
Cerebrovascular Events in the HOPE (Heart 
Outcomes Prevention Evaluation) Trial 905-4 l 
3248 
Implications of Statin Use on the Health Burden and 
Economic Costs of Acute Coronary Syndromes 
Without ST Elevation: Prospective Registry of 
Acute Ischaemic Syndromes (PRAIS) in the 
United Kingdom 853-6 l 551A 
Influenza Vaccination and Reduced Risk of 
Recurrent Association of Myocaxlial Infarction 
1015.131*337A 
Is the Risk of Cardiovascular Events the Same for 
the West Scotland Coronary Prevention Trial 
Study Group (WOSCOPS) Patients and 
Hypercholesterolemic United States Men? 
906-l l 325A 
Is Use of a Statin Agent at the Time of Presentation 
for Acute Myocardial Infarction Associated 
With a Favorable Outcome? 1009-171 l 314A 
Low Molecular Weight Heparin Versus Minidose 
&fractionated Heparin for Prophylaxis Against 
Venous Thromboetnbolism in Medical Intensive 
Care Unit Patients: A Randomized, Controlled 
Trial 905-6 l 325A 
Nonlipid Lowering Effects of Statin Medication in 
Patients With Coronary Heart Disease 1046-l 1 
l 256A 
Prevention of Heart Failure by Ramipril in High 
Risk Patients Without Heart Failure or Systolic 
Dysfunction 863-3 l 203A 
Ramipril Prevents Cardiovascular Events in High 
Risk Diabetic Participants: Results of the HOPE 
Study 807-2*301A 
Tamoxifen Is Not Associated With Decreased 
Cardiac Event Rates in Women With or Without 
Preexisting Heart Disease 807-5 l 301A 
Prognosis 
A Common Variant of the AMPDl Gene Predicts 
Improved Survival in Patients With Coronary 
Artery Disease 10X4-127*365A 
A Novel Noninvasive Short Hospital Stay Strategy 
for Low Risk Myocardial Infarction: Six-Month 
Follow-Up 1038-140.3478 
A Parameter of Recovery After a Maximal Exercise 
Is an Independent Predictor of Survival in 
Patients With Left Ventricular Systolic 
Dysfunction 1115.146*194A 
A Simple, Easily Computed Clinical Score Provides 
Independent Prognostic Information to Rest 
Ejection Fraction in Patients With Coronary 
Artery Disease 1016-103.3388 
Aborted Myocardial Infarction Is a Predictor of 
R&faction After Successful Thrombolysis 
856.2*374A 
Activated Protein C Resistance and Van Willebrand 
Factor Are Useful Markers for One-Year 
Mortality After Acute Coronary Syndromes 
908-6*411A 
Acute Myocardial Infarction Morbidity After 
Previous Revasculatization: Prediction Using 
Neural Networks 1504-l l 556A 
Admission Heart Rate Is a Useful Tool for Risk 
Stratification of Patients With Acute Myocardial 
Infarction in the Reperfwion Era 1173.141 l 
398A 
An Enhanced Response of Circulating Monocytes to 
Low-Grade Inflammatory Stimuli in Unstable 
Angina Is Associated With Recurrence of 
Coronary Events 1005.170.359A 
Aspirin 300 mg Daily After Successful 
Thrombolysis Prevents Reocclusion of A ~90 
Baroreflexsensitivity and Heart Rate Variability Are 
Independent Risk Indicators for One-Year 
Mortality in Patients After Acute Transmwal 
Myocardial Infarction and Individually 
Optimized Therapy: Results of the Post-Infarct 
Risk Stratification Study (PIR 880.3 l 145A 
Benefit Versus Bleeding Complications After 
Thrombolysis for Acute Myocatdial Infarction 
in Patients With History of Gastroduodenal 
Ulcers 873-4 l 386A 
C-Reactive Protein Levels Do Not Correlate With 
the Severity of Coronary Atherosclerosis 
1005.176.36OA 
Cardiac Mortality of Patients With Left 
Bundle-Branch Block Following Rest 
201Tl&ress 99mTc-Sesttibi Dual-Isotope 
Myocardial Perfusion X58-6 l 456A 
Cardiovascular Disease and Prognosis in Adults 
With Glucose Disorders: The Strong Heart 
Stady 1069-17.2638 
Cardiovascular Risk: A Coronary Heart Disease 
Risk Calculator-Advisor 1504-2 l 556A 
Cbronotropic Incompetence and Abnormal Heart 
Rate Recovery Predict Moaality in Patients 
Undergoing Exercise Testing Without Imaging 
874-6 l 214A 
Clinical and Economic Analysis of Myocardial 
Perfusion SPECT Scintigraphy in Patients With 
LBBB 8X4-5*474A 
Clinical Features of Patients With Heart Failure 
After an Acute Coronary Syndrome: Findings 
From GUSTO-IIb 872-5 l 212A 
Comparison of the Prognostic Value of Cardiac 
I-123 Metaiodobenzylguanidiine and 
Neurohumoral Factors in Patients With 
Congestive Heart Failure 119 1-7 l 480A 
Comparison of the Prognostic Value of Left 
Ventricular Filling and Peak Oxygen Uptake in 
Patients With Heart Failure 827-4 l 182A 
Complex Plaque of the Ascssending Aorta and Arch 
Predicts Cardiovascular Events 1122-27-4518 
Coronary Artery Bypass Versus Coronary 
Angioplasty: Prognostic Impact in Patients With 
Three Vessel Disease, Left Ventricular 
Dysfunction, and Maintained Myocardial 
Viability 1038-129 l 3458 
Delineation of Prognostic Blood Pressure Values for 
Abnormal Blood Pressure Response to Exercise 
in Hypertrophic Cardiomyopathy 1096.154 l 
188A 
Differential Prognostic Value of Neurohumoral 
Activation in Left Ventricular Dysfunction: 
Coronary Heart Disease Versus Dilated 
Cardiomyopathy in 428 Nonselected Patients 
1115-145*194A 
Do Exercise and Dobutamine Echo Convey 
Equivalent Information About Risk of Death? 
1101.29*438A 
Echocaxliographic Determinants of Prognosis After 
Acute Myocardial Infarction: Beyond Ejection 
Fraction 1148-135*386A 
Effect of Cardiac Sympathetic Nervous Tone on 
Mode of Death in Chronic Heart Failure 
1183-145.2238 
Effect of Right Venhicular Size on Prognosis in 
Patients With Left Ventricular Dysfunction: 
Results From a Cohort of 2265 Patients With 
Left Ventlicular Ejection Fraction <=40 
Elevated Levels of C-Reactive Protein in Patients 
With Acute Myocardial Infarction Are a 
Predictor of Mortality and Heart Failure but Not 
of New Coronary Events 1149.6903898 
Elevated Levels of D-Dimer in Patients With 
Unstable Angina Predict Higher Risk of 
Thrombotic Complications 908-l l 4lOA 
&FY: Abstract title, Session-abstract number l page number 
MCC February 2000 
Elevated Levels of Serum C-Reactive Protein May 
Predict Prognosis of Patients With Chronic 
HeartFailure 109%144*186A 
Evolution of Hypertension From Nonhypertensive 
Blood Pressure Levels: Rates of Progression in 
the Framingham Heart Study 869-2*292A 
Heart Rate Recovery Immediately Following 
Exercise Testing: A Powerful New Predictor of 
Mortality 414. I *5%2A 
Heart Rate Turbulence and Mottality in Chronic 
Heart Failure 1053-60*106A 
Heart Transplant Recipients Witb Normal Coronary 
Angiograms: Is Intravascular- Ultrasound Really 
Necessary? 120% 125 *239A 
Hear-type Fatty Acid Binding Protein: An 
Important Predictor of Cardiac Events in Heart 
Failure X45-l l 19OA 
Impact of Prostacyclm on Five-Year Survival for 
Preliminary Pulmonary Hypertension 894-20 
322A 
Impact of the Presence and Degree of Aortic 
Stenosis on Survival in 2265 Patients With Left 
Ventricular Dysfunction X05-3 * 5328 
Importance of Right Bundle Branch Block as an 
Independent Predictor of All-Cause Mortality: 
Report of 2.485 Patients From a Single Center 
1031-60.998 
Improved Predictive Ability by Combination of 
Time Domain and Spectral Temporal Mapping 
Analysis in Chronic Ischemic Cardiomyopathy 
1211.61*159A 
Incidence, Risk Factors, and Clinical Outcome of 
Stroke After Acute Myocardial Infarction in 
Clinical Practice 873-303858 
Inflammatory Markers Fail to Predict Three-Month 
Outcome in Unselected Patients With Chest Pain 
Presumed Secondary to Myocardial Ischemia 
1149.67 *388A 
Influence of Diabetes Mellitus on Initial and 
Long-Term Outcome of Stented Patients With 
Multivessel Coronary Disease 1130-91 l 57A 
Influence of the Presence and Type of Diabetes 
Mellitus on the Initial and Long-Term Outcome 
After Coronary Stenting 1176-86 *VA 
Is C-Reactive Protein a Marker for First and 
Recurrent Acute Coronary Events in Very 
Different Subsets of Stable Ischemic Heart 
Disease? 887-4.3138 
Is Increased Heart Rate Predictive of Poor Survival 
in Patients With Preserved Left Ventricular 
Systolic Function? 1027-147*164A 
Is the Response to Chlamydia Pneumoniae Infection 
in Unstable Angina Genetically Mediated? The 
Role of the Lewis Antigenic System lOO5-171* 
359A 
Is Treadmill Exercise Testing Useful in the Elderly? 
A Population-Based Study in Olmsted County, 
Minnesota 1163.126*22OA 
Modeling the Risk of Major In-Hospital 
Complications Following Percutaneous 
Coronary Intervention 835-3 l 3lA 
Myocardial Infarction During the First 72 Hours of 
Hospitalization Is a Predictor of Late-Tetm 
Mortality in Patients Presenting With 
Non-ST-Elevation Acute Coronary Syndromes 
856.3*3YjA 
New Doppier Indices of Left Ventricular Function to 
Predict Survival in Congestive Heart Failure 
414.4*553A 
Not So Benign Short-and Long-Term Prognosis of a 
Non-Q Wave Myocardial Infarction Following 
Thrombolytic Therapy 1084-134.3668 
Observed Protective Effect of Glycoprotein llb/llla 
Antagonists Against In-Hospital Death Stratified 
by Patient Risk 1199-88 *91A 
Outcome of Mitral Valve Prolapse: A Large 
Population-Based Study 1070.65*528A 
Percutaneous Coronary Revasculatization for 
Multivessel Disease in the Stent Era: Acute and 
Long-Term Outcome 834-3 *29A 
Perfusion Defects of Multiple Vessel Territories on 
Exercise SPECT Thallium Imaging Predict 
Long-Tetm All-Cause Mortality 858-5 l 4gSA 
Prediction of Outcomes in Patients With Suspected 
or Known Coronary Artery Disease by Tc-99m 
Tetrofosmin Stress Myocardial Perfusion 
Imaging Studies 1034-30*416A 
Predictive Value of the Annual Electrocardiogram 
1163-124*220A 
Predictors for Late Death of Patients With 
Chronically Occluded Coronary Arteries 
1040.79 l 12A 
Preexisting Atherosclerotic Disease as a 
Predominant Determining Factor for Ultra 
Long-Term Prognosis of Vasospastic Angina 
Treated With Calcium Channel Antagonists: 
Evidence From 20.Year Follow-Up Study 
1039.132*348A 
Prognosis of Patients With Cardiac Fabry Disease: 
Comparison With Classical Type 1138-158. 
209A 
Prognosis of Viable Myocardium Early After Acute 
Myocardial Infarction: Relation to Indicators of 
Left Ventricular Systolic Dysfunction 892-20 
483A 
Prognostic Implications of Hysteresis of the 
ST-Segment/Heart Rate Recovery Loop 
Following Maximal Exercise 874-3 l 213A 
Prognostic Influence of Cardiac Troponin I After 
Coronary Angioplasty 1107-75 l 42A 
Prognostic Influence of Different Cardiac Troponin I 
Curves at One-Year Follow-Up in Unstable 
Angina 1084.130*365A 
Prognostic Significance of Abnormal Peak Early to 
Late Diastolic Filling Ratio in Middle-Aged to 
Elderly Adult American Indians: The Strong 
Heart Study 869-5 l 293A 
Prognostic Significatye of Left Main Disease 
Assessed by Three-Dimensional IVUS 
1043-115*17A 
Prognostic Significance of Rest 201TLStress 
99mTcSestamibi Dual-Isotope Myocardial 
Perfusion SPECT in Very Elderly Patients 
858-3*455A 
Prognostic Significance of Transient Ischemic 
Dilation of the Left Ventricle in Normal 
Dual-Isotope Myocardial Perfusion SPECT 
1034-29 *416A 
Prognostic Value of Coronary Calcification in a 
Chest Pain Population 1145.33*462A 
Prognostic Value of Exercise Echocardiography: Is 
There a Gender Effect? 1101-26 *437A 
Prognostic Value of Recurrent Episodes of CK-MB 
Elevation Following Repeated Catheter-Based 
Coronary Interventions 117%77.75A 
Prognostic Value of stress 
Technetium-99ln-Sestamibi Myocardial 
Perfusion Imaging in Asymptomatic Diabetics 
858.2*454A 
Prognostic Value of the “Circulatory” Power During 
Exercise in Patients With Heart Failure 827-3 l 
MA 
Quality of Life Measures Predict Mortality and 
Hospitalization in Patients With Advanced Heart 
Failure: Insights From the EPICAL Study 
1207-159*238A 
Rapidly Progressive Coronary Artery Disease and 
C-Reactive Protein: Is There Any Relation? 
1156-46 l 305A 
Recurrent Ischemia During Continuous Multilead 
Electrocardiogramischemia Monitoring 
Identifies Patients With Unstable Angina at High 
Risk and Subsequent Cardiac Events. 
Meta-Analysis of Three Studies Involving 995 
Patients 908.3*410A 
Safety and Prognostic Value of Early 
Dobutamine-Atropine Stress Echocardiography 
in Patients With Spontaneous Chest Pain and a 
Nondiagnostic Electrocardiogram 1212-40 
4868 
Serum Cardiac Tropinin I Increase in Acute Type A 
Aortic Dissection: A New Independent Predictor 
of Mortality 1091.10*276A 
Simply Counting the Number of Risk Factors 
Provides an Estimate of the Mortality Rate of 
the Projected Coronary Bypass Surgery 
3128-128*3SlA 
SUBJECT INDEX 681A 
Smoking and Mnttality: A Propensity Analysis With 
Consideration for the Effects of Alcohol 
1125.14*551A 
Smoking Cessation Reduces Mortality After 
Coronary Artery Bypass Surgery: A 20-Year 
Follow-Up Study 112X-127*381A 
Survival Rates Are Similar Between 
African-Americans and Other Races With Heart 
Failure 1072-152 l 177A 
Systolic Versus Diastolic Heart Failure in 
Community Practice: Clinical Features and 
Outcomes in 1,694 Patients 1027.1420 163A 
The Deleterious Prognostic Impact of Cardiac 
Troponin I Re-Elevation Following 
Percutaneous Coronary Intervention in Patients 
With Acute Coronary Sydromes 1175-76*75A 
The Kansas City Cardiomyopathy Questionnaire 
Predicts Heart Failure Admissions and Death 
1003.173*541A 
The Long-Term Predictive Value of Peak Oxygen 
Intake in 12,169 Men Referred for Cardiac 
Rehabilitation 874-l l 213A 
The Prognostic Role of Relative Lymphocyte 
Concentration in Patients With Heart Failure and 
Low Ejection Fraction 1183.149*224A 
The Relation Between Endothelial Dysfunction of 
Coronary Artery and Major Adverse Coronary 
Events 1061.1340354A 
Treadmill Exercise Stress Echocardiography in 
Patients With Left Bundle Branch Block: Is 
There Prognostic Value? llOl-25*437A 
Unrestricted Availability of Coronary Stems 
Correlates With Decreased Risk of Mortality 
and Major Adverse Clinical Events 834.6*30A 
Utility of Dipyridamole Tc-99m Sestamibi SPECT 
Myocardial Perfusion Imaging to Predict 
Short-Term Cardiac Events Following Primary 
Angioplasty 1034.34*417A 
Utility of Troponin-I in Predicting Short-Term 
Cardiovascular Events in Patients With Unstable 
Angina and Normal CK-MB Levels 1082.1020 
361A 
Value of Classic and New Risk Indicators for 
Identifying Patients at High Mortality Risk: 
Results of the Post-Infarct Risk Stratification 
Study (PIRS) 880-5 l 1458 
Visible T-Wave Altemans in Carriers of LQTl, 
LQT2, and LQT3 Gene Mutations 910-l l 160.4 
Wall Motion Abnormalities in Multiple Vessel 
Territories on Exercise Stress Echocardiography 
Predict All-Cause Mortality 1101.28.4388 
Wavelet Decomposition of the Signal-Averaged 
Electrocardiogram in Evaluation of Prognosis in 
Idiopathic Dilated Cardiomyopathy 12 11-60 l 
159A 
Which Is the Best Cardiopulmonary Exercise 
Parameter to Identify High Risk Chronic Heart 
Failure Patients? 874-5 l 214A 
Prostacyclin 
Adenoviral Gene Transfer of Cyxlooxygenase-1 
Improves Luminal Area and Blood Flow After 
Carotid Balloon-Injury in Atherosclerotic 
Watanabe Rabbits 852.4*279A 
Impact of Prostacyclin on Five-Year Survival for 
Preliminary Pulmonary Hypertension 894-20 
3228 
Long-Term Effects of Prostacyclin on 
Hemodynamics in Primary Pulmonary 
Hypertension: Are Continued Dose Increases 
Necessary 1113-56.2818 
Orally Active Prostacyclin Analogue Improves 
Exercise Capacity in Patients With Primary or 
Thromboembolic Pulmonary Hypertension 
1113-55*286A 
Prostaglandins 
Cycle-Oxygenase Inhibitor Diclofenac Improves 
Chlamydia Pneumoniae-Induced Endothelial 
Dysfunction 1022-56*244A 
Influence of Aging on Vascular Effects of Thrombin: 
Role of Endothelium-Derived Nitric Oxide and 
Vasoconstrictive Prostaglandins 1089-41*271A 
Preserved Long-Term Efficacy of Iloprost Inhalation 
Therapy Over Two Years in Patients With 
Primary Pulmonaty Hypertension 1113-52~ 
2868 
KEY: Abstract title, Session-abstract number l page nttmber 
682A SUBJECT INDEX 
Role of Alprostadil (PGEl) in Acute Drug Testing 
for Pulmonary Hypertension (PH) 1113-57 l 
287A 
The Positive Inotropic Effects of Hydrostatic 
Pressure Are Buffered by the Endocardial 
Endothelim via Prostaglandins 1071.148*176A 
Prosthetic valves 
Determinants of Acute and Long-Term Suwival in 
245 Patients With Infective Endocarditis 
1205.63 l 536A 
Quantitative Assessment of Mechanical Prothestic 
Valve Area With Three-Dimensional 
Transesophageal Echocardiography 1122-32 l 
452A 
Repeat Aoltic Valve Replacement for Isolated 
Patient-Prosthesis Mismatch Associated With an 
Excellent Short-Term Survival 1160-55 l 534A 
Subvalvular Stenosis at Repeat Aortic Valve 
Replacement for Patient-Prosthesis Mismatch 
1160.56*534A 
The Relative Impact of Atrial Fibrillation on Left 
and Right Atria1 Size in Patients Following 
Mitral Valve Replacement 1209.73 l 156A 
Tbrombolytic Therapy for Prosthetic Valve 
Thrombosis: Do the Long-Term Results Parallel 
the Acute Gains? 1114.63 l 531A 
Pulmonary artery 
Angiogenic Growth Factor Levels Are Abnormal in 
Patients With Severe Pulmonary Hypertension 
1113.53*286A 
Contrast Echocardiography Versus Cardiac 
~Catheteriza+~ for Detection of Pulmonary 
Arteriovenous Malformations 1124-165.5078 
Stenting of Severely Hypoplastic Pulmonary Arteries 
in Pulmonary Ah-&a With Ventricular Septal 
Defect Following Early Repair 903-l l 519A 
Twenty-Year Experience With Anomalous Left 
Coronarv Ark-xv Arising From the Pulmonani 
Artery ilO3.165.503ii 
Puhnonarv circulation 
Angiog&ic Growth Factor Levels Are Abnormal in 
Patients With Severe Pulmonary Hypertension 
1113.53*286A 
Gene Expression of C-Type Natriuretic Peptide Is 
Induced by Heart Failure and Markedly 
Suppressed by Aging in the Mouse Lung 
12.06-147*235A 
Increased Endothelin-1 Concentrations in Response 
to Pulmonary Hypertension in the Newborn 
Lamb 1113-50*285A 
Orally Active Prostacyclin Analogue Improves 
Exercise Capacity in Patients With Primary or 
Thromboembolic Pulmonary Hypertension 
1113-55.286A 
Preserved Long-Term Efficacy of Iloprost Inhalation 
Therapy Over Two Years in Patients With 
Primary Pulmonary Hypertension 1113-52 l 
286A 
Pulmonary Vascular Response to Priming With 
Inhaled Nitric Oxide During Hyperoxia, 
Normoxia, and Hypoxia 894-3 l 322A 
The Contribution of Endothelin to Pulmonary 
Vascular Tone Under Normoxic and Hypoxic 
Conditions X68-3 l 290A 
Pulmonary edema 
High Prevalence of Patent Foreman Ovale at an 
Altitude of 4559 Meters in Subjects Susceptible 
to Height Altitude Pulmonary Edema 894-l l 
322A 
Is Flash Pulmonary Edema Due to Diastolic 
Dysfunction or Transient Systolic Dysfunction? 
1027-144.1638 
Pulmonary embolism 
Is Doppler Echocardiography Useful in the 
Diagnostic Work-Up of Pulmonary Embolism? 
1180-46.319A 
Pulmonary function 
An Exaggerated Ventilatory Response to Exercise Is 
Related to Abnormal Exercise Hemodynamics 
in Patients With Chronic Heart Failure 
1095.147.187A 
Relationship Between Reduced Pulmonary Diffusion 
Capacity and Excessive Ventilatory Response to 
Exercise in Patients With Chronic Heat Failure 
827-l l 181A 
Pulmonary heart disease 
Development of a Noninvasive Ultrasound Color 
M-Mode Means of Estimating Pulmonary 
Vascular Resistance in Pediatric Pulmonary 
Hypertension 1124-164 l 506A 
Impact of Prostacyclin on Five-Year Survival for 
Preliminary Pulmonary Hypertension 894-2. 
322A 
Long-Term Effects of Prostacyclin on 
Hemodynamics in Primary Pulmonary 
Hypertension: Are Continued Dose Increases 
Necessary 1113-56 l 287A 
Superiority of Mixed ET A/B Over Specific ETA 
Antagonist in Treatment of Pulmonary 
Hypertension and Right Ventricular 
Hypertrophy in the Monocrotaline Rat Model 
894.4 l 323A 
The Response to Inhaled Nitric Oxide in Adult 
Patients With Primary Pulmonary Hypertension 
and Pulmonary Hypertension From Secondary 
Causes 1113-54 l 286A 
Pulmonary valve 
Assessment of Ventricular Function and Pulmonary 
Regurgitation After Total Repair of Tetralogy of 
Fallot During Supine Physical Exercise by 
Ultra-Fast Magnetic Resonance Imaging 859-5 
l 509A 
Improved Efficacy and Long-Term Outcome of 
Balloon Valvuloplasty of Critical Pulmonary 
Stenosis in Newborns 903.4*519A 
Pulmonary Valve Replacement in Adults Late After 
Repair of Tetralogy of Fall&: Are We Operating 
on Too Late? 804-3 l 509A 
The Fate of Clinic Arrhythmia Following Pulmonary 
Valve Replacement After Repair of Tetralogy of 
Fallot: A Multicenter Study 1007.174*512A 
VenPro Contegra Pulmonary Valved Conduit: 
Preliminary Results From a Multicenter, 
European Trial 1103-163 l 503A 
Purkinje fibers 
Transcription Factors in the Purkinje Fibers 
1186-67 l 147A 
QT interval 
An Increase in Corrected QT Dispersion on Exercise 
Predicts Sudden Death in Patients With Chronic 
Heart Failure: A Prospective Study 1095.148 l 
187A 
Beat-to-Beat QT Variability Identifies Myocardial 
Ischemia 1031.71 l lOlA 
Cardioversion of Atrial Fibrillation or Flutter in 
Patients Receiving Combination Ibutilide and 
Amiodarone Therapy 902-2 l 153A 
Comparison Between T-Wave Altemans, Late 
Potentials, QTc Dispersion, and Ejection 
Fraction in Predicting Arrhythmic Events After 
Acute Myocardial Infarction: A Prospective 
Shtdy 1076-61 l 114A 
Comparison of Repolarization Abnormality During 
Exercise in Dilated Cardiomyopathy and 
Hypertrophic Cardiomyopathy 1076.600 114A 
Determinant of QT Dispersion in Patients With 
Hypertmpbic Cardiomyopathy 1099-620 122A 
Does Dispersion of Repolarization Depend on 
Cmiiac Cycle Length and Should It Be 
Rate-Corrected? Observations in 1096 Healthy 
Subjects 1166-600 143A 
Effect of Selective and Nonselective Beta-Receptor 
Antagonism on QT Interval Response to 
Exercise and Recovery in LQTl Type of Long 
QT Syndrome 1045-41 l 253A 
Lipophilic Beta-Blockers Exert Greater Effect on 
Dynamic Ventricular Repolarization Than 
Hydmpilic Ones 1166-59 l 143A 
Prognostic Significance of QTc Dispersion in 
Patients After Myocardial Infarction With and 
Without Late Potential, Ventricular Tachycardia, 
and Sudden Cardiac Death 1099-600 121A 
Prolonged QT Interval and QT Dispersion Induced 
by Coronary Rotational Atherectomy 1197-800 
88A 
QT Dispersion Should Not Be Corrected for Heart 
Rate in Normal Subjects and Patients With 
Ventricular Tachycardia 1166.61 l 143A 
QT Dynamicity, Influence of the Autonomic 
Nervous System and the Risk of Major 
JACC February 2000 
Arrhytbmic Events in Idiopathic Dilated 
Cardiomyopathy 1099-61 l 121A 
QT syndrome-inherited 
Antimalarial Drug Halofantine Induces Ventricular 
Tachycadia in Patients With Long QT 
Syndrome Caused by a Mutation of the Cardiac 
Sodium Channel Gene SCN5A 1066-49.2608 
Clinical Aspects of LQTS in Probands of Parents 
With and Without Clinical Manifestations of 
LQTS 1142.59 l 136A 
Effect of Selective and Nonselective Beta-Receptor 
Antagonism on QT Interval Response to 
Exercise and Recovery in LQTl Type of Long 
QT. Syndrome 1045.41 l 253A 
Heti Rate Variability Measures Are Equivalent in 
Genetically Affected and Unaffected Members 
of a Family With the Long QT Syndrome Due to 
a HERG Mutation 1142.60 l 137A 
Index of Morphological Dissimilarity: A Novel 
Approach to Quantify Spatial Heterogeneity of 
Ventricular Repoltization Morphology 
1142.62 l 137A 
Microvolt Level T-Wave Altemans Are Prevalent in 
a Family With Congenital Long QT Syndrome 
Due to a HERG Mutation 1142-61 l 137A 
Swimming Is a Gene-Specific Arrhytbmogenic 
Trigger for Inherited Long QT Syndrome 910-2 
l 160A 
Visible T-Wave Altemans in Carriers of LQTl, 
LQT2, and LQT3 Gene Mutations 910-l l 16OA 
Quality improvement 
An Emergency Department Chest Pain Center 
Impacts the Disposition of All Patients With 
Acute Chest Pain: A Two-Year Registry 
1216-13.5598 
B-Blocker Use in Heart Failure: Which Patient 
Characteristics Determine Physician Use of 
B-Blockers in Community Practice? 1162.154* 
217A 
Comparison of Point-of-Care and Standard 
Reference Laboratory PT/lNR Testing in 
Patients on Routine Warfarin Therapy: An 
Engineering Work Process Flow Study 1216-14 
l 559A 
Computer-Based Information Prompts Modify 
Physician Ordering 1505-l l 560A 
Disease Management Program Improves Care of 
Patients Hospitalized With Congestive Heart 
Failure 1171.16*556A 
Effect of End-of-Month Admission on Discharge 
Quality Parameters for Acute Myocardial 
Infarction Patients 1104-14.5478 
Effect of End-of-Month Admission on Length of 
Stay for Acute Myocardial Infarction Patients 
105X-14.5438 
Enhancing Implementation of Critical Care 
Pathways for Heart Failure: Lessons Learned 
From a Multicenter Trial 1003-174.5428 
Impact of Quality Improvement Initiative on 
Long-Term Compliance to Key Quality of Care 
Indicators After Acute Myocardial Infarction 
1171.13*555A 
Is the Quality of Care in Octogenarians With Acute 
Myowdial Infarction Optimal? 1147-15 l 554A 
It’s Quality Not Quantity That Counts! Operator 
Performance in Coronary Angioplasty: The 
Utility of One-Month Outcomes 835-4.318 
Promoting Best Physician Practices: The Canadian 
Congestive Heart Failure Clinics Network 
1207-15582378 
Reduction in Mortality With Aggressive Multiple 
Risk Factor Interventions in Younger Patients 
With Symptomatic Coronary Artery Disease 
1171.15*556A 
.The Cost Benefit of Implementing a Heart Failure 
Program 1207.156*237A 
The Diagnostic Evaluation of Newly Discovered 
Heart Failure: Opportunities for Improvement 
From the R.E.A.C.H. Study 1207.158*237A 
Very Low Dose Heparin (30 UI/kg) for Routine 
Coronary Angioplasty With Immediate 6F 
Sheath Ablation 1107.78 l 42A 
KEY: Abstract title, Session-abstract number l page number 
JACC February 2000 
Quality of life 
A Prospective Study of Changes in the,Quality of 
Life of Patients Following Aortic Valve 
Replacement 83 i-3 l 5298 
Academic Detailing and Provider Feedback Improve 
Implementation of the Heart Failure Guidelines 
by Primary Care Providers 1003.176*542A 
Coronary Bypass Surgery in Women: A Long-Term 
Comparative Study of Quality of Life Following 
Bilateral Internal Mammary Artery Grafting in 
Men and Women 1017-1270340A 
Defibrillator Shocks and Self-Perceived Quality of 
Life in the Antiarrhythmics Versus Implanted 
Defibrillators (AVID) Trial X91-4* 153A 
Depression in Heart Failure: Clinical Characteristics 
and Impact on Outcomes 1072.1530 178A 
Determinants of Cognitive Functioning Before and 
After Coronary Artery Bypass Graft 1017-141 l 
342A 
Functional Capacity Following Emergency 
Revascu1arization in Cardiogenic Shock 
Patients: Preliminary Results From the SHOCK 
Trial 873-2 0 385A 
Impact of Managed Care Heart Failure Support 
Service on Quality of Life and Resource 
Utilization 1207-157-2378 
Impact of New Onset Atria1 Fibrillation on Quality 
of Life: Initial Findings of a Prospective, 
Multicenter Registly 1209.70~ 155A 
Predictors of Outcome After Transmyocardial 
Revascularization 1017.140*342A 
Quality of Life After Coronary Artery Bypass Graft 
Surgery: Predicting Mental Health Status 
1081.14.544A 
Quality of Life in Unstable Coronaw Artery 
Disease-A Comparison of Early Invasive Versus 
Noninvasive Treatment: Six-Month Follow-Up 
From the FRISC II Invasive Trial 837.403578 
Quality of Life in Women With Chest Pain: The 
NHLBI-Sponsored WISE Study 1147.140 
554A 
Quality of Life Measures Predict Mortality and 
Hospitalization in Patients With Advanced Heart 
Failure: Insights From the EPICAL Study 
1207.159.238A 
Quality of Life With End-Stage Coronary Artery 
Disease 1147.16*554A 
The Kansas City Cardiomyopathy Questionnaire 
Predicts Heart Failure Admissions and Death 
1003.173*541A 
Radiation 
A New Phosphorus-32 Balloon Catheter Device for 
Intracoronary Brachytherapy: Results From the 
Porcine Stent Model X54-6*51A 
A Novel Gamma Emitting Radioactive Stent 
Constructed by Targeted Radioimmunotherapy 
896-6 * 83A 
A Randomized. Controlled Trial of Groin Shielding 
During Catheter Ablation and Cardiac 
Catheterization 1129-79*54A 
Absence of Late Coronary Occlusions After Beta 
Radiation Following a Modified Antiplatelet 
Regimen in 120 Consecutive Patients 101X-81 l 
2A 
Angiographic and Histologic Effect of Endovascular 
Irradiation on Normal Pig Coronary Arteries at 
Six Months 1065-l 18*25A 
Angiography Reliably Differentiates In-Stent Versus 
Stent Edge Restenosis: An IVUS Validation 
Study From the lsostent R&en&s Registry 
1021.116*7A 
Are the Intravascular Ultrasound Findings After 
Brachytherapy Treatment of In-Stent Restenosis 
Reproducible? 1021.114*6A 
Brachytherapy Induces Positive Vascular 
Remodeling Using Self-Expanding Stents 
1063.llO*ZlA 
Combined Assessment of Myocardial Perfusion and 
Left Ventricular Function for the Evaluation of 
Patients With Breast Cancer Undergoing 
Radiation Therapy 1191.27 *481A 
Compassionate Use of Intracoronary Gamma 
Radiation Therapy for Patients With Refractory 
In-Stent Restenosis 896-l -82A 
Cost-Effectiveness of Emerging Antiproliferative 
Therapies That Reduce Restenosis After 
Coronary Angioplasty 853.2*550A 
Does “Stent-On-Stent” for In-Stent Restenosis 
Exaggerate Intimal Hyperplasia? A Volumetric 
Intravascular Ultrasound Analysis 897-5 l 84A 
Dosimetry of the RDX Cylindrical Shell P-32 
Balloon Source 1018.78.1A 
Economic Assessment of Gamma-Brachytherapy for 
Treatment of In-Stent R&en&s: Results From 
the Randomized GAMMA-l Trial 896-4 -82A 
Effect of Gamma-Irradiation on Hydrated Collagen 
Gel Seeded With Arterial Smooth Muscle Cells 
X26-3 l 28A 
Effects of Intracoronary Radiation on Healing 
Dissection and Thrombosis Following Balloon 
Injury in the Porcine Model 1063-109-208 
Gamma Radiation Versus Placebo in Focal Versus 
Diffuse In-Stent Restenosis: The Length Makes 
the Difference 896-Z l 82A 
Geographical Miss: A Cause of Treatment Failure in 
Radio-Oncology Applied to Intracoronary 
Radiotherapy 854-3 l 50A 
How Does Brachytherapy Affect Coronary Artery 
Vasa Vasormn and Vessel Wall 
Neovascularization After Angioplasty? 
Three-Dimensional Analysis by Microscopic 
ComputedTomography 11%114971A 
Intracoronary Brachytherapy for In-Stent Restenosis 
With a 188Re Liquid-Filled Balloon System: 
Results From the Pilot Phase of a Randomized 
Trial 1018-79*2A 
Intracoronary Radiation Therapy With Liquid 
Rhenium-186: The Radio&h Trial 101X-77* 
1A 
Intravascular Brachytherapy With Rhenium-l 88 
Balloon: RADIANT Pilot Study 1018.82*2A 
Long-Term Morphological Effect of Post 
Angioplasty b-Radiation: An IVUS Study 
1018-76*1A 
Low Versus High Dose Radiation Has Divergent 
Effects on Special Mouth Care Migratory and 
Adhesive Behavior 826-2 l 28A 
New Dose-Effectiveness Model for Intracoronary 
Brachytherapy Predicts External Beam 
Irradiation Results in the Pig Model 1018.830 
2A 
One-Year Follow-Up After Intravascular Radiation 
Therapy Following Balloon Angioplasty of 
Narrowed Femoral-Popliteal Arteries: Results of 
the PARIS Feasibility Clinical Trial 854.5051A 
One-Year Follow-Up of Endovascular Irradiation in 
Pig Coronary Arteries 826-l l 27A 
Onset of Cardiac Symptoms After Mediastinal 
Irradiation an Ominous Sign Due to Frequently 
Combined Disease of Coronary Arteries, Heart 
Valves, Pericardium, and Conduction System 
1184.155*225A 
Patient Radiation Exposure Related to Complexity 
of Coronary Interventional Procedures 1129-80 
*54A 
Probucol and Brachytherapy as a Combined Strategy 
to Prevent Restenosis After Angioplasty of the 
Lower Limb Arteries Percutaneous 
Transluminal Angioplasty (PTA): A Valid 
Model to Prevent Restenosis After Percutaneous 
Transluminal Coronary Angioplasty? 1154-85 l 
67A 
Prolonged Antiplatelet Therapy Prevents Late 
Thrombosis After Radiation Therapy in Patients 
With In-Stent Restenosis 1022-S3*243A 
Safety and Efficacy of Manual Stepping and 
Overlapping of a b-Emitter for Diffuse In-Stent 
Restenosis Lesions 1063-l 13*21A 
Scanning-Beam Digital X-Ray System Significantly 
Reduces X-Ray Exposure for Cardiac 
Angiography 1129-S 1*54A 
Single-Session Radiation of Two Coronary Arteries 
for Prevention of Restenosis in De-Now 
Lesions: Safety Using a Six-Month Protocol of 
Clopidogrel 854-i l 49A 
Six-Month Angiographic Results of Single 32P 
Radioactive B-Emitting Stents With an Initial 
Activity Level Up to 21 uCi Implanted in 
SUBJECT INDEX 683A 
Patients With Coronary Artery Disease 896-3 * 
82A 
Six-Month Follow-Up of Endovascular B-Irradiation 
in Balloon-Injured Pig Coronary Arteries 
1110-l 11 l 48A 
Stent and Stent-Edge Remodeling After 
Conventional and Radioactive Stent 
Implantation 1063.114*22A 
The Effect of b-Radiation Therapy on Stented in 
Coronary Segments and Adjacent Stem Edges: 
A Three-Dimensional Intravascular Ultrasound 
Interpretation 896-5 l 83A 
The Effect of Catheter-Based b-Radiotherapy on 
Coronary Artery Remodeling and Plaque 
Formation After Percutaneous Interventions 
854-2 l 50A 
The Gamma II Trial of Localized Radiation Therapy 
to Inhibit Restenosis After Coronary Stenting 
854.4.5OA 
Tungsten-l 88 Radioactive Coil Delivered 
Intracoronary Inhibits Neointima Formation 
After Balloon and Stent Injury of Porcine 
Coronary Arteries 1063-I 11*21A 
Two-Year Follow-Up-After Intracoronary Gamma 
Radiation Therapy for In-Stent Restenosis: 
Results From a Randomized Clinical Trial 83-4 
l 10A 
Two-Year Follow-Up After Post-PTCA b-Radiation: 
A Quantitative Coronary Angiography Analysis 
1018.75.1A 
Vascular Remodeling Following Intracoronary 
Radiation in the Porcine Model 1131-l 17*58A 
Vessel Wall Distance Variation Between Centered 
and Non-Centered Radiation: Cross-Sectional 
and Longitudinal Analysis by Intravascular 
Ultrasound 1021.115*7A 
Radioisotopes 
IRFDG-PET, 201TI-SPECT Findings and 
Histopathological Characteristics of Syndrome 
X 1191.31 l 482A 
A New Phosphorus-32 Balloon Catheter Device for 
Intracoronary Brachytherapy: Results From the 
Porcine Stent Model 854.6*51A 
A Novel Gamma Emitting Radioactive Stent 
Constructed by Targeted Radioimmunotherapy 
896-6 l 83A 
Cardiac Sympathetic Innervation Abnormalities in 
Patients Paced Chronically From the Right 
Ventricular Apex: An I123 
Metaiobobentozylquanidine (MIBG) Cardiac 
Scintigraphic Study 1165.99 l 142A 
Coronsuy Artery Bypass Versus Coronary 
Angioplasty: Prognostic Impact in Patients With 
Three Vessel Disease, Left Ventricular 
Dysfunction, and Maintained Myocardial 
Viability 1038.1299345A 
Diagnostic Value of Thallium 201 Myocardial 
Perfusion in Pexnanent Paced Patients 1075.98 
l 113A 
Dosimetry of the RDX Cylindrical Shell P-32 
Balloon Source 1018-7X* 1A 
Enhanced Diagnostic Accuracy to Predict 
Improvement of Left Ventricular Ejection 
Fraction Post-Revascularization by Sequential 
Thallium-201 Imaging and Dobutamine 
Echocardiography 1079-34 l 4298 
Exercise Perfusion Scintigraphy Positivity Is 
Associated With Peripheral Vascular Endothelial 
Dysfunction in Patients With Normal Coronary 
Arteries 1191.29.482A 
In Viva Noninvasive Serial Monitoring of 
Atherosclerotic Progression and Regression 
With FDG-PET in a Rabbit Model 91 l-4*493A 
Is Thallium Scintigraphy a Reliable Test in 
Hypertensive African-Americans? 1204.19* 
332A 
New Dose-Effectiveness Model for Intracoronary 
Brachytherapy Predicts External Beam 
Irradiation Results in the Pig Model 1018.83* 
2A 
Oxidative Metabolism, Glucose Utilization, 
Perfusion, and Contractile Reserve in Patients 
With Chronic Ischemic Left Ventricular 
Dysfunction 1079.29 0 428A 
KEY: Abstract title. Session-abstract number l page number 
684A SUBJECT INDEX 
Safety and Efficacy of Manual Stepping and 
Overlapping of a b-Emitter for Diffuse In-Stent 
Restenosis Lesions 1063.113*21A 
Radionucfide imaging 
13N-Ammonia Myocardial Uptake but Not Blood 
Flow Identifies Regions With Positive 
Contractile Reserve to Low-Dose Dobutamine 
1079.33*429A 
IIFDG-PET, 20lTI-SPECT Findings and 
Histopathological Characteristics of Syndrome 
X 1191.31*482A 
ACC/AHA Guidelines for Coronary Angiography: 
Analysis of Patients With Nonsignificant of 
Coronary Artery Disease 1197-75 l 86A 
Accuracy and Feasibility of Technetimw99m 
Tetrofosmin Myocardial Perfusion Imaging to 
Detect Spontaneous Recanalization in Patients 
With Acute Anterior Myocardial Infarction 
1079-37 l 430A 
An Emergency Department Chest Pain Center 
Impacts the Disposition of All Patients With 
Acute Chest Pain: A Two-Year Registry 
1216-13.5598 
Angiographic No-Reflow During Angioplasty 
Portends Impaired Six-Week Perfusion and 
Functional Recovery: A Dipyridamole Tc99m 
Sestamibi Gated SPECT Imaging Study 
1083.141.364A 
Assessment of Ejection Fraction by 201-Thallium 
Gated Tomography in Extended Myocardial 
Infarction: Repeatability in a 
Rest-Redistribution Study and Accuracy Versus 
Planar Angiography 1191.28.4818 
Assessment of Left Ventricular Function by 
Real-Time Three-Dimensional 
Echocardiography Compared With Conventional 
Noninvasive Methods 1168.26 l 4698 
Cardiac Mortality of Patients With Left 
Bundle-Branch Block Following Rest 
201Tl/Stress 99mTc-Sestamibi Dual-Isotope 
Myocardial Perfusion 8%6.4568 
Changes in Absolute Myocardial Blood Flow With 
Beta-Blocker Therapy in Heart Failure 1191-60 
480A 
Circumferential Profile Analysis for Quantitative 
Comparison of Simultaneous Pulse Inversion 
and SPECT Dipyridamole Stress Studies of 
Myocardial Perfusion 1169-39*472A 
Clinical and Economic Analysis of Myocardial 
Perfusion SPECT Scintigraphy in Patients With 
LBBB X84-5 l 474A 
Clinical Performance of Simultaneous Acquisition of 
Rest Tl-201 and Post Stress Tc-99m Sestamibi 
Electrocardiogram-Gated SPECT: Comparison 
With Dual Sequential Studies 884.204738 
Combined Assessment of Myocardial Perfusion and 
Left Ventricular Function for the Evaluation of 
Patients With Breast Cancer Undergoing 
Radiation Therapy 1191-27.4818 
Comparison of Left Ventricular Functional Analysis 
in Heart Failure by Echocardiography, 
Radionuclide Ventriculography, and Magnetic 
Resonance: Implications for Research and 
Clinical Practice 107X-25 04278 
Comparison of the Prognostic Value of Cardiac 
I-123 Metaiodobenaylguanidine and 
Neurohumoral Factors in Patients With 
Congestive Heart Failure 1191-7 l 480A 
Coronary Artery Constriction: A Mechanism for 
Abnormal Nuclear Perfusion Scans 1061.1320 
353A 
Correlation of Myocardial Perfusion and Wall 
Thickening Abnormalities Detected With 
Intravenous Optison and Low Mechanical Index 
Harmonic Imaging With Radionuclide SPECT 
During Exercise Stress 1055.28*422A 
Description of a Cost Analysis Model for 
Performance of Myocardial Perfusion SPECT 
Imaging 1034.32.4178 
Detection of Platelet-Rich Coronary Thrombi Using 
a Novel Radionuclide Imaging Agent 
(Technetium 99m-DMP-444) in a Canine 
Model: Interaction With Abciximab 911-20 
4928 
Detection of Residual Coronzy Stenoses by 
Assessing Coronary Flow Reserve Using 
99mTc-N-NOET Vasodilator Stress Imaging 
Early After Coronary Reperfusion in a Canine 
Model of Infarction 91 l-5 l 493A 
Determination of Regional Myocardial Blood Flow 
by Magnetic Resonance Imaging in Comparison 
to Positron Emission Tomography 904-3 l 484A 
Diagnostic Accuracy of Simultaneous Acquisition 
Dual Isotope (Rest Tl-ZOl/Stress Sestamibi) 
Electrocardiogram-Gated Myocardial Perfusion 
SPECT 1034.35 l 417A 
Diagnostic Value of Thallium 201 Myocardial 
Perfusion in Permanent Paced Patients 1075.98 ’ 
l 113A 
Does Cardiologist Subspecialization Affect the 
Cost-Effective Management of Acute 
Myocardial Infarction Patients Undergoing 
Pm-Discharge SPECT? 884.604748 
Exercise Thallium Testing Predicts Significant 
Coronary Disease on Augiography in 
Asymptomatic Siblings of Persons With 
Premature Heart Disease 1006-174.4478 
Hemodynamic Determinants of Exercise-Induced 
Hypotension in Hypertrophic Cardiomyopathy 
1096-157.1898 
Heterogeneous Myowdial Sympathetic Innervation 
Influences on Myocardial Repoltization in 
German Shepherd Dogs With Inherited 
Ventricular Arrhythmia 1210.99*15SA 
High Diagnostic Accuracy of Parametric Magnetic 
Resonance Perfusion Maps for the Detection of 
Coronary Artery Disease in Comparison With 
Positron Emission Tomography and X-Ray 
Coronary Angiography 904-2*484A 
Is Dobutamine Superior to Dipyridamole in 
Evaluating the Severity and Reversibility of 
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Imaging in Patients With Coronaw Artery 
Disease? 884-3 l 473A 
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1061-129*353A 
Judicious Use of Radionuclide Myocardial Perfusion 
Imaging in an Emergency Department Chest 
Pain Center Optimizes the Triage of Patients 
With Chest Pain X84-4*474A 
Left Ventricular Ejection Fraction Following Acute 
Myocardial Infarction: Echo, MUGA and 
MRI-Preliminary Results From the MARRYEL 
Study X06-2 l 464A 
Myocardial Innervation After Percutaneous 
Myocardial Laser Revascularization 1196.103 l 
408A 
Myocardial Salvage in Patients With Non-ST 
Elevation Myocardial Infarction: Results Using 
Technetium-99m Sestamibi Myocardial 
Perfusion Imaging 1079.36*430A 
New Assessment of Systemic Sympathetic Activity 
With Skeletal Muscle 123 
I-Metaiodobenzylguanidine (MIBG) 
Scintigraphy in Patients of Chronic Heart 
Failure 1191-8*480A 
Nitrate-Enhanced Tc-99m Sestamibi Single Photon 
Emission Computed Tomography Is Comparable 
to Tl-201 for Detection of Myocaidial Viability 
and for Predicting Outcome in Patients With 
Heart Failure 1006.173 l 447A 
Noninvasive Detection of Transplant Vasculopathy 
Using I&urn-l 11 Tagged 2D3 Antibody in a 
Swine Model 1185-123*227A 
Noninvasive Imaging of Atherosclerotic Plaques 
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Outcome Validation of a Stepwise Visual Approach 
for Distinction of Attenuation Artifacts From 
Perfusion Defects on SPECT Perfusion Imaging 
1034-36.417A 
Prediction of Abnormal Coronary Flow Reserve 
With Electron Beam Computed Tomography for 
Coronary Calcification 904.4*484A 
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Prevalence and Significance of Exercise-Induced 
Left Ventricular Dysfunction Determined From 
Electrocardiogram-Gated SPECT Myocardial 
Perfusion Scintigraphy 858.4*455A 
Prognostic Significance of Rest 20lTl/Stress 
99mTc-Sestamibi Dual-Isotope Myocardial 
Perfusion SPECT in Very Elderly Patients 
858-3 l 4558 
Prognostic Significance of Transient Ischemic 
Dilation of the Left Ventricle in Normal 
Dual-Isotope Myocardial Perfusion SPECT 
1034-29*416A 
Prognostic value of stress 
Technetium-99m-Sestamibi Myocardial 
Perfusion Imaging in Asymptomatic Diabetics 
858-2*454A 
PrognoxTM (99mTechnetium-HL91) Can Identify 
Hypoxic, Viable Regions in 
Ischemic-Rep&used Myocardium With Infarct 
911.6*493A 
Quantitative Myocardial Perfusion Studies: 
Comparison of Pulse Inversion Technique, 
Harmonic Power Doppler, and Second 
Harmonic Imaging With Simultaneous 
Technetium SPECT Studies 1032.4.4138 
Reduction in Stress Myocardial Ischemia by Basic 
Fibroblast Growth Factor (rFGF-2) in Severe 
Ischemic Heart Disease 879.4974A 
Regional Left Ventricular Response to Low-Dose 
Dobutamine Infusion During ECG-Gated 
Tc-99m Sestamibi Single Photon Emission 
Computed Tomography Image Acquisition 
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With 1006-167*446A 
Relationship Between Exercise Capacity and 
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Determined With 123 
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l 174A 
Relationship Between T Wave Altemans and 
Cardiac Sympathetic Nervous Dysfunction in 
Patients With Nonischemic Heart Disease 
1076-62.1148 
Reversible Perfusion Defects on 99mTc Sestamibi 
Imaging Are Not Due to Changes in Myocanlial 
Blood Flow, but to Changes in Myocardial 
Blood Volume 884- 1 l 4738 
Reversible Perfusion Defects on Thallium-201 
SPECT Scintigraphy Early After Coronary 
Stenting Occur Frequently and Do Not Predict 
Late Target Lesion Revascularization 1152-81 l 
65A 
Strategies for Selecting Patients for Stress Testing to 
Avoid Unnecessary Myocardial Imaging 
1034.33*417A 
Stress Modality for Myocardial Perfusion Imaging in 
Patients With Left Bundle Branch Block: 
Exercise or Vasodilator Stress? 1034-37 l 418A 
Stress SPECT Myocardial Perfusion Imaging for 
Predicting Future Cardiac Events in Diabetic 
Women: Confirmation of Gender and 
Myocardial Ischemia Interaction 1016-1020 
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Stress Technetium-99m Sestamibi Gated SPECT 
Lqaging Can Differentiate Nonischemic, 
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The Extent of Ischemic and Nonischemic Viable 
Tissue Predicts the Degree of Recovery of Left 
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1079-31*428A 
The Impact of Direct Percutaneous Myocardial 
Laser Revascularization (Biosense DMR) on 
Myocardial Perfusion and Function as Assessed 
by Gated SPECT Myocardial Perfusion 
Imaging: Results of the Phase I Multicenter 
DMR Trial 871-l 03838 
Usefulness of Iodine 123 Metaidobenzylguanidine 
Scintigmphy in Assessing Sympathetic 
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Activation in Patients With Mild Heart Failure 
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Utility of Dipyridamole Tc-99m Sestamibi SPECT 
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Adjunctive Infusion of a Novel P21-Receptor 
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and One-Year Outcomes 1129.75.538 
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Uncontrolled Hypertension 1154-89 l 68A 
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11X1-21*321A 
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Renal Artery Stenosis 1204.18.3328 
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Effect 1045.18.253A 
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1049-154*171A 
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Insufficiency and Diabetes Mellitus on Late 
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The Effect of Sibrtiban, an Oral llb/lIIa Platelet 
Receptor Antagonist, on Platelet Function in 
Patients With Chronic Renal Failure 1158.IO* 
308A 
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With Omapahilat in Hypertension 1045.170 
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Reperfusion 
A Randomized Trial of Thrombolysis Versus 
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AIR PAM1 Trial 864-3 -376A 
Beyond TIMI- Flow: The Importance of Restored 
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900.4 l 403A 
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Syndrome Family Members 1166-62*144A 
Comparison of a 60 Versus 90 Minute Measurement 
of ST-Segment Resolution After Thrornbolytic 
Therapy 1173-136*397A 
Diabetes Mellitus in Cardiogenic Shock 
Complicating Acute Myocardial Infarction: 
Report From the SHOCK Registry I1 16.1200 
196A 
Effects of Primary Percutaneous Transluminal 
Coronary Angioplasty on Time Course of Heart 
Rate Variability in Acute Myocardial Infarction: 
Early Versus Late Reperfusion 1173.134*397A 
Noninvasive Extraco~~oreal Venous Thrombolysis 
With Shock Waves 1180.48*319A 
Noninvasive Transthoracic Low Frequency 
Ultrasound Greatly Augments Thrombolysis in 
a Canine Model of Acute Myocardial Infarction 
1195-128.407A 
Platelet Glycoprotein IIb/TIIa Receptor Blockade 
After Failed Thrombolysis Is Associated With 
Risk of Bleeding 1106-101 l 37lA 
Postischemic Apoptosis and Functional Recovery 
After Angiotensin II Type 1 Receptor Blockade 
in the Isolated Working Rat Heart 1172-I 08 l 
395A 
Relative Prognostic Importance of Preserved 
Antegrade Coronary Blood Flow Before 
Compared to After Angioplasty in Patients 
Undergoing Primary Percutaneous Transluminal 
Coronary Angioplasty 1083-l 380 363A 
Repetiusion Therapy Among Paded Patients With 
Acute Myocardial Infarction 1173.131 l 396A 
Roles of Apoptosis and Cytokine Families on the 
Reperfusion Injury in the Patient With Acute 
Myocardial Infarction 1049.159*173A 
Stent PAMI: Twelve-Month Results and Predictors 
of Mortality 900. I l 402A 
The Relationship of Primary Angioplasty Volume 
and Survival Among Interventional Hospitals in 
the National Registry of Myocardial Infarction 
1062.83*20A 
Time Course and Prognostic Implications of 
QT-Interval Dynamicity and Variability After 
Successful Reperfusion by Primary 
Percutaneous Transluminal Coronary 
Angioplasty 1173.133*396A 
Tirofiban and Heparin Are Synergistic With Low 
Frequency High Intensity Ultrasound for In 
Vitro Blood Clot Dissolution 1106-1060372A 
What Should Be Done Acutely for Patients With 
Noninvasive Evidence of Spontaneous 
Reperfusion in Acute Myocardial Infarction? 
X64-5 l 3778 
Repolarization 
Beat-to-Beat QT Variability Identifies Myocardial 
Ischemia 1031-71 l 1OlA 
Comparison of Repolarization Abnormality During 
Exercise in Dilated Cardiomyopathy and 
Hypertrophic Cardiomyopathy 1076.600 114A 
Determinant of QT Dispersion in Patients With 
Hypertrophic Cardiomyopathy 1099-620 122A 
Does Dispersion of Repolarization Depend on 
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Pi-oarrhythmic Potential 1030.94 l 97A 
Index of Morphological Dissimilarity: A Novel 
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1142.62 l 137A 
Lipophilic Beta-Blockers Exert Greater Effect on 
Dynamic Ventricular Repolarization Than 
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Pure Iridium Metal Microelectrode for 
Transmembrane Potential Recording in Isolated 
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QT Dispersion: Repoltization Heterogeneity or 
Abnormality? The Strong Heart Study 1099.59 
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Cost-Effectiveness of Emerging Antiproliferative 
Therapies That Reduce Restenosis After 
Coronary Angioplasty 853-2*550A 
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826-3 l 28A 
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Injury in the Porcine Model 1063-109 l 20A 
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Extent of Neointima Predicts Subsequent Neointimal 
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Muscle Cell Proliferation In Vitro and Prevents 
Neointimal Formation In Viva 1042-l 13 l 16A 
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Neointimal Proliferation After Porcine Coronary 
Overstretch X70-6.618 
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